<!DOCTYPE html><html lang="en" data-critters-container><head><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <meta charset="utf-8">
  <title>MedicineSearch</title>
  <base href="/MedicineSearch">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="icon" type="image/x-icon" href="favicon.ico">
  <style>@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOlCnqEu92Fr1MmSU5fCRc4EsA.woff2) format('woff2');unicode-range:U+0460-052F, U+1C80-1C8A, U+20B4, U+2DE0-2DFF, U+A640-A69F, U+FE2E-FE2F;}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOlCnqEu92Fr1MmSU5fABc4EsA.woff2) format('woff2');unicode-range:U+0301, U+0400-045F, U+0490-0491, U+04B0-04B1, U+2116;}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOlCnqEu92Fr1MmSU5fCBc4EsA.woff2) format('woff2');unicode-range:U+1F00-1FFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOlCnqEu92Fr1MmSU5fBxc4EsA.woff2) format('woff2');unicode-range:U+0370-0377, U+037A-037F, U+0384-038A, U+038C, U+038E-03A1, U+03A3-03FF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOlCnqEu92Fr1MmSU5fCxc4EsA.woff2) format('woff2');unicode-range:U+0102-0103, U+0110-0111, U+0128-0129, U+0168-0169, U+01A0-01A1, U+01AF-01B0, U+0300-0301, U+0303-0304, U+0308-0309, U+0323, U+0329, U+1EA0-1EF9, U+20AB;}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOlCnqEu92Fr1MmSU5fChc4EsA.woff2) format('woff2');unicode-range:U+0100-02BA, U+02BD-02C5, U+02C7-02CC, U+02CE-02D7, U+02DD-02FF, U+0304, U+0308, U+0329, U+1D00-1DBF, U+1E00-1E9F, U+1EF2-1EFF, U+2020, U+20A0-20AB, U+20AD-20C0, U+2113, U+2C60-2C7F, U+A720-A7FF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:300;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOlCnqEu92Fr1MmSU5fBBc4.woff2) format('woff2');unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOmCnqEu92Fr1Mu72xKOzY.woff2) format('woff2');unicode-range:U+0460-052F, U+1C80-1C8A, U+20B4, U+2DE0-2DFF, U+A640-A69F, U+FE2E-FE2F;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOmCnqEu92Fr1Mu5mxKOzY.woff2) format('woff2');unicode-range:U+0301, U+0400-045F, U+0490-0491, U+04B0-04B1, U+2116;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOmCnqEu92Fr1Mu7mxKOzY.woff2) format('woff2');unicode-range:U+1F00-1FFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOmCnqEu92Fr1Mu4WxKOzY.woff2) format('woff2');unicode-range:U+0370-0377, U+037A-037F, U+0384-038A, U+038C, U+038E-03A1, U+03A3-03FF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOmCnqEu92Fr1Mu7WxKOzY.woff2) format('woff2');unicode-range:U+0102-0103, U+0110-0111, U+0128-0129, U+0168-0169, U+01A0-01A1, U+01AF-01B0, U+0300-0301, U+0303-0304, U+0308-0309, U+0323, U+0329, U+1EA0-1EF9, U+20AB;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOmCnqEu92Fr1Mu7GxKOzY.woff2) format('woff2');unicode-range:U+0100-02BA, U+02BD-02C5, U+02C7-02CC, U+02CE-02D7, U+02DD-02FF, U+0304, U+0308, U+0329, U+1D00-1DBF, U+1E00-1E9F, U+1EF2-1EFF, U+2020, U+20A0-20AB, U+20AD-20C0, U+2113, U+2C60-2C7F, U+A720-A7FF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:400;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOmCnqEu92Fr1Mu4mxK.woff2) format('woff2');unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOlCnqEu92Fr1MmEU9fCRc4EsA.woff2) format('woff2');unicode-range:U+0460-052F, U+1C80-1C8A, U+20B4, U+2DE0-2DFF, U+A640-A69F, U+FE2E-FE2F;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOlCnqEu92Fr1MmEU9fABc4EsA.woff2) format('woff2');unicode-range:U+0301, U+0400-045F, U+0490-0491, U+04B0-04B1, U+2116;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOlCnqEu92Fr1MmEU9fCBc4EsA.woff2) format('woff2');unicode-range:U+1F00-1FFF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOlCnqEu92Fr1MmEU9fBxc4EsA.woff2) format('woff2');unicode-range:U+0370-0377, U+037A-037F, U+0384-038A, U+038C, U+038E-03A1, U+03A3-03FF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOlCnqEu92Fr1MmEU9fCxc4EsA.woff2) format('woff2');unicode-range:U+0102-0103, U+0110-0111, U+0128-0129, U+0168-0169, U+01A0-01A1, U+01AF-01B0, U+0300-0301, U+0303-0304, U+0308-0309, U+0323, U+0329, U+1EA0-1EF9, U+20AB;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOlCnqEu92Fr1MmEU9fChc4EsA.woff2) format('woff2');unicode-range:U+0100-02BA, U+02BD-02C5, U+02C7-02CC, U+02CE-02D7, U+02DD-02FF, U+0304, U+0308, U+0329, U+1D00-1DBF, U+1E00-1E9F, U+1EF2-1EFF, U+2020, U+20A0-20AB, U+20AD-20C0, U+2113, U+2C60-2C7F, U+A720-A7FF;}@font-face{font-family:'Roboto';font-style:normal;font-weight:500;font-display:swap;src:url(https://fonts.gstatic.com/s/roboto/v32/KFOlCnqEu92Fr1MmEU9fBBc4.woff2) format('woff2');unicode-range:U+0000-00FF, U+0131, U+0152-0153, U+02BB-02BC, U+02C6, U+02DA, U+02DC, U+0304, U+0308, U+0329, U+2000-206F, U+20AC, U+2122, U+2191, U+2193, U+2212, U+2215, U+FEFF, U+FFFD;}</style>
  <style>@font-face{font-family:'Material Icons';font-style:normal;font-weight:400;src:url(https://fonts.gstatic.com/s/materialicons/v142/flUhRq6tzZclQEJ-Vdg-IuiaDsNc.woff2) format('woff2');}.material-icons{font-family:'Material Icons';font-weight:normal;font-style:normal;font-size:24px;line-height:1;letter-spacing:normal;text-transform:none;display:inline-block;white-space:nowrap;word-wrap:normal;direction:ltr;-webkit-font-feature-settings:'liga';-webkit-font-smoothing:antialiased;}</style>
<style>@charset "UTF-8";html{--mat-app-background-color:#faf9fd;--mat-app-text-color:#1a1b1f;--mat-app-elevation-shadow-level-0:0px 0px 0px 0px rgba(0, 0, 0, .2), 0px 0px 0px 0px rgba(0, 0, 0, .14), 0px 0px 0px 0px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-1:0px 2px 1px -1px rgba(0, 0, 0, .2), 0px 1px 1px 0px rgba(0, 0, 0, .14), 0px 1px 3px 0px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-2:0px 3px 1px -2px rgba(0, 0, 0, .2), 0px 2px 2px 0px rgba(0, 0, 0, .14), 0px 1px 5px 0px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-3:0px 3px 3px -2px rgba(0, 0, 0, .2), 0px 3px 4px 0px rgba(0, 0, 0, .14), 0px 1px 8px 0px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-4:0px 2px 4px -1px rgba(0, 0, 0, .2), 0px 4px 5px 0px rgba(0, 0, 0, .14), 0px 1px 10px 0px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-5:0px 3px 5px -1px rgba(0, 0, 0, .2), 0px 5px 8px 0px rgba(0, 0, 0, .14), 0px 1px 14px 0px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-6:0px 3px 5px -1px rgba(0, 0, 0, .2), 0px 6px 10px 0px rgba(0, 0, 0, .14), 0px 1px 18px 0px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-7:0px 4px 5px -2px rgba(0, 0, 0, .2), 0px 7px 10px 1px rgba(0, 0, 0, .14), 0px 2px 16px 1px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-8:0px 5px 5px -3px rgba(0, 0, 0, .2), 0px 8px 10px 1px rgba(0, 0, 0, .14), 0px 3px 14px 2px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-9:0px 5px 6px -3px rgba(0, 0, 0, .2), 0px 9px 12px 1px rgba(0, 0, 0, .14), 0px 3px 16px 2px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-10:0px 6px 6px -3px rgba(0, 0, 0, .2), 0px 10px 14px 1px rgba(0, 0, 0, .14), 0px 4px 18px 3px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-11:0px 6px 7px -4px rgba(0, 0, 0, .2), 0px 11px 15px 1px rgba(0, 0, 0, .14), 0px 4px 20px 3px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-12:0px 7px 8px -4px rgba(0, 0, 0, .2), 0px 12px 17px 2px rgba(0, 0, 0, .14), 0px 5px 22px 4px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-13:0px 7px 8px -4px rgba(0, 0, 0, .2), 0px 13px 19px 2px rgba(0, 0, 0, .14), 0px 5px 24px 4px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-14:0px 7px 9px -4px rgba(0, 0, 0, .2), 0px 14px 21px 2px rgba(0, 0, 0, .14), 0px 5px 26px 4px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-15:0px 8px 9px -5px rgba(0, 0, 0, .2), 0px 15px 22px 2px rgba(0, 0, 0, .14), 0px 6px 28px 5px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-16:0px 8px 10px -5px rgba(0, 0, 0, .2), 0px 16px 24px 2px rgba(0, 0, 0, .14), 0px 6px 30px 5px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-17:0px 8px 11px -5px rgba(0, 0, 0, .2), 0px 17px 26px 2px rgba(0, 0, 0, .14), 0px 6px 32px 5px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-18:0px 9px 11px -5px rgba(0, 0, 0, .2), 0px 18px 28px 2px rgba(0, 0, 0, .14), 0px 7px 34px 6px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-19:0px 9px 12px -6px rgba(0, 0, 0, .2), 0px 19px 29px 2px rgba(0, 0, 0, .14), 0px 7px 36px 6px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-20:0px 10px 13px -6px rgba(0, 0, 0, .2), 0px 20px 31px 3px rgba(0, 0, 0, .14), 0px 8px 38px 7px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-21:0px 10px 13px -6px rgba(0, 0, 0, .2), 0px 21px 33px 3px rgba(0, 0, 0, .14), 0px 8px 40px 7px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-22:0px 10px 14px -6px rgba(0, 0, 0, .2), 0px 22px 35px 3px rgba(0, 0, 0, .14), 0px 8px 42px 7px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-23:0px 11px 14px -7px rgba(0, 0, 0, .2), 0px 23px 36px 3px rgba(0, 0, 0, .14), 0px 9px 44px 8px rgba(0, 0, 0, .12);--mat-app-elevation-shadow-level-24:0px 11px 15px -7px rgba(0, 0, 0, .2), 0px 24px 38px 3px rgba(0, 0, 0, .14), 0px 9px 46px 8px rgba(0, 0, 0, .12);--mat-ripple-color:rgba(26, 27, 31, .1);--mat-option-selected-state-label-text-color:#131c2b;--mat-option-label-text-color:#1a1b1f;--mat-option-hover-state-layer-color:rgba(26, 27, 31, .08);--mat-option-focus-state-layer-color:rgba(26, 27, 31, .12);--mat-option-selected-state-layer-color:#dae2f9;--mat-option-label-text-font:Roboto, sans-serif;--mat-option-label-text-line-height:1.25rem;--mat-option-label-text-size:1rem;--mat-option-label-text-tracking:.006rem;--mat-option-label-text-weight:400;--mat-optgroup-label-text-color:#44474e;--mat-optgroup-label-text-font:Roboto, sans-serif;--mat-optgroup-label-text-line-height:1.25rem;--mat-optgroup-label-text-size:.875rem;--mat-optgroup-label-text-tracking:.006rem;--mat-optgroup-label-text-weight:500;--mat-full-pseudo-checkbox-selected-icon-color:#005cbb;--mat-full-pseudo-checkbox-selected-checkmark-color:#ffffff;--mat-full-pseudo-checkbox-unselected-icon-color:#44474e;--mat-full-pseudo-checkbox-disabled-selected-checkmark-color:#faf9fd;--mat-full-pseudo-checkbox-disabled-unselected-icon-color:rgba(26, 27, 31, .38);--mat-full-pseudo-checkbox-disabled-selected-icon-color:rgba(26, 27, 31, .38);--mat-minimal-pseudo-checkbox-selected-checkmark-color:#005cbb;--mat-minimal-pseudo-checkbox-disabled-selected-checkmark-color:rgba(26, 27, 31, .38);--mdc-elevated-card-container-color:#f4f3f6;--mdc-elevated-card-container-elevation:0px 2px 1px -1px rgba(0, 0, 0, .2), 0px 1px 1px 0px rgba(0, 0, 0, .14), 0px 1px 3px 0px rgba(0, 0, 0, .12);--mdc-elevated-card-container-shape:12px;--mdc-outlined-card-container-color:#faf9fd;--mdc-outlined-card-outline-color:#c4c6d0;--mdc-outlined-card-container-elevation:0px 0px 0px 0px rgba(0, 0, 0, .2), 0px 0px 0px 0px rgba(0, 0, 0, .14), 0px 0px 0px 0px rgba(0, 0, 0, .12);--mdc-outlined-card-container-shape:12px;--mdc-outlined-card-outline-width:1px;--mat-card-subtitle-text-color:#1a1b1f;--mat-card-title-text-font:Roboto, sans-serif;--mat-card-title-text-line-height:1.75rem;--mat-card-title-text-size:1.375rem;--mat-card-title-text-tracking:0;--mat-card-title-text-weight:400;--mat-card-subtitle-text-font:Roboto, sans-serif;--mat-card-subtitle-text-line-height:1.5rem;--mat-card-subtitle-text-size:1rem;--mat-card-subtitle-text-tracking:.009rem;--mat-card-subtitle-text-weight:500;--mdc-linear-progress-active-indicator-color:#005cbb;--mdc-linear-progress-track-color:#e0e2ec;--mdc-linear-progress-active-indicator-height:4px;--mdc-linear-progress-track-height:4px;--mdc-linear-progress-track-shape:0;--mdc-plain-tooltip-container-color:#2f3033;--mdc-plain-tooltip-supporting-text-color:#f2f0f4;--mdc-plain-tooltip-supporting-text-line-height:1rem;--mdc-plain-tooltip-supporting-text-font:Roboto, sans-serif;--mdc-plain-tooltip-supporting-text-size:.75rem;--mdc-plain-tooltip-supporting-text-weight:400;--mdc-plain-tooltip-supporting-text-tracking:.025rem;--mdc-plain-tooltip-container-shape:4px;--mdc-filled-text-field-caret-color:#005cbb;--mdc-filled-text-field-focus-active-indicator-color:#005cbb;--mdc-filled-text-field-focus-label-text-color:#005cbb;--mdc-filled-text-field-container-color:#e0e2ec;--mdc-filled-text-field-disabled-container-color:rgba(26, 27, 31, .04);--mdc-filled-text-field-label-text-color:#44474e;--mdc-filled-text-field-hover-label-text-color:#44474e;--mdc-filled-text-field-disabled-label-text-color:rgba(26, 27, 31, .38);--mdc-filled-text-field-input-text-color:#1a1b1f;--mdc-filled-text-field-disabled-input-text-color:rgba(26, 27, 31, .38);--mdc-filled-text-field-input-text-placeholder-color:#44474e;--mdc-filled-text-field-error-hover-label-text-color:#410002;--mdc-filled-text-field-error-focus-label-text-color:#ba1a1a;--mdc-filled-text-field-error-label-text-color:#ba1a1a;--mdc-filled-text-field-active-indicator-color:#44474e;--mdc-filled-text-field-disabled-active-indicator-color:rgba(26, 27, 31, .38);--mdc-filled-text-field-hover-active-indicator-color:#1a1b1f;--mdc-filled-text-field-error-active-indicator-color:#ba1a1a;--mdc-filled-text-field-error-focus-active-indicator-color:#ba1a1a;--mdc-filled-text-field-error-hover-active-indicator-color:#410002;--mdc-filled-text-field-label-text-font:Roboto, sans-serif;--mdc-filled-text-field-label-text-size:1rem;--mdc-filled-text-field-label-text-tracking:.031rem;--mdc-filled-text-field-label-text-weight:400;--mdc-filled-text-field-active-indicator-height:1px;--mdc-filled-text-field-focus-active-indicator-height:2px;--mdc-filled-text-field-container-shape:4px;--mdc-outlined-text-field-caret-color:#005cbb;--mdc-outlined-text-field-focus-outline-color:#005cbb;--mdc-outlined-text-field-focus-label-text-color:#005cbb;--mdc-outlined-text-field-label-text-color:#44474e;--mdc-outlined-text-field-hover-label-text-color:#1a1b1f;--mdc-outlined-text-field-disabled-label-text-color:rgba(26, 27, 31, .38);--mdc-outlined-text-field-input-text-color:#1a1b1f;--mdc-outlined-text-field-disabled-input-text-color:rgba(26, 27, 31, .38);--mdc-outlined-text-field-input-text-placeholder-color:#44474e;--mdc-outlined-text-field-error-focus-label-text-color:#ba1a1a;--mdc-outlined-text-field-error-label-text-color:#ba1a1a;--mdc-outlined-text-field-error-hover-label-text-color:#410002;--mdc-outlined-text-field-outline-color:#74777f;--mdc-outlined-text-field-disabled-outline-color:rgba(26, 27, 31, .12);--mdc-outlined-text-field-hover-outline-color:#1a1b1f;--mdc-outlined-text-field-error-focus-outline-color:#ba1a1a;--mdc-outlined-text-field-error-hover-outline-color:#410002;--mdc-outlined-text-field-error-outline-color:#ba1a1a;--mdc-outlined-text-field-label-text-font:Roboto, sans-serif;--mdc-outlined-text-field-label-text-size:1rem;--mdc-outlined-text-field-label-text-tracking:.031rem;--mdc-outlined-text-field-label-text-weight:400;--mdc-outlined-text-field-outline-width:1px;--mdc-outlined-text-field-focus-outline-width:2px;--mdc-outlined-text-field-container-shape:4px;--mat-form-field-focus-select-arrow-color:#005cbb;--mat-form-field-disabled-input-text-placeholder-color:rgba(26, 27, 31, .38);--mat-form-field-state-layer-color:#1a1b1f;--mat-form-field-error-text-color:#ba1a1a;--mat-form-field-select-option-text-color:#1a1b1f;--mat-form-field-select-disabled-option-text-color:rgba(26, 27, 31, .38);--mat-form-field-leading-icon-color:#44474e;--mat-form-field-disabled-leading-icon-color:rgba(26, 27, 31, .38);--mat-form-field-trailing-icon-color:#44474e;--mat-form-field-disabled-trailing-icon-color:rgba(26, 27, 31, .38);--mat-form-field-error-focus-trailing-icon-color:#ba1a1a;--mat-form-field-error-hover-trailing-icon-color:#410002;--mat-form-field-error-trailing-icon-color:#ba1a1a;--mat-form-field-enabled-select-arrow-color:#44474e;--mat-form-field-disabled-select-arrow-color:rgba(26, 27, 31, .38);--mat-form-field-hover-state-layer-opacity:.08;--mat-form-field-container-text-font:Roboto, sans-serif;--mat-form-field-container-text-line-height:1.5rem;--mat-form-field-container-text-size:1rem;--mat-form-field-container-text-tracking:.031rem;--mat-form-field-container-text-weight:400;--mat-form-field-subscript-text-font:Roboto, sans-serif;--mat-form-field-subscript-text-line-height:1rem;--mat-form-field-subscript-text-size:.75rem;--mat-form-field-subscript-text-tracking:.025rem;--mat-form-field-subscript-text-weight:400;--mat-form-field-container-height:56px;--mat-form-field-filled-label-display:block;--mat-form-field-container-vertical-padding:16px;--mat-form-field-filled-with-label-container-padding-top:24px;--mat-form-field-filled-with-label-container-padding-bottom:8px;--mat-form-field-focus-state-layer-opacity:0;--mat-select-panel-background-color:#efedf0;--mat-select-enabled-trigger-text-color:#1a1b1f;--mat-select-disabled-trigger-text-color:rgba(26, 27, 31, .38);--mat-select-placeholder-text-color:#44474e;--mat-select-enabled-arrow-color:#44474e;--mat-select-disabled-arrow-color:rgba(26, 27, 31, .38);--mat-select-focused-arrow-color:#005cbb;--mat-select-invalid-arrow-color:#ba1a1a;--mat-select-trigger-text-font:Roboto, sans-serif;--mat-select-trigger-text-line-height:1.5rem;--mat-select-trigger-text-size:1rem;--mat-select-trigger-text-tracking:.031rem;--mat-select-trigger-text-weight:400;--mat-select-arrow-transform:translateY(-8px);--mat-select-container-elevation-shadow:0px 3px 1px -2px rgba(0, 0, 0, .2), 0px 2px 2px 0px rgba(0, 0, 0, .14), 0px 1px 5px 0px rgba(0, 0, 0, .12);--mat-autocomplete-background-color:#efedf0;--mat-autocomplete-container-shape:4px;--mat-autocomplete-container-elevation-shadow:0px 3px 1px -2px rgba(0, 0, 0, .2), 0px 2px 2px 0px rgba(0, 0, 0, .14), 0px 1px 5px 0px rgba(0, 0, 0, .12);--mdc-dialog-container-color:#faf9fd;--mdc-dialog-subhead-color:#1a1b1f;--mdc-dialog-supporting-text-color:#44474e;--mdc-dialog-subhead-font:Roboto, sans-serif;--mdc-dialog-subhead-line-height:2rem;--mdc-dialog-subhead-size:1.5rem;--mdc-dialog-subhead-weight:400;--mdc-dialog-subhead-tracking:0;--mdc-dialog-supporting-text-font:Roboto, sans-serif;--mdc-dialog-supporting-text-line-height:1.25rem;--mdc-dialog-supporting-text-size:.875rem;--mdc-dialog-supporting-text-weight:400;--mdc-dialog-supporting-text-tracking:.016rem;--mdc-dialog-container-shape:28px;--mat-dialog-container-elevation-shadow:none;--mat-dialog-container-max-width:560px;--mat-dialog-container-small-max-width: calc(100vw - 32px) ;--mat-dialog-container-min-width:280px;--mat-dialog-actions-alignment:flex-end;--mat-dialog-actions-padding:16px 24px;--mat-dialog-content-padding:20px 24px;--mat-dialog-with-actions-content-padding:20px 24px 0;--mat-dialog-headline-padding:6px 24px 13px;--mdc-chip-outline-color:#74777f;--mdc-chip-disabled-outline-color:rgba(26, 27, 31, .12);--mdc-chip-focus-outline-color:#44474e;--mdc-chip-hover-state-layer-opacity:.08;--mdc-chip-selected-hover-state-layer-opacity:.08;--mdc-chip-disabled-label-text-color:rgba(26, 27, 31, .38);--mdc-chip-elevated-selected-container-color:#dae2f9;--mdc-chip-flat-disabled-selected-container-color:rgba(26, 27, 31, .12);--mdc-chip-focus-state-layer-color:#44474e;--mdc-chip-hover-state-layer-color:#44474e;--mdc-chip-selected-hover-state-layer-color:#131c2b;--mdc-chip-focus-state-layer-opacity:.12;--mdc-chip-selected-focus-state-layer-color:#131c2b;--mdc-chip-selected-focus-state-layer-opacity:.12;--mdc-chip-label-text-color:#44474e;--mdc-chip-selected-label-text-color:#131c2b;--mdc-chip-with-icon-icon-color:#44474e;--mdc-chip-with-icon-disabled-icon-color:#1a1b1f;--mdc-chip-with-icon-selected-icon-color:#131c2b;--mdc-chip-with-trailing-icon-disabled-trailing-icon-color:#1a1b1f;--mdc-chip-with-trailing-icon-trailing-icon-color:#44474e;--mdc-chip-label-text-font:Roboto, sans-serif;--mdc-chip-label-text-line-height:1.25rem;--mdc-chip-label-text-size:.875rem;--mdc-chip-label-text-tracking:.006rem;--mdc-chip-label-text-weight:500;--mdc-chip-container-height:32px;--mdc-chip-container-shape-radius:8px;--mdc-chip-with-avatar-avatar-shape-radius:24px;--mdc-chip-with-avatar-avatar-size:24px;--mdc-chip-with-icon-icon-size:18px;--mdc-chip-outline-width:1px;--mdc-chip-with-avatar-disabled-avatar-opacity:.38;--mdc-chip-flat-selected-outline-width:0;--mdc-chip-with-trailing-icon-disabled-trailing-icon-opacity:.38;--mdc-chip-with-icon-disabled-icon-opacity:.38;--mdc-chip-elevated-container-color:transparent;--mat-chip-trailing-action-state-layer-color:#44474e;--mat-chip-selected-trailing-action-state-layer-color:#131c2b;--mat-chip-trailing-action-hover-state-layer-opacity:.08;--mat-chip-trailing-action-focus-state-layer-opacity:.12;--mat-chip-selected-disabled-trailing-icon-color:#1a1b1f;--mat-chip-selected-trailing-icon-color:#131c2b;--mat-chip-disabled-container-opacity:1;--mat-chip-trailing-action-opacity:1;--mat-chip-trailing-action-focus-opacity:1;--mdc-switch-selected-focus-state-layer-opacity:.12;--mdc-switch-selected-hover-state-layer-opacity:.08;--mdc-switch-selected-pressed-state-layer-opacity:.12;--mdc-switch-unselected-focus-state-layer-opacity:.12;--mdc-switch-unselected-hover-state-layer-opacity:.08;--mdc-switch-unselected-pressed-state-layer-opacity:.12;--mdc-switch-selected-focus-state-layer-color:#005cbb;--mdc-switch-selected-handle-color:#ffffff;--mdc-switch-selected-hover-state-layer-color:#005cbb;--mdc-switch-selected-pressed-state-layer-color:#005cbb;--mdc-switch-selected-focus-handle-color:#d7e3ff;--mdc-switch-selected-hover-handle-color:#d7e3ff;--mdc-switch-selected-pressed-handle-color:#d7e3ff;--mdc-switch-selected-focus-track-color:#005cbb;--mdc-switch-selected-hover-track-color:#005cbb;--mdc-switch-selected-pressed-track-color:#005cbb;--mdc-switch-selected-track-color:#005cbb;--mdc-switch-disabled-selected-handle-color:#faf9fd;--mdc-switch-disabled-selected-icon-color:#1a1b1f;--mdc-switch-disabled-selected-track-color:#1a1b1f;--mdc-switch-disabled-unselected-handle-color:#1a1b1f;--mdc-switch-disabled-unselected-icon-color:#e0e2ec;--mdc-switch-disabled-unselected-track-color:#e0e2ec;--mdc-switch-selected-icon-color:#001b3f;--mdc-switch-unselected-focus-handle-color:#44474e;--mdc-switch-unselected-focus-state-layer-color:#1a1b1f;--mdc-switch-unselected-focus-track-color:#e0e2ec;--mdc-switch-unselected-handle-color:#74777f;--mdc-switch-unselected-hover-handle-color:#44474e;--mdc-switch-unselected-hover-state-layer-color:#1a1b1f;--mdc-switch-unselected-hover-track-color:#e0e2ec;--mdc-switch-unselected-icon-color:#e0e2ec;--mdc-switch-unselected-pressed-handle-color:#44474e;--mdc-switch-unselected-pressed-state-layer-color:#1a1b1f;--mdc-switch-unselected-pressed-track-color:#e0e2ec;--mdc-switch-unselected-track-color:#e0e2ec;--mdc-switch-disabled-selected-icon-opacity:.38;--mdc-switch-disabled-track-opacity:.12;--mdc-switch-disabled-unselected-icon-opacity:.38;--mdc-switch-handle-shape:9999px;--mdc-switch-selected-icon-size:16px;--mdc-switch-track-height:32px;--mdc-switch-track-shape:9999px;--mdc-switch-track-width:52px;--mdc-switch-unselected-icon-size:16px;--mdc-switch-state-layer-size:40px;--mat-switch-track-outline-color:#74777f;--mat-switch-disabled-unselected-track-outline-color:#1a1b1f;--mat-switch-label-text-color:#1a1b1f;--mat-switch-label-text-font:Roboto, sans-serif;--mat-switch-label-text-line-height:1.25rem;--mat-switch-label-text-size:.875rem;--mat-switch-label-text-tracking:.016rem;--mat-switch-label-text-weight:400;--mat-switch-disabled-selected-handle-opacity:1;--mat-switch-disabled-unselected-handle-opacity:.38;--mat-switch-unselected-handle-size:16px;--mat-switch-selected-handle-size:24px;--mat-switch-pressed-handle-size:28px;--mat-switch-with-icon-handle-size:24px;--mat-switch-selected-handle-horizontal-margin:0 24px;--mat-switch-selected-with-icon-handle-horizontal-margin:0 24px;--mat-switch-selected-pressed-handle-horizontal-margin:0 22px;--mat-switch-unselected-handle-horizontal-margin:0 8px;--mat-switch-unselected-with-icon-handle-horizontal-margin:0 4px;--mat-switch-unselected-pressed-handle-horizontal-margin:0 2px;--mat-switch-visible-track-opacity:1;--mat-switch-hidden-track-opacity:0;--mat-switch-visible-track-transition:opacity 75ms;--mat-switch-hidden-track-transition:opacity 75ms;--mat-switch-track-outline-width:2px;--mat-switch-selected-track-outline-width:2px;--mat-switch-selected-track-outline-color:transparent;--mat-switch-disabled-unselected-track-outline-width:2px;--mdc-radio-disabled-selected-icon-color:#1a1b1f;--mdc-radio-disabled-unselected-icon-color:#1a1b1f;--mdc-radio-unselected-hover-icon-color:#1a1b1f;--mdc-radio-unselected-focus-icon-color:#1a1b1f;--mdc-radio-unselected-icon-color:#44474e;--mdc-radio-unselected-pressed-icon-color:#1a1b1f;--mdc-radio-selected-focus-icon-color:#005cbb;--mdc-radio-selected-hover-icon-color:#005cbb;--mdc-radio-selected-icon-color:#005cbb;--mdc-radio-selected-pressed-icon-color:#005cbb;--mdc-radio-state-layer-size:40px;--mdc-radio-disabled-selected-icon-opacity:.38;--mdc-radio-disabled-unselected-icon-opacity:.38;--mat-radio-ripple-color:#1a1b1f;--mat-radio-checked-ripple-color:#005cbb;--mat-radio-disabled-label-color:rgba(26, 27, 31, .38);--mat-radio-label-text-color:#1a1b1f;--mat-radio-label-text-font:Roboto, sans-serif;--mat-radio-label-text-line-height:1.25rem;--mat-radio-label-text-size:.875rem;--mat-radio-label-text-tracking:.016rem;--mat-radio-label-text-weight:400;--mat-radio-touch-target-display:block;--mdc-slider-handle-elevation:0px 2px 1px -1px rgba(0, 0, 0, .2), 0px 1px 1px 0px rgba(0, 0, 0, .14), 0px 1px 3px 0px rgba(0, 0, 0, .12);--mdc-slider-handle-color:#005cbb;--mdc-slider-focus-handle-color:#005cbb;--mdc-slider-hover-handle-color:#005cbb;--mdc-slider-active-track-color:#005cbb;--mdc-slider-inactive-track-color:#e0e2ec;--mdc-slider-with-tick-marks-inactive-container-color:#44474e;--mdc-slider-with-tick-marks-active-container-color:#ffffff;--mdc-slider-disabled-active-track-color:#1a1b1f;--mdc-slider-disabled-handle-color:#1a1b1f;--mdc-slider-disabled-inactive-track-color:#1a1b1f;--mdc-slider-label-container-color:#005cbb;--mdc-slider-label-label-text-color:#ffffff;--mdc-slider-with-overlap-handle-outline-color:#ffffff;--mdc-slider-with-tick-marks-disabled-container-color:#1a1b1f;--mdc-slider-label-label-text-font:Roboto, sans-serif;--mdc-slider-label-label-text-size:.75rem;--mdc-slider-label-label-text-line-height:1rem;--mdc-slider-label-label-text-tracking:.031rem;--mdc-slider-label-label-text-weight:500;--mdc-slider-active-track-height:4px;--mdc-slider-active-track-shape:9999px;--mdc-slider-handle-height:20px;--mdc-slider-handle-shape:9999px;--mdc-slider-handle-width:20px;--mdc-slider-inactive-track-height:4px;--mdc-slider-inactive-track-shape:9999px;--mdc-slider-with-overlap-handle-outline-width:1px;--mdc-slider-with-tick-marks-active-container-opacity:.38;--mdc-slider-with-tick-marks-container-shape:9999px;--mdc-slider-with-tick-marks-container-size:2px;--mdc-slider-with-tick-marks-inactive-container-opacity:.38;--mat-slider-ripple-color:#005cbb;--mat-slider-hover-state-layer-color:rgba(0, 92, 187, .05);--mat-slider-focus-state-layer-color:rgba(0, 92, 187, .2);--mat-slider-value-indicator-width:28px;--mat-slider-value-indicator-height:28px;--mat-slider-value-indicator-caret-display:none;--mat-slider-value-indicator-border-radius:50% 50% 50% 0;--mat-slider-value-indicator-padding:0;--mat-slider-value-indicator-text-transform:rotate(45deg);--mat-slider-value-indicator-container-transform:translateX(-50%) rotate(-45deg);--mat-slider-value-indicator-opacity:1;--mat-menu-item-label-text-color:#1a1b1f;--mat-menu-item-icon-color:#44474e;--mat-menu-item-hover-state-layer-color:rgba(26, 27, 31, .08);--mat-menu-item-focus-state-layer-color:rgba(26, 27, 31, .12);--mat-menu-container-color:#efedf0;--mat-menu-divider-color:#e0e2ec;--mat-menu-item-label-text-font:Roboto, sans-serif;--mat-menu-item-label-text-size:.875rem;--mat-menu-item-label-text-tracking:.006rem;--mat-menu-item-label-text-line-height:1.25rem;--mat-menu-item-label-text-weight:500;--mat-menu-container-shape:4px;--mat-menu-divider-bottom-spacing:8px;--mat-menu-divider-top-spacing:8px;--mat-menu-item-spacing:12px;--mat-menu-item-icon-size:24px;--mat-menu-item-leading-spacing:12px;--mat-menu-item-trailing-spacing:12px;--mat-menu-item-with-icon-leading-spacing:12px;--mat-menu-item-with-icon-trailing-spacing:12px;--mat-menu-base-elevation-level:2;--mdc-list-list-item-container-color:transparent;--mdc-list-list-item-leading-avatar-color:#d7e3ff;--mdc-list-list-item-disabled-state-layer-color:#1a1b1f;--mdc-list-list-item-disabled-state-layer-opacity:.12;--mdc-list-list-item-label-text-color:#1a1b1f;--mdc-list-list-item-supporting-text-color:#44474e;--mdc-list-list-item-leading-icon-color:#44474e;--mdc-list-list-item-trailing-supporting-text-color:#44474e;--mdc-list-list-item-trailing-icon-color:#44474e;--mdc-list-list-item-selected-trailing-icon-color:#005cbb;--mdc-list-list-item-disabled-label-text-color:#1a1b1f;--mdc-list-list-item-disabled-leading-icon-color:#1a1b1f;--mdc-list-list-item-disabled-trailing-icon-color:#1a1b1f;--mdc-list-list-item-hover-label-text-color:#1a1b1f;--mdc-list-list-item-focus-label-text-color:#1a1b1f;--mdc-list-list-item-hover-state-layer-color:#1a1b1f;--mdc-list-list-item-hover-state-layer-opacity:.08;--mdc-list-list-item-focus-state-layer-color:#1a1b1f;--mdc-list-list-item-focus-state-layer-opacity:.12;--mdc-list-list-item-label-text-font:Roboto, sans-serif;--mdc-list-list-item-label-text-line-height:1.5rem;--mdc-list-list-item-label-text-size:1rem;--mdc-list-list-item-label-text-tracking:.031rem;--mdc-list-list-item-label-text-weight:400;--mdc-list-list-item-supporting-text-font:Roboto, sans-serif;--mdc-list-list-item-supporting-text-line-height:1.25rem;--mdc-list-list-item-supporting-text-size:.875rem;--mdc-list-list-item-supporting-text-tracking:.016rem;--mdc-list-list-item-supporting-text-weight:400;--mdc-list-list-item-trailing-supporting-text-font:Roboto, sans-serif;--mdc-list-list-item-trailing-supporting-text-line-height:1rem;--mdc-list-list-item-trailing-supporting-text-size:.688rem;--mdc-list-list-item-trailing-supporting-text-tracking:.031rem;--mdc-list-list-item-trailing-supporting-text-weight:500;--mdc-list-list-item-one-line-container-height:48px;--mdc-list-list-item-two-line-container-height:64px;--mdc-list-list-item-three-line-container-height:88px;--mdc-list-list-item-container-shape:0;--mdc-list-list-item-leading-avatar-shape:9999px;--mdc-list-list-item-leading-icon-size:24px;--mdc-list-list-item-leading-avatar-size:40px;--mdc-list-list-item-trailing-icon-size:24px;--mdc-list-list-item-disabled-label-text-opacity:.3;--mdc-list-list-item-disabled-leading-icon-opacity:.38;--mdc-list-list-item-disabled-trailing-icon-opacity:.38;--mat-list-active-indicator-color:#dae2f9;--mat-list-list-item-leading-icon-start-space:16px;--mat-list-list-item-leading-icon-end-space:16px;--mat-list-active-indicator-shape:9999px;--mat-paginator-container-text-color:#1a1b1f;--mat-paginator-container-background-color:#faf9fd;--mat-paginator-enabled-icon-color:#44474e;--mat-paginator-disabled-icon-color:rgba(26, 27, 31, .38);--mat-paginator-container-text-font:Roboto, sans-serif;--mat-paginator-container-text-line-height:1rem;--mat-paginator-container-text-size:.75rem;--mat-paginator-container-text-tracking:.025rem;--mat-paginator-container-text-weight:400;--mat-paginator-select-trigger-text-size:.75rem;--mat-paginator-container-size:56px;--mat-paginator-form-field-container-height:40px;--mat-paginator-form-field-container-vertical-padding:8px;--mat-paginator-touch-target-display:block;--mdc-secondary-navigation-tab-container-height:48px;--mdc-tab-indicator-active-indicator-color:#005cbb;--mdc-tab-indicator-active-indicator-height:2px;--mdc-tab-indicator-active-indicator-shape:0;--mat-tab-header-divider-color:#e0e2ec;--mat-tab-header-pagination-icon-color:#1a1b1f;--mat-tab-header-inactive-label-text-color:#1a1b1f;--mat-tab-header-active-label-text-color:#1a1b1f;--mat-tab-header-active-ripple-color:#1a1b1f;--mat-tab-header-inactive-ripple-color:#1a1b1f;--mat-tab-header-inactive-focus-label-text-color:#1a1b1f;--mat-tab-header-inactive-hover-label-text-color:#1a1b1f;--mat-tab-header-active-focus-label-text-color:#1a1b1f;--mat-tab-header-active-hover-label-text-color:#1a1b1f;--mat-tab-header-active-focus-indicator-color:#005cbb;--mat-tab-header-active-hover-indicator-color:#005cbb;--mat-tab-header-label-text-font:Roboto, sans-serif;--mat-tab-header-label-text-size:.875rem;--mat-tab-header-label-text-tracking:.006rem;--mat-tab-header-label-text-line-height:1.25rem;--mat-tab-header-label-text-weight:500;--mat-tab-header-divider-height:1px;--mdc-checkbox-disabled-selected-checkmark-color:#faf9fd;--mdc-checkbox-selected-focus-state-layer-opacity:.12;--mdc-checkbox-selected-hover-state-layer-opacity:.08;--mdc-checkbox-selected-pressed-state-layer-opacity:.12;--mdc-checkbox-unselected-focus-state-layer-opacity:.12;--mdc-checkbox-unselected-hover-state-layer-opacity:.08;--mdc-checkbox-unselected-pressed-state-layer-opacity:.12;--mdc-checkbox-selected-pressed-icon-color:#005cbb;--mdc-checkbox-disabled-selected-icon-color:rgba(26, 27, 31, .38);--mdc-checkbox-disabled-unselected-icon-color:rgba(26, 27, 31, .38);--mdc-checkbox-selected-checkmark-color:#ffffff;--mdc-checkbox-selected-focus-icon-color:#005cbb;--mdc-checkbox-selected-hover-icon-color:#005cbb;--mdc-checkbox-selected-icon-color:#005cbb;--mdc-checkbox-unselected-focus-icon-color:#1a1b1f;--mdc-checkbox-unselected-hover-icon-color:#1a1b1f;--mdc-checkbox-unselected-icon-color:#44474e;--mdc-checkbox-selected-focus-state-layer-color:#005cbb;--mdc-checkbox-selected-hover-state-layer-color:#005cbb;--mdc-checkbox-selected-pressed-state-layer-color:#1a1b1f;--mdc-checkbox-unselected-focus-state-layer-color:#1a1b1f;--mdc-checkbox-unselected-hover-state-layer-color:#1a1b1f;--mdc-checkbox-unselected-pressed-state-layer-color:#005cbb;--mdc-checkbox-state-layer-size:40px;--mat-checkbox-disabled-label-color:rgba(26, 27, 31, .38);--mat-checkbox-label-text-color:#1a1b1f;--mat-checkbox-label-text-font:Roboto, sans-serif;--mat-checkbox-label-text-line-height:1.25rem;--mat-checkbox-label-text-size:.875rem;--mat-checkbox-label-text-tracking:.016rem;--mat-checkbox-label-text-weight:400;--mat-checkbox-touch-target-display:block;--mdc-text-button-label-text-color:#005cbb;--mdc-text-button-disabled-label-text-color:rgba(26, 27, 31, .38);--mdc-text-button-label-text-font:Roboto, sans-serif;--mdc-text-button-label-text-size:.875rem;--mdc-text-button-label-text-tracking:.006rem;--mdc-text-button-label-text-weight:500;--mdc-text-button-container-height:40px;--mdc-text-button-container-shape:9999px;--mdc-protected-button-container-elevation-shadow:0px 2px 1px -1px rgba(0, 0, 0, .2), 0px 1px 1px 0px rgba(0, 0, 0, .14), 0px 1px 3px 0px rgba(0, 0, 0, .12);--mdc-protected-button-disabled-container-elevation-shadow:0px 0px 0px 0px rgba(0, 0, 0, .2), 0px 0px 0px 0px rgba(0, 0, 0, .14), 0px 0px 0px 0px rgba(0, 0, 0, .12);--mdc-protected-button-focus-container-elevation-shadow:0px 2px 1px -1px rgba(0, 0, 0, .2), 0px 1px 1px 0px rgba(0, 0, 0, .14), 0px 1px 3px 0px rgba(0, 0, 0, .12);--mdc-protected-button-hover-container-elevation-shadow:0px 3px 3px -2px rgba(0, 0, 0, .2), 0px 3px 4px 0px rgba(0, 0, 0, .14), 0px 1px 8px 0px rgba(0, 0, 0, .12);--mdc-protected-button-pressed-container-elevation-shadow:0px 2px 1px -1px rgba(0, 0, 0, .2), 0px 1px 1px 0px rgba(0, 0, 0, .14), 0px 1px 3px 0px rgba(0, 0, 0, .12);--mdc-protected-button-container-color:#faf9fd;--mdc-protected-button-label-text-color:#005cbb;--mdc-protected-button-disabled-container-color:rgba(26, 27, 31, .12);--mdc-protected-button-disabled-label-text-color:rgba(26, 27, 31, .38);--mdc-protected-button-label-text-font:Roboto, sans-serif;--mdc-protected-button-label-text-size:.875rem;--mdc-protected-button-label-text-tracking:.006rem;--mdc-protected-button-label-text-weight:500;--mdc-protected-button-container-height:40px;--mdc-protected-button-container-shape:9999px;--mdc-filled-button-container-color:#005cbb;--mdc-filled-button-label-text-color:#ffffff;--mdc-filled-button-disabled-container-color:rgba(26, 27, 31, .12);--mdc-filled-button-disabled-label-text-color:rgba(26, 27, 31, .38);--mdc-filled-button-label-text-font:Roboto, sans-serif;--mdc-filled-button-label-text-size:.875rem;--mdc-filled-button-label-text-tracking:.006rem;--mdc-filled-button-label-text-weight:500;--mdc-filled-button-container-height:40px;--mdc-filled-button-container-shape:9999px;--mdc-outlined-button-disabled-outline-color:rgba(26, 27, 31, .12);--mdc-outlined-button-disabled-label-text-color:rgba(26, 27, 31, .38);--mdc-outlined-button-label-text-color:#005cbb;--mdc-outlined-button-outline-color:#74777f;--mdc-outlined-button-label-text-font:Roboto, sans-serif;--mdc-outlined-button-label-text-size:.875rem;--mdc-outlined-button-label-text-tracking:.006rem;--mdc-outlined-button-label-text-weight:500;--mdc-outlined-button-container-height:40px;--mdc-outlined-button-outline-width:1px;--mdc-outlined-button-container-shape:9999px;--mat-text-button-state-layer-color:#005cbb;--mat-text-button-disabled-state-layer-color:#44474e;--mat-text-button-ripple-color:rgba(0, 92, 187, .12);--mat-text-button-hover-state-layer-opacity:.08;--mat-text-button-focus-state-layer-opacity:.12;--mat-text-button-pressed-state-layer-opacity:.12;--mat-text-button-touch-target-display:block;--mat-text-button-horizontal-padding:12px;--mat-text-button-with-icon-horizontal-padding:16px;--mat-text-button-icon-spacing:8px;--mat-text-button-icon-offset:-4px;--mat-protected-button-state-layer-color:#005cbb;--mat-protected-button-disabled-state-layer-color:#44474e;--mat-protected-button-ripple-color:rgba(0, 92, 187, .12);--mat-protected-button-hover-state-layer-opacity:.08;--mat-protected-button-focus-state-layer-opacity:.12;--mat-protected-button-pressed-state-layer-opacity:.12;--mat-protected-button-touch-target-display:block;--mat-protected-button-horizontal-padding:24px;--mat-protected-button-icon-spacing:8px;--mat-protected-button-icon-offset:-8px;--mat-filled-button-state-layer-color:#ffffff;--mat-filled-button-disabled-state-layer-color:#44474e;--mat-filled-button-ripple-color:rgba(255, 255, 255, .12);--mat-filled-button-hover-state-layer-opacity:.08;--mat-filled-button-focus-state-layer-opacity:.12;--mat-filled-button-pressed-state-layer-opacity:.12;--mat-filled-button-touch-target-display:block;--mat-filled-button-horizontal-padding:24px;--mat-filled-button-icon-spacing:8px;--mat-filled-button-icon-offset:-8px;--mat-outlined-button-state-layer-color:#005cbb;--mat-outlined-button-disabled-state-layer-color:#44474e;--mat-outlined-button-ripple-color:rgba(0, 92, 187, .12);--mat-outlined-button-hover-state-layer-opacity:.08;--mat-outlined-button-focus-state-layer-opacity:.12;--mat-outlined-button-pressed-state-layer-opacity:.12;--mat-outlined-button-touch-target-display:block;--mat-outlined-button-horizontal-padding:24px;--mat-outlined-button-icon-spacing:8px;--mat-outlined-button-icon-offset:-8px;--mdc-icon-button-icon-color:#44474e;--mdc-icon-button-disabled-icon-color:rgba(26, 27, 31, .38);--mdc-icon-button-state-layer-size:40px;--mdc-icon-button-icon-size:24px;--mat-icon-button-state-layer-color:#44474e;--mat-icon-button-disabled-state-layer-color:#44474e;--mat-icon-button-ripple-color:rgba(68, 71, 78, .12);--mat-icon-button-hover-state-layer-opacity:.08;--mat-icon-button-focus-state-layer-opacity:.12;--mat-icon-button-pressed-state-layer-opacity:.12;--mat-icon-button-touch-target-display:block;--mdc-extended-fab-container-elevation-shadow:0px 3px 5px -1px rgba(0, 0, 0, .2), 0px 6px 10px 0px rgba(0, 0, 0, .14), 0px 1px 18px 0px rgba(0, 0, 0, .12);--mdc-extended-fab-focus-container-elevation-shadow:0px 3px 5px -1px rgba(0, 0, 0, .2), 0px 6px 10px 0px rgba(0, 0, 0, .14), 0px 1px 18px 0px rgba(0, 0, 0, .12);--mdc-extended-fab-hover-container-elevation-shadow:0px 5px 5px -3px rgba(0, 0, 0, .2), 0px 8px 10px 1px rgba(0, 0, 0, .14), 0px 3px 14px 2px rgba(0, 0, 0, .12);--mdc-extended-fab-pressed-container-elevation-shadow:0px 3px 5px -1px rgba(0, 0, 0, .2), 0px 6px 10px 0px rgba(0, 0, 0, .14), 0px 1px 18px 0px rgba(0, 0, 0, .12);--mdc-extended-fab-label-text-font:Roboto, sans-serif;--mdc-extended-fab-label-text-size:.875rem;--mdc-extended-fab-label-text-tracking:.006rem;--mdc-extended-fab-label-text-weight:500;--mdc-extended-fab-container-height:56px;--mdc-extended-fab-container-shape:16px;--mdc-fab-container-elevation-shadow:0px 3px 5px -1px rgba(0, 0, 0, .2), 0px 6px 10px 0px rgba(0, 0, 0, .14), 0px 1px 18px 0px rgba(0, 0, 0, .12);--mdc-fab-focus-container-elevation-shadow:0px 3px 5px -1px rgba(0, 0, 0, .2), 0px 6px 10px 0px rgba(0, 0, 0, .14), 0px 1px 18px 0px rgba(0, 0, 0, .12);--mdc-fab-hover-container-elevation-shadow:0px 5px 5px -3px rgba(0, 0, 0, .2), 0px 8px 10px 1px rgba(0, 0, 0, .14), 0px 3px 14px 2px rgba(0, 0, 0, .12);--mdc-fab-pressed-container-elevation-shadow:0px 3px 5px -1px rgba(0, 0, 0, .2), 0px 6px 10px 0px rgba(0, 0, 0, .14), 0px 1px 18px 0px rgba(0, 0, 0, .12);--mdc-fab-container-color:#d7e3ff;--mdc-fab-container-shape:16px;--mdc-fab-small-container-elevation-shadow:0px 3px 5px -1px rgba(0, 0, 0, .2), 0px 6px 10px 0px rgba(0, 0, 0, .14), 0px 1px 18px 0px rgba(0, 0, 0, .12);--mdc-fab-small-focus-container-elevation-shadow:0px 3px 5px -1px rgba(0, 0, 0, .2), 0px 6px 10px 0px rgba(0, 0, 0, .14), 0px 1px 18px 0px rgba(0, 0, 0, .12);--mdc-fab-small-hover-container-elevation-shadow:0px 5px 5px -3px rgba(0, 0, 0, .2), 0px 8px 10px 1px rgba(0, 0, 0, .14), 0px 3px 14px 2px rgba(0, 0, 0, .12);--mdc-fab-small-pressed-container-elevation-shadow:0px 3px 5px -1px rgba(0, 0, 0, .2), 0px 6px 10px 0px rgba(0, 0, 0, .14), 0px 1px 18px 0px rgba(0, 0, 0, .12);--mdc-fab-small-container-color:#d7e3ff;--mdc-fab-small-container-shape:12px;--mat-fab-foreground-color:#001b3f;--mat-fab-state-layer-color:#001b3f;--mat-fab-ripple-color:rgba(0, 27, 63, .12);--mat-fab-hover-state-layer-opacity:.08;--mat-fab-focus-state-layer-opacity:.12;--mat-fab-pressed-state-layer-opacity:.12;--mat-fab-disabled-state-container-color:rgba(26, 27, 31, .12);--mat-fab-disabled-state-foreground-color:rgba(26, 27, 31, .38);--mat-fab-touch-target-display:block;--mat-fab-small-foreground-color:#001b3f;--mat-fab-small-state-layer-color:#001b3f;--mat-fab-small-ripple-color:rgba(0, 27, 63, .12);--mat-fab-small-hover-state-layer-opacity:.08;--mat-fab-small-focus-state-layer-opacity:.12;--mat-fab-small-pressed-state-layer-opacity:.12;--mat-fab-small-disabled-state-container-color:rgba(26, 27, 31, .12);--mat-fab-small-disabled-state-foreground-color:rgba(26, 27, 31, .38);--mdc-snackbar-container-color:#2f3033;--mdc-snackbar-supporting-text-color:#f2f0f4;--mdc-snackbar-supporting-text-font:Roboto, sans-serif;--mdc-snackbar-supporting-text-line-height:1.25rem;--mdc-snackbar-supporting-text-size:.875rem;--mdc-snackbar-supporting-text-weight:400;--mdc-snackbar-container-shape:4px;--mat-snack-bar-button-color:#abc7ff;--mat-table-background-color:#faf9fd;--mat-table-header-headline-color:#1a1b1f;--mat-table-row-item-label-text-color:#1a1b1f;--mat-table-row-item-outline-color:#74777f;--mat-table-header-headline-font:Roboto, sans-serif;--mat-table-header-headline-line-height:1.25rem;--mat-table-header-headline-size:.875rem;--mat-table-header-headline-weight:500;--mat-table-header-headline-tracking:.006rem;--mat-table-row-item-label-text-font:Roboto, sans-serif;--mat-table-row-item-label-text-line-height:1.25rem;--mat-table-row-item-label-text-size:.875rem;--mat-table-row-item-label-text-weight:400;--mat-table-row-item-label-text-tracking:.016rem;--mat-table-footer-supporting-text-font:Roboto, sans-serif;--mat-table-footer-supporting-text-line-height:1.25rem;--mat-table-footer-supporting-text-size:.875rem;--mat-table-footer-supporting-text-weight:400;--mat-table-footer-supporting-text-tracking:.016rem;--mat-table-header-container-height:56px;--mat-table-footer-container-height:52px;--mat-table-row-item-container-height:52px;--mat-table-row-item-outline-width:1px;--mdc-circular-progress-active-indicator-color:#005cbb;--mdc-circular-progress-active-indicator-width:4px;--mdc-circular-progress-size:48px;--mat-badge-background-color:#ba1a1a;--mat-badge-text-color:#ffffff;--mat-badge-disabled-state-background-color:rgba(186, 26, 26, .38);--mat-badge-disabled-state-text-color:#ffffff;--mat-badge-text-font:Roboto, sans-serif;--mat-badge-text-size:.688rem;--mat-badge-text-weight:500;--mat-badge-large-size-text-size:.688rem;--mat-badge-container-shape:9999px;--mat-badge-container-size:16px;--mat-badge-small-size-container-size:6px;--mat-badge-large-size-container-size:16px;--mat-badge-legacy-container-size:unset;--mat-badge-legacy-small-size-container-size:unset;--mat-badge-legacy-large-size-container-size:unset;--mat-badge-container-offset:-12px 0;--mat-badge-small-size-container-offset:-6px 0;--mat-badge-large-size-container-offset:-12px 0;--mat-badge-container-overlap-offset:-12px;--mat-badge-small-size-container-overlap-offset:-6px;--mat-badge-large-size-container-overlap-offset:-12px;--mat-badge-container-padding:0 4px;--mat-badge-small-size-container-padding:0;--mat-badge-large-size-container-padding:0 4px;--mat-badge-line-height:16px;--mat-badge-small-size-text-size:0;--mat-badge-small-size-line-height:6px;--mat-badge-large-size-line-height:16px;--mat-bottom-sheet-container-text-color:#1a1b1f;--mat-bottom-sheet-container-background-color:#f4f3f6;--mat-bottom-sheet-container-text-font:Roboto, sans-serif;--mat-bottom-sheet-container-text-line-height:1.5rem;--mat-bottom-sheet-container-text-size:1rem;--mat-bottom-sheet-container-text-tracking:.031rem;--mat-bottom-sheet-container-text-weight:400;--mat-bottom-sheet-container-shape:28px;--mat-standard-button-toggle-hover-state-layer-opacity:.08;--mat-standard-button-toggle-focus-state-layer-opacity:.12;--mat-standard-button-toggle-text-color:#1a1b1f;--mat-standard-button-toggle-state-layer-color:#1a1b1f;--mat-standard-button-toggle-selected-state-background-color:#dae2f9;--mat-standard-button-toggle-selected-state-text-color:#131c2b;--mat-standard-button-toggle-disabled-state-text-color:rgba(26, 27, 31, .38);--mat-standard-button-toggle-disabled-selected-state-text-color:rgba(26, 27, 31, .38);--mat-standard-button-toggle-disabled-selected-state-background-color:rgba(26, 27, 31, .12);--mat-standard-button-toggle-divider-color:#74777f;--mat-standard-button-toggle-label-text-font:Roboto, sans-serif;--mat-standard-button-toggle-label-text-line-height:1.25rem;--mat-standard-button-toggle-label-text-size:.875rem;--mat-standard-button-toggle-label-text-tracking:.006rem;--mat-standard-button-toggle-label-text-weight:500;--mat-standard-button-toggle-height:40px;--mat-standard-button-toggle-shape:9999px;--mat-standard-button-toggle-background-color:transparent;--mat-standard-button-toggle-disabled-state-background-color:transparent;--mat-datepicker-calendar-date-selected-state-text-color:#ffffff;--mat-datepicker-calendar-date-selected-state-background-color:#005cbb;--mat-datepicker-calendar-date-selected-disabled-state-background-color:rgba(26, 27, 31, .38);--mat-datepicker-calendar-date-today-selected-state-outline-color:#005cbb;--mat-datepicker-calendar-date-focus-state-background-color:rgba(26, 27, 31, .12);--mat-datepicker-calendar-date-hover-state-background-color:rgba(26, 27, 31, .08);--mat-datepicker-toggle-active-state-icon-color:#44474e;--mat-datepicker-calendar-date-in-range-state-background-color:#d7e3ff;--mat-datepicker-calendar-date-in-comparison-range-state-background-color:#e0e0ff;--mat-datepicker-calendar-date-in-overlap-range-state-background-color:#dae2f9;--mat-datepicker-calendar-date-in-overlap-range-selected-state-background-color:#565e71;--mat-datepicker-toggle-icon-color:#44474e;--mat-datepicker-calendar-body-label-text-color:#1a1b1f;--mat-datepicker-calendar-period-button-text-color:#44474e;--mat-datepicker-calendar-period-button-icon-color:#44474e;--mat-datepicker-calendar-navigation-button-icon-color:#44474e;--mat-datepicker-calendar-header-text-color:#44474e;--mat-datepicker-calendar-date-today-outline-color:#005cbb;--mat-datepicker-calendar-date-today-disabled-state-outline-color:rgba(26, 27, 31, .38);--mat-datepicker-calendar-date-text-color:#1a1b1f;--mat-datepicker-calendar-date-disabled-state-text-color:rgba(26, 27, 31, .38);--mat-datepicker-calendar-date-preview-state-outline-color:#005cbb;--mat-datepicker-range-input-separator-color:#1a1b1f;--mat-datepicker-range-input-disabled-state-separator-color:rgba(26, 27, 31, .38);--mat-datepicker-range-input-disabled-state-text-color:rgba(26, 27, 31, .38);--mat-datepicker-calendar-container-background-color:#e9e7eb;--mat-datepicker-calendar-container-text-color:#1a1b1f;--mat-datepicker-calendar-text-font:Roboto, sans-serif;--mat-datepicker-calendar-text-size:.875rem;--mat-datepicker-calendar-body-label-text-size:.875rem;--mat-datepicker-calendar-body-label-text-weight:500;--mat-datepicker-calendar-period-button-text-size:.875rem;--mat-datepicker-calendar-period-button-text-weight:500;--mat-datepicker-calendar-header-text-size:.875rem;--mat-datepicker-calendar-header-text-weight:500;--mat-datepicker-calendar-container-shape:16px;--mat-datepicker-calendar-container-touch-shape:28px;--mat-datepicker-calendar-container-elevation-shadow:0px 0px 0px 0px rgba(0, 0, 0, .2), 0px 0px 0px 0px rgba(0, 0, 0, .14), 0px 0px 0px 0px rgba(0, 0, 0, .12);--mat-datepicker-calendar-container-touch-elevation-shadow:0px 0px 0px 0px rgba(0, 0, 0, .2), 0px 0px 0px 0px rgba(0, 0, 0, .14), 0px 0px 0px 0px rgba(0, 0, 0, .12);--mat-datepicker-calendar-header-divider-color:transparent;--mat-datepicker-calendar-date-outline-color:transparent;--mat-divider-color:#74777f;--mat-divider-width:1px;--mat-expansion-container-background-color:#faf9fd;--mat-expansion-container-text-color:#1a1b1f;--mat-expansion-actions-divider-color:#74777f;--mat-expansion-header-hover-state-layer-color:rgba(26, 27, 31, .08);--mat-expansion-header-focus-state-layer-color:rgba(26, 27, 31, .12);--mat-expansion-header-disabled-state-text-color:rgba(26, 27, 31, .38);--mat-expansion-header-text-color:#1a1b1f;--mat-expansion-header-description-color:#44474e;--mat-expansion-header-indicator-color:#44474e;--mat-expansion-header-text-font:Roboto, sans-serif;--mat-expansion-header-text-size:1rem;--mat-expansion-header-text-weight:500;--mat-expansion-header-text-line-height:1.5rem;--mat-expansion-header-text-tracking:.009rem;--mat-expansion-container-text-font:Roboto, sans-serif;--mat-expansion-container-text-line-height:1.5rem;--mat-expansion-container-text-size:1rem;--mat-expansion-container-text-tracking:.031rem;--mat-expansion-container-text-weight:400;--mat-expansion-header-collapsed-state-height:48px;--mat-expansion-header-expanded-state-height:64px;--mat-expansion-container-shape:12px;--mat-expansion-legacy-header-indicator-display:none;--mat-expansion-header-indicator-display:inline-block;--mat-grid-list-tile-header-primary-text-size:400 1rem / 1.5rem Roboto, sans-serif;--mat-grid-list-tile-header-secondary-text-size:400 .875rem / 1.25rem Roboto, sans-serif;--mat-grid-list-tile-footer-primary-text-size:400 1rem / 1.5rem Roboto, sans-serif;--mat-grid-list-tile-footer-secondary-text-size:400 .875rem / 1.25rem Roboto, sans-serif;--mat-icon-color:inherit;--mat-sidenav-container-background-color:#faf9fd;--mat-sidenav-container-text-color:#44474e;--mat-sidenav-content-background-color:#faf9fd;--mat-sidenav-content-text-color:#1a1b1f;--mat-sidenav-scrim-color:rgba(45, 48, 56, .4);--mat-sidenav-container-shape:16px;--mat-sidenav-container-elevation-shadow:none;--mat-sidenav-container-width:360px;--mat-sidenav-container-divider-color:transparent;--mat-stepper-header-icon-foreground-color:#faf9fd;--mat-stepper-header-selected-state-icon-background-color:#005cbb;--mat-stepper-header-selected-state-icon-foreground-color:#ffffff;--mat-stepper-header-edit-state-icon-background-color:#005cbb;--mat-stepper-header-edit-state-icon-foreground-color:#ffffff;--mat-stepper-container-color:#faf9fd;--mat-stepper-line-color:#74777f;--mat-stepper-header-hover-state-layer-color:rgba(47, 48, 51, .08);--mat-stepper-header-focus-state-layer-color:rgba(47, 48, 51, .12);--mat-stepper-header-label-text-color:#44474e;--mat-stepper-header-optional-label-text-color:#44474e;--mat-stepper-header-selected-state-label-text-color:#44474e;--mat-stepper-header-error-state-label-text-color:#ba1a1a;--mat-stepper-header-icon-background-color:#44474e;--mat-stepper-header-error-state-icon-foreground-color:#ba1a1a;--mat-stepper-container-text-font:Roboto, sans-serif;--mat-stepper-header-label-text-font:Roboto, sans-serif;--mat-stepper-header-label-text-size:.875rem;--mat-stepper-header-label-text-weight:500;--mat-stepper-header-error-state-label-text-size:.875rem;--mat-stepper-header-selected-state-label-text-size:.875rem;--mat-stepper-header-selected-state-label-text-weight:500;--mat-stepper-header-height:72px;--mat-stepper-header-focus-state-layer-shape:12px;--mat-stepper-header-hover-state-layer-shape:12px;--mat-stepper-header-error-state-icon-background-color:transparent;--mat-sort-arrow-color:#1a1b1f;--mat-toolbar-container-background-color:#faf9fd;--mat-toolbar-container-text-color:#1a1b1f;--mat-toolbar-title-text-font:Roboto, sans-serif;--mat-toolbar-title-text-line-height:1.75rem;--mat-toolbar-title-text-size:1.375rem;--mat-toolbar-title-text-tracking:0;--mat-toolbar-title-text-weight:400;--mat-toolbar-standard-height:64px;--mat-toolbar-mobile-height:56px;--mat-tree-container-background-color:#faf9fd;--mat-tree-node-text-color:#1a1b1f;--mat-tree-node-text-font:Roboto, sans-serif;--mat-tree-node-text-size:1rem;--mat-tree-node-text-weight:400;--mat-tree-node-min-height:48px}.mat-typography{font:400 1rem/1.5rem Roboto,sans-serif;letter-spacing:.031rem}.mat-typography p{margin:0 0 .75em}:root{--bs-blue:#0d6efd;--bs-indigo:#6610f2;--bs-purple:#6f42c1;--bs-pink:#d63384;--bs-red:#dc3545;--bs-orange:#fd7e14;--bs-yellow:#ffc107;--bs-green:#198754;--bs-teal:#20c997;--bs-cyan:#0dcaf0;--bs-black:#000;--bs-white:#fff;--bs-gray:#6c757d;--bs-gray-dark:#343a40;--bs-gray-100:#f8f9fa;--bs-gray-200:#e9ecef;--bs-gray-300:#dee2e6;--bs-gray-400:#ced4da;--bs-gray-500:#adb5bd;--bs-gray-600:#6c757d;--bs-gray-700:#495057;--bs-gray-800:#343a40;--bs-gray-900:#212529;--bs-primary:#0d6efd;--bs-secondary:#6c757d;--bs-success:#198754;--bs-info:#0dcaf0;--bs-warning:#ffc107;--bs-danger:#dc3545;--bs-light:#f8f9fa;--bs-dark:#212529;--bs-primary-rgb:13,110,253;--bs-secondary-rgb:108,117,125;--bs-success-rgb:25,135,84;--bs-info-rgb:13,202,240;--bs-warning-rgb:255,193,7;--bs-danger-rgb:220,53,69;--bs-light-rgb:248,249,250;--bs-dark-rgb:33,37,41;--bs-primary-text-emphasis:#052c65;--bs-secondary-text-emphasis:#2b2f32;--bs-success-text-emphasis:#0a3622;--bs-info-text-emphasis:#055160;--bs-warning-text-emphasis:#664d03;--bs-danger-text-emphasis:#58151c;--bs-light-text-emphasis:#495057;--bs-dark-text-emphasis:#495057;--bs-primary-bg-subtle:#cfe2ff;--bs-secondary-bg-subtle:#e2e3e5;--bs-success-bg-subtle:#d1e7dd;--bs-info-bg-subtle:#cff4fc;--bs-warning-bg-subtle:#fff3cd;--bs-danger-bg-subtle:#f8d7da;--bs-light-bg-subtle:#fcfcfd;--bs-dark-bg-subtle:#ced4da;--bs-primary-border-subtle:#9ec5fe;--bs-secondary-border-subtle:#c4c8cb;--bs-success-border-subtle:#a3cfbb;--bs-info-border-subtle:#9eeaf9;--bs-warning-border-subtle:#ffe69c;--bs-danger-border-subtle:#f1aeb5;--bs-light-border-subtle:#e9ecef;--bs-dark-border-subtle:#adb5bd;--bs-white-rgb:255,255,255;--bs-black-rgb:0,0,0;--bs-font-sans-serif:system-ui,-apple-system,"Segoe UI",Roboto,"Helvetica Neue","Noto Sans","Liberation Sans",Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol","Noto Color Emoji";--bs-font-monospace:SFMono-Regular,Menlo,Monaco,Consolas,"Liberation Mono","Courier New",monospace;--bs-gradient:linear-gradient(180deg, rgba(255, 255, 255, .15), rgba(255, 255, 255, 0));--bs-body-font-family:var(--bs-font-sans-serif);--bs-body-font-size:1rem;--bs-body-font-weight:400;--bs-body-line-height:1.5;--bs-body-color:#212529;--bs-body-color-rgb:33,37,41;--bs-body-bg:#fff;--bs-body-bg-rgb:255,255,255;--bs-emphasis-color:#000;--bs-emphasis-color-rgb:0,0,0;--bs-secondary-color:rgba(33, 37, 41, .75);--bs-secondary-color-rgb:33,37,41;--bs-secondary-bg:#e9ecef;--bs-secondary-bg-rgb:233,236,239;--bs-tertiary-color:rgba(33, 37, 41, .5);--bs-tertiary-color-rgb:33,37,41;--bs-tertiary-bg:#f8f9fa;--bs-tertiary-bg-rgb:248,249,250;--bs-heading-color:inherit;--bs-link-color:#0d6efd;--bs-link-color-rgb:13,110,253;--bs-link-decoration:underline;--bs-link-hover-color:#0a58ca;--bs-link-hover-color-rgb:10,88,202;--bs-code-color:#d63384;--bs-highlight-color:#212529;--bs-highlight-bg:#fff3cd;--bs-border-width:1px;--bs-border-style:solid;--bs-border-color:#dee2e6;--bs-border-color-translucent:rgba(0, 0, 0, .175);--bs-border-radius:.375rem;--bs-border-radius-sm:.25rem;--bs-border-radius-lg:.5rem;--bs-border-radius-xl:1rem;--bs-border-radius-xxl:2rem;--bs-border-radius-2xl:var(--bs-border-radius-xxl);--bs-border-radius-pill:50rem;--bs-box-shadow:0 .5rem 1rem rgba(0, 0, 0, .15);--bs-box-shadow-sm:0 .125rem .25rem rgba(0, 0, 0, .075);--bs-box-shadow-lg:0 1rem 3rem rgba(0, 0, 0, .175);--bs-box-shadow-inset:inset 0 1px 2px rgba(0, 0, 0, .075);--bs-focus-ring-width:.25rem;--bs-focus-ring-opacity:.25;--bs-focus-ring-color:rgba(13, 110, 253, .25);--bs-form-valid-color:#198754;--bs-form-valid-border-color:#198754;--bs-form-invalid-color:#dc3545;--bs-form-invalid-border-color:#dc3545}*,:after,:before{box-sizing:border-box}@media (prefers-reduced-motion:no-preference){:root{scroll-behavior:smooth}}body{margin:0;font-family:var(--bs-body-font-family);font-size:var(--bs-body-font-size);font-weight:var(--bs-body-font-weight);line-height:var(--bs-body-line-height);color:var(--bs-body-color);text-align:var(--bs-body-text-align);background-color:var(--bs-body-bg);-webkit-text-size-adjust:100%;-webkit-tap-highlight-color:transparent}p{margin-top:0;margin-bottom:1rem}b{font-weight:bolder}a{color:rgba(var(--bs-link-color-rgb),var(--bs-link-opacity,1));text-decoration:underline}a:hover{--bs-link-color-rgb:var(--bs-link-hover-color-rgb)}button{border-radius:0}button:focus:not(:focus-visible){outline:0}button,input{margin:0;font-family:inherit;font-size:inherit;line-height:inherit}button{text-transform:none}button{-webkit-appearance:button}button:not(:disabled){cursor:pointer}.container{--bs-gutter-x:1.5rem;--bs-gutter-y:0;width:100%;padding-right:calc(var(--bs-gutter-x) * .5);padding-left:calc(var(--bs-gutter-x) * .5);margin-right:auto;margin-left:auto}@media (min-width:576px){.container{max-width:540px}}@media (min-width:768px){.container{max-width:720px}}@media (min-width:992px){.container{max-width:960px}}@media (min-width:1200px){.container{max-width:1140px}}@media (min-width:1400px){.container{max-width:1320px}}:root{--bs-breakpoint-xs:0;--bs-breakpoint-sm:576px;--bs-breakpoint-md:768px;--bs-breakpoint-lg:992px;--bs-breakpoint-xl:1200px;--bs-breakpoint-xxl:1400px}.form-control{display:block;width:100%;padding:.375rem .75rem;font-size:1rem;font-weight:400;line-height:1.5;color:var(--bs-body-color);-webkit-appearance:none;-moz-appearance:none;appearance:none;background-color:var(--bs-body-bg);background-clip:padding-box;border:var(--bs-border-width) solid var(--bs-border-color);border-radius:var(--bs-border-radius);transition:border-color .15s ease-in-out,box-shadow .15s ease-in-out}@media (prefers-reduced-motion:reduce){.form-control{transition:none}}.form-control:focus{color:var(--bs-body-color);background-color:var(--bs-body-bg);border-color:#86b7fe;outline:0;box-shadow:0 0 0 .25rem #0d6efd40}.form-control::-webkit-date-and-time-value{min-width:85px;height:1.5em;margin:0}.form-control::-webkit-datetime-edit{display:block;padding:0}.form-control::-moz-placeholder{color:var(--bs-secondary-color);opacity:1}.form-control::placeholder{color:var(--bs-secondary-color);opacity:1}.form-control:disabled{background-color:var(--bs-secondary-bg);opacity:1}.form-control::-webkit-file-upload-button{padding:.375rem .75rem;margin:-.375rem -.75rem;-webkit-margin-end:.75rem;margin-inline-end:.75rem;color:var(--bs-body-color);background-color:var(--bs-tertiary-bg);pointer-events:none;border-color:inherit;border-style:solid;border-width:0;border-inline-end-width:var(--bs-border-width);border-radius:0;-webkit-transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out;transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out}.form-control::file-selector-button{padding:.375rem .75rem;margin:-.375rem -.75rem;-webkit-margin-end:.75rem;margin-inline-end:.75rem;color:var(--bs-body-color);background-color:var(--bs-tertiary-bg);pointer-events:none;border-color:inherit;border-style:solid;border-width:0;border-inline-end-width:var(--bs-border-width);border-radius:0;transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out}@media (prefers-reduced-motion:reduce){.form-control::-webkit-file-upload-button{-webkit-transition:none;transition:none}.form-control::file-selector-button{transition:none}}.form-control:hover:not(:disabled):not([readonly])::-webkit-file-upload-button{background-color:var(--bs-secondary-bg)}.form-control:hover:not(:disabled):not([readonly])::file-selector-button{background-color:var(--bs-secondary-bg)}.btn{--bs-btn-padding-x:.75rem;--bs-btn-padding-y:.375rem;--bs-btn-font-family: ;--bs-btn-font-size:1rem;--bs-btn-font-weight:400;--bs-btn-line-height:1.5;--bs-btn-color:var(--bs-body-color);--bs-btn-bg:transparent;--bs-btn-border-width:var(--bs-border-width);--bs-btn-border-color:transparent;--bs-btn-border-radius:var(--bs-border-radius);--bs-btn-hover-border-color:transparent;--bs-btn-box-shadow:inset 0 1px 0 rgba(255, 255, 255, .15),0 1px 1px rgba(0, 0, 0, .075);--bs-btn-disabled-opacity:.65;--bs-btn-focus-box-shadow:0 0 0 .25rem rgba(var(--bs-btn-focus-shadow-rgb), .5);display:inline-block;padding:var(--bs-btn-padding-y) var(--bs-btn-padding-x);font-family:var(--bs-btn-font-family);font-size:var(--bs-btn-font-size);font-weight:var(--bs-btn-font-weight);line-height:var(--bs-btn-line-height);color:var(--bs-btn-color);text-align:center;text-decoration:none;vertical-align:middle;cursor:pointer;-webkit-user-select:none;-moz-user-select:none;user-select:none;border:var(--bs-btn-border-width) solid var(--bs-btn-border-color);border-radius:var(--bs-btn-border-radius);background-color:var(--bs-btn-bg);transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out}@media (prefers-reduced-motion:reduce){.btn{transition:none}}.btn:hover{color:var(--bs-btn-hover-color);background-color:var(--bs-btn-hover-bg);border-color:var(--bs-btn-hover-border-color)}.btn:focus-visible{color:var(--bs-btn-hover-color);background-color:var(--bs-btn-hover-bg);border-color:var(--bs-btn-hover-border-color);outline:0;box-shadow:var(--bs-btn-focus-box-shadow)}.btn:first-child:active,:not(.btn-check)+.btn:active{color:var(--bs-btn-active-color);background-color:var(--bs-btn-active-bg);border-color:var(--bs-btn-active-border-color)}.btn:first-child:active:focus-visible,:not(.btn-check)+.btn:active:focus-visible{box-shadow:var(--bs-btn-focus-box-shadow)}.btn:disabled{color:var(--bs-btn-disabled-color);pointer-events:none;background-color:var(--bs-btn-disabled-bg);border-color:var(--bs-btn-disabled-border-color);opacity:var(--bs-btn-disabled-opacity)}.card{--bs-card-spacer-y:1rem;--bs-card-spacer-x:1rem;--bs-card-title-spacer-y:.5rem;--bs-card-title-color: ;--bs-card-subtitle-color: ;--bs-card-border-width:var(--bs-border-width);--bs-card-border-color:var(--bs-border-color-translucent);--bs-card-border-radius:var(--bs-border-radius);--bs-card-box-shadow: ;--bs-card-inner-border-radius:calc(var(--bs-border-radius) - (var(--bs-border-width)));--bs-card-cap-padding-y:.5rem;--bs-card-cap-padding-x:1rem;--bs-card-cap-bg:rgba(var(--bs-body-color-rgb), .03);--bs-card-cap-color: ;--bs-card-height: ;--bs-card-color: ;--bs-card-bg:var(--bs-body-bg);--bs-card-img-overlay-padding:1rem;--bs-card-group-margin:.75rem;position:relative;display:flex;flex-direction:column;min-width:0;height:var(--bs-card-height);color:var(--bs-body-color);word-wrap:break-word;background-color:var(--bs-card-bg);background-clip:border-box;border:var(--bs-card-border-width) solid var(--bs-card-border-color);border-radius:var(--bs-card-border-radius)}.card-body{flex:1 1 auto;padding:var(--bs-card-spacer-y) var(--bs-card-spacer-x);color:var(--bs-card-color)}.card-title{margin-bottom:var(--bs-card-title-spacer-y);color:var(--bs-card-title-color)}.d-flex{display:flex!important}.flex-wrap{flex-wrap:wrap!important}.justify-content-center{justify-content:center!important}.mt-4{margin-top:1.5rem!important}.gap-3{gap:1rem!important}.text-center{text-align:center!important}html,body{height:100%;overflow-y:auto}body{background-color:#121212;color:#fff;font-family:Arial,sans-serif;margin:0;padding:0}
</style><link rel="stylesheet" href="MedicineSearch/styles-G7LQISCG.css" media="print" onload="this.media='all'"><noscript><link rel="stylesheet" href="styles-G7LQISCG.css"></noscript><style ng-app-id="ng">.container[_ngcontent-ng-c1557943716]{max-width:800px;margin:2rem auto;padding:0 1rem}.logo[_ngcontent-ng-c1557943716]{text-align:center;margin-bottom:2rem}.logo-text[_ngcontent-ng-c1557943716]{font-family:Cambria,Cochin,Georgia,Times,Times New Roman,serif;font-size:2.5rem;font-weight:700;color:#ff6f61;border-bottom:3px solid white}.search-bar[_ngcontent-ng-c1557943716]{display:flex;gap:1rem;margin-bottom:2rem;position:relative}.form-control[_ngcontent-ng-c1557943716]{flex:1}.card[_ngcontent-ng-c1557943716]{border-radius:8px;box-shadow:0 2px 4px #0000001a}.card-title[_ngcontent-ng-c1557943716]{color:#007bff;margin-bottom:1rem}.alert[_ngcontent-ng-c1557943716]{border-radius:8px}.spinner-border[_ngcontent-ng-c1557943716]{width:3rem;height:3rem}.card-header[_ngcontent-ng-c1557943716]{display:flex;justify-content:space-between;align-items:center;width:100%}.card-title[_ngcontent-ng-c1557943716]{flex:1;margin:0;word-break:break-word}.ai-summarize-button[_ngcontent-ng-c1557943716]{white-space:nowrap;margin-left:10px;background:linear-gradient(90deg,#d807ab,#0752f3);color:#fff;border:none;padding:10px 20px;border-radius:5px;cursor:pointer;font-size:16px;transition:background .3s ease}.language-chooser[_ngcontent-ng-c1557943716]   .btn[_ngcontent-ng-c1557943716]{transition:background .3s ease;border-radius:5px}.language-chooser[_ngcontent-ng-c1557943716]   .btn[_ngcontent-ng-c1557943716]:hover, .language-chooser[_ngcontent-ng-c1557943716]   .btn[_ngcontent-ng-c1557943716]:focus, .language-chooser[_ngcontent-ng-c1557943716]   .btn.active[_ngcontent-ng-c1557943716], .language-chooser[_ngcontent-ng-c1557943716]   .btn[_ngcontent-ng-c1557943716]:active{background:linear-gradient(90deg,#d807ab,#0752f3)!important;color:#fff!important;border-color:transparent!important}.ai-summarize-button[_ngcontent-ng-c1557943716]:hover{background:linear-gradient(45deg,#0752f3,#d807ab)}.horizontal-line[_ngcontent-ng-c1557943716]   hr[_ngcontent-ng-c1557943716]{border:none;height:4px;background-color:red;margin:20px 0}.suggestions-dropdown[_ngcontent-ng-c1557943716]{position:absolute;top:calc(100% + 5px);left:0;width:88%;max-width:calc(100% - 20px);background-color:#fff;border:1px solid #ccc;z-index:1000;max-height:200px;overflow-y:auto;border-radius:4px;box-shadow:0 2px 5px #0003;list-style-type:none;padding:0;margin:0;color:#000}.suggestions-dropdown[_ngcontent-ng-c1557943716]   li[_ngcontent-ng-c1557943716]{padding:10px;cursor:pointer}.suggestions-dropdown[_ngcontent-ng-c1557943716]   li[_ngcontent-ng-c1557943716]:hover{background-color:#f0f0f0}.suggestions-dropdown.visible[_ngcontent-ng-c1557943716]{display:block}.custom-suggestion[_ngcontent-ng-c1557943716]{margin-top:40px}</style><style ng-app-id="ng">.content[_ngcontent-ng-c121079201]{padding-bottom:60px}.fixed-footer[_ngcontent-ng-c121079201]{position:fixed;bottom:0;left:0;width:100%;background-color:teal;color:#fff;padding:15px 0;box-shadow:0 -2px 5px #0003}.fixed-footer[_ngcontent-ng-c121079201]   nav[_ngcontent-ng-c121079201]{display:flex;align-items:center;justify-content:center;gap:30px}.footer-link[_ngcontent-ng-c121079201]{color:#fff;text-decoration:none;font-size:20px;display:flex;align-items:center}.footer-link[_ngcontent-ng-c121079201]   i[_ngcontent-ng-c121079201]{margin-right:8px}.footer-link[_ngcontent-ng-c121079201]:hover{text-decoration:underline}</style><style ng-app-id="ng">.suggestions-container[_ngcontent-ng-c2114960693]{width:100%;display:flex;flex-wrap:wrap;gap:10px;justify-content:center;padding-top:20px;margin-top:30px}.suggestion-card[_ngcontent-ng-c2114960693]{flex:1 1 20%;max-width:100%;min-width:120px;box-shadow:0 2px 4px #0000001a;transition:transform .3s ease;padding:5px;font-size:.9rem;border-radius:5px;cursor:pointer}.suggestion-card[_ngcontent-ng-c2114960693]   .card-body[_ngcontent-ng-c2114960693]{padding:10px}.suggestion-card[_ngcontent-ng-c2114960693]   .card-title[_ngcontent-ng-c2114960693]{font-size:.9rem;font-weight:500;font-family:Trebuchet MS,Lucida Sans Unicode,Lucida Grande,Lucida Sans,Arial,sans-serif;color:#00f}.suggestion-card[_ngcontent-ng-c2114960693]:hover{transform:scale(1.05)}@media (max-width: 768px){.suggestion-card[_ngcontent-ng-c2114960693]{flex:1 1 40%}}@media (max-width: 576px){.suggestion-card[_ngcontent-ng-c2114960693]{flex:1 1 80%}}</style></head>
<body class="mat-typography"><!--nghm-->
  <app-root ng-version="18.2.9" ngh="2" ng-server-context="ssg"><app-search _nghost-ng-c1557943716 ngh="1"><div _ngcontent-ng-c1557943716 class="container"><div _ngcontent-ng-c1557943716 class="logo"><span _ngcontent-ng-c1557943716 class="logo-text">MediSearch</span></div><div _ngcontent-ng-c1557943716 class="search-bar"><input _ngcontent-ng-c1557943716 type="text" placeholder="Enter medicine name" class="form-control ng-untouched ng-pristine ng-valid" value><button _ngcontent-ng-c1557943716 class="btn" style="background-color: #008080; color: white;"><span _ngcontent-ng-c1557943716>Search</span><!----><!----></button><!----></div><div _ngcontent-ng-c1557943716 class="custom-suggestion" style="margin-top: 190px;"><app-medicine-suggestions _ngcontent-ng-c1557943716 _nghost-ng-c2114960693 ngh="0"><div _ngcontent-ng-c2114960693 class="text-center"><p _ngcontent-ng-c2114960693 style="font-size: 1.5rem;"><span _ngcontent-ng-c2114960693 style="border-bottom: 2px solid white; font-family: 'Franklin Gothic Medium', 'Arial Narrow', Arial, sans-serif;">Some Widely Used Medicines</span></p></div><div _ngcontent-ng-c2114960693 class="suggestions-container d-flex flex-wrap justify-content-center gap-3 mt-4" style="margin-top: 40px;"><div _ngcontent-ng-c2114960693 class="suggestion-card card"><div _ngcontent-ng-c2114960693 class="card-body text-center"><p _ngcontent-ng-c2114960693 class="card-title"><b _ngcontent-ng-c2114960693>QUETIAPINE FUMARATE</b></p></div></div><div _ngcontent-ng-c2114960693 class="suggestion-card card"><div _ngcontent-ng-c2114960693 class="card-body text-center"><p _ngcontent-ng-c2114960693 class="card-title"><b _ngcontent-ng-c2114960693>NITISINONE</b></p></div></div><div _ngcontent-ng-c2114960693 class="suggestion-card card"><div _ngcontent-ng-c2114960693 class="card-body text-center"><p _ngcontent-ng-c2114960693 class="card-title"><b _ngcontent-ng-c2114960693>VENLAFAXINE HYDROCHLORIDE</b></p></div></div><div _ngcontent-ng-c2114960693 class="suggestion-card card"><div _ngcontent-ng-c2114960693 class="card-body text-center"><p _ngcontent-ng-c2114960693 class="card-title"><b _ngcontent-ng-c2114960693>ONA-MAST</b></p></div></div><div _ngcontent-ng-c2114960693 class="suggestion-card card"><div _ngcontent-ng-c2114960693 class="card-body text-center"><p _ngcontent-ng-c2114960693 class="card-title"><b _ngcontent-ng-c2114960693>DEXMETHYLPHENIDATE HYDROCHLORIDE</b></p></div></div><div _ngcontent-ng-c2114960693 class="suggestion-card card"><div _ngcontent-ng-c2114960693 class="card-body text-center"><p _ngcontent-ng-c2114960693 class="card-title"><b _ngcontent-ng-c2114960693>TOLSURA</b></p></div></div><div _ngcontent-ng-c2114960693 class="suggestion-card card"><div _ngcontent-ng-c2114960693 class="card-body text-center"><p _ngcontent-ng-c2114960693 class="card-title"><b _ngcontent-ng-c2114960693>OXALIPLATIN</b></p></div></div><div _ngcontent-ng-c2114960693 class="suggestion-card card"><div _ngcontent-ng-c2114960693 class="card-body text-center"><p _ngcontent-ng-c2114960693 class="card-title"><b _ngcontent-ng-c2114960693>BUTALBITAL AND ACETAMINOPHEN</b></p></div></div><!----></div></app-medicine-suggestions></div><!----><!----><!----><!----></div></app-search><app-header _nghost-ng-c121079201 ngh="2"><header _ngcontent-ng-c121079201 class="fixed-footer"><nav _ngcontent-ng-c121079201><a _ngcontent-ng-c121079201 href="#home" class="footer-link"><i _ngcontent-ng-c121079201 class="fas fa-home"></i> Home </a><a _ngcontent-ng-c121079201 href="#medisearch" class="footer-link"><i _ngcontent-ng-c121079201 class="fas fa-search"></i> MediSearch </a><a _ngcontent-ng-c121079201 href="#nutriscan" class="footer-link"><i _ngcontent-ng-c121079201 class="fas fa-apple-alt"></i> NutriScan </a></nav></header></app-header></app-root>
<script src="MedicineSearch/polyfills-FFHMD2TL.js" type="module"></script><script src="MedicineSearch/main-5OZZDWN7.js" type="module"></script>

<script id="ng-state" type="application/json">{"3088930788":{"b":{"meta":{"disclaimer":"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.","terms":"https://open.fda.gov/terms/","license":"https://open.fda.gov/license/","last_updated":"2024-12-10","results":{"skip":0,"limit":100,"total":27847}},"results":[{"submissions":[{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20060111","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20040806","application_docs":[{"id":"8910","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/76422ltr.pdf","date":"20040806","type":"Letter"},{"id":"22557","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/076422_CiclopiroxTOC.cfm","date":"20070402","type":"Review"}]}],"application_number":"ANDA076422","sponsor_name":"FOUGERA PHARMS","products":[{"product_number":"001","reference_drug":"No","brand_name":"CICLOPIROX","active_ingredients":[{"name":"CICLOPIROX","strength":"0.77%"}],"reference_standard":"No","dosage_form":"SUSPENSION","route":"TOPICAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20090528","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20050727"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20091228","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20071030","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA076705","sponsor_name":"DR REDDYS LABS INC","products":[{"product_number":"001","reference_drug":"No","brand_name":"RANITIDINE HYDROCHLORIDE","active_ingredients":[{"name":"RANITIDINE HYDROCHLORIDE","strength":"EQ 150MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"002","reference_drug":"No","brand_name":"RANITIDINE HYDROCHLORIDE","active_ingredients":[{"name":"RANITIDINE HYDROCHLORIDE","strength":"EQ 300MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"20071010","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"19","submission_status":"AP","submission_status_date":"20141205","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20050809","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"23","submission_status":"AP","submission_status_date":"20210607","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"21","submission_status":"AP","submission_status_date":"20151023","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"13","submission_status":"AP","submission_status_date":"20100830","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"20090709","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"20081017","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"20080707","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20061005","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"28","submission_status":"AP","submission_status_date":"20210607","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"26","submission_status":"AP","submission_status_date":"20210607","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"18","submission_status":"AP","submission_status_date":"20141205","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"16","submission_status":"AP","submission_status_date":"20141205","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"22","submission_status":"AP","submission_status_date":"20210607","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"14","submission_status":"AP","submission_status_date":"20120228","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20041213","application_docs":[{"id":"23845","url":"http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm109352.htm","date":"20050801","type":"Other Important Information from FDA"}]},{"submission_type":"SUPPL","submission_number":"20","submission_status":"AP","submission_status_date":"20141205","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"20100317","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"20081017","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA076990","sponsor_name":"SUN PHARM INDS LTD","openfda":{"application_number":["ANDA076990"],"brand_name":["FLUOXETINE"],"generic_name":["FLUOXETINE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["63304-632"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FLUOXETINE HYDROCHLORIDE"],"rxcui":["313989"],"spl_id":["db910c53-3c87-40cb-b799-53bbb95a983c"],"spl_set_id":["bfd18a45-06cc-4281-b181-40eb5d192a9b"],"package_ndc":["63304-632-30","63304-632-90","63304-632-01","63304-632-05","63304-632-10","63304-632-80"],"unii":["I9W7N6B1KJ"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"FLUOXETINE HYDROCHLORIDE","active_ingredients":[{"name":"FLUOXETINE HYDROCHLORIDE","strength":"EQ 40MG BASE"}],"reference_standard":"No","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Discontinued","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20060203"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20100119","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20080629","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA077280","sponsor_name":"WATSON LABS","products":[{"product_number":"003","reference_drug":"No","brand_name":"GLIMEPIRIDE","active_ingredients":[{"name":"GLIMEPIRIDE","strength":"4MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"001","reference_drug":"No","brand_name":"GLIMEPIRIDE","active_ingredients":[{"name":"GLIMEPIRIDE","strength":"1MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"002","reference_drug":"No","brand_name":"GLIMEPIRIDE","active_ingredients":[{"name":"GLIMEPIRIDE","strength":"2MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20230628","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20171214","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20090709"}],"application_number":"ANDA077587","sponsor_name":"CHARTWELL RX","products":[{"product_number":"003","reference_drug":"No","brand_name":"GALANTAMINE HYDROBROMIDE","active_ingredients":[{"name":"GALANTAMINE HYDROBROMIDE","strength":"EQ 12MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"001","reference_drug":"No","brand_name":"GALANTAMINE HYDROBROMIDE","active_ingredients":[{"name":"GALANTAMINE HYDROBROMIDE","strength":"EQ 4MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"002","reference_drug":"No","brand_name":"GALANTAMINE HYDROBROMIDE","active_ingredients":[{"name":"GALANTAMINE HYDROBROMIDE","strength":"EQ 8MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"18","submission_status":"AP","submission_status_date":"20191025","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"16","submission_status":"AP","submission_status_date":"20191025","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"22","submission_status":"AP","submission_status_date":"20220928","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"14","submission_status":"AP","submission_status_date":"20141213","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"20090121","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20070423","application_docs":[{"id":"31297","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/077884s000ltr.pdf","date":"20070501","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"19","submission_status":"AP","submission_status_date":"20191025","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"17","submission_status":"AP","submission_status_date":"20191025","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20080529","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"15","submission_status":"AP","submission_status_date":"20191025","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"13","submission_status":"AP","submission_status_date":"20141213","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"20110204","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA077884","sponsor_name":"APOTEX INC","products":[{"product_number":"001","reference_drug":"No","brand_name":"ZOLPIDEM TARTRATE","active_ingredients":[{"name":"ZOLPIDEM TARTRATE","strength":"5MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"002","reference_drug":"No","brand_name":"ZOLPIDEM TARTRATE","active_ingredients":[{"name":"ZOLPIDEM TARTRATE","strength":"10MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"TA","submission_status_date":"20140529"}],"application_number":"ANDA078475","sponsor_name":"CIPLA LTD","products":[{"product_number":"001","reference_drug":"No","brand_name":"ZOLEDRONIC ACID","active_ingredients":[{"name":"ZOLEDRONIC ACID","strength":"4MG/5ML(0.8MG/ML)"}],"dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"None (Tentative Approval)"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20120529","application_docs":[{"id":"22627","url":"http://www.accessdata.fda.gov/drugsatfda_docs/anda/2012/078773Orig1s000.pdf","date":"20150309","type":"Review"},{"id":"31387","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/078773s000ltr.pdf","date":"20111201","type":"Letter"}]}],"application_number":"ANDA078773","sponsor_name":"TEVA PHARMS","products":[{"product_number":"004","reference_drug":"No","brand_name":"ATORVASTATIN CALCIUM","active_ingredients":[{"name":"ATORVASTATIN CALCIUM","strength":"EQ 80MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"002","reference_drug":"No","brand_name":"ATORVASTATIN CALCIUM","active_ingredients":[{"name":"ATORVASTATIN CALCIUM","strength":"EQ 20MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"003","reference_drug":"No","brand_name":"ATORVASTATIN CALCIUM","active_ingredients":[{"name":"ATORVASTATIN CALCIUM","strength":"EQ 40MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"001","reference_drug":"No","brand_name":"ATORVASTATIN CALCIUM","active_ingredients":[{"name":"ATORVASTATIN CALCIUM","strength":"EQ 10MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"20231102","review_priority":"UNKNOWN","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"20180717","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20151117","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20151117","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20180717","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20151117","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20090130","application_docs":[{"id":"18477","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078185s000lbl.pdf","date":"20090224","type":"Label"},{"id":"31343","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/078185s000ltr.pdf","date":"20090203","type":"Letter"}]}],"application_number":"ANDA078185","sponsor_name":"HIKMA","openfda":{"application_number":["ANDA078185"],"brand_name":["GALANTAMINE HYDROBROMIDE"],"generic_name":["GALANTAMINE HYDROBROMIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0054-0137"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["GALANTAMINE HYDROBROMIDE"],"rxcui":["860901"],"spl_id":["b2bf3efc-7521-4ff7-b77c-6e312e34b3c4"],"spl_set_id":["d5b0e225-e94d-4324-afb2-b6e51c949dd0"],"package_ndc":["0054-0137-49"],"unii":["MJ4PTD2VVW"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"GALANTAMINE HYDROBROMIDE","active_ingredients":[{"name":"GALANTAMINE HYDROBROMIDE","strength":"4MG/ML"}],"reference_standard":"Yes","dosage_form":"SOLUTION","route":"ORAL","marketing_status":"Prescription"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"21","submission_status":"AP","submission_status_date":"20200103","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20111027","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20110225","application_docs":[{"id":"9220","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/079086s000ltr.pdf","date":"20110302","type":"Letter"}]}],"application_number":"ANDA079086","sponsor_name":"PETNET","openfda":{"application_number":["ANDA079086"],"brand_name":["FLUDEOXYGLUCOSE F 18"],"generic_name":["FLUDEOXYGLUCOSE F 18"],"manufacturer_name":["PETNET Solutions, Inc."],"product_ndc":["40028-511"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["FLUDEOXYGLUCOSE F-18"],"spl_id":["129003a8-c755-41e8-b61f-a06f31490b82"],"spl_set_id":["caaa9ab5-e3f4-489d-9f4c-0ecbee6fca83"],"package_ndc":["40028-511-30","40028-511-50"],"nui":["N0000177914","N0000000205"],"pharm_class_epc":["Radioactive Diagnostic Agent [EPC]"],"pharm_class_moa":["Radiopharmaceutical Activity [MoA]"],"unii":["0Z5B2CJX4D"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"FLUDEOXYGLUCOSE F18","active_ingredients":[{"name":"FLUDEOXYGLUCOSE F-18","strength":"20-200mCi/ML"}],"reference_standard":"Yes","dosage_form":"INJECTABLE","route":"INTRAVENOUS","marketing_status":"Prescription","te_code":"AP"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19730718"},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"19850729","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"10","submission_status":"AP","submission_status_date":"19850729","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"19850729","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"ANDA080344","sponsor_name":"WHITEWORTH TOWN PLSN","products":[{"product_number":"002","reference_drug":"No","brand_name":"HYDROCORTISONE","active_ingredients":[{"name":"HYDROCORTISONE","strength":"20MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"001","reference_drug":"No","brand_name":"HYDROCORTISONE","active_ingredients":[{"name":"HYDROCORTISONE","strength":"10MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19761203"},{"submission_type":"SUPPL","submission_number":"14","submission_status":"AP","submission_status_date":"19850909","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"ANDA080857","sponsor_name":"CHARTWELL MOLECULAR","products":[{"product_number":"002","reference_drug":"No","brand_name":"DIPHENYLAN SODIUM","active_ingredients":[{"name":"PHENYTOIN SODIUM","strength":"100MG PROMPT"}],"reference_standard":"No","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"001","reference_drug":"No","brand_name":"DIPHENYLAN SODIUM","active_ingredients":[{"name":"PHENYTOIN SODIUM","strength":"30MG PROMPT"}],"reference_standard":"No","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"18","submission_status":"AP","submission_status_date":"19820416","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"32","submission_status":"AP","submission_status_date":"19840922","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"24","submission_status":"AP","submission_status_date":"19820622","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"19800807","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"16","submission_status":"AP","submission_status_date":"19811221","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"22","submission_status":"AP","submission_status_date":"19830711","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"14","submission_status":"AP","submission_status_date":"19810629","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"67","submission_status":"AP","submission_status_date":"20190529","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"58892","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016677s169,018016s067,020178s021lbl.pdf","date":"20190530","type":"Label"},{"id":"58967","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/016677Orig1s169, 018016Orig1s067, 020178Orig1s021ltr.pdf","date":"20190604","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"19790614","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"19800731","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"57","submission_status":"AP","submission_status_date":"20050826","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)","application_docs":[{"id":"782","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/013684s092,016677s139,et al_ltr.pdf","date":"20050831","type":"Letter"},{"id":"11117","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/013684s092,016677s139,et al_lbl.pdf","date":"20050831","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"71","submission_status":"AP","submission_status_date":"20240724","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"79214","url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/016677Orig1s185,016682Orig1s124,018016Orig1s071ltr.pdf","date":"20240725","type":"Letter"},{"id":"79226","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/016677s185,016682s124,018016s071lbl.pdf","date":"20240729","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"49","submission_status":"AP","submission_status_date":"20020403","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"780","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/16677s124ltr.pdf","date":"20020403","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"47","submission_status":"AP","submission_status_date":"19940218","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"61","submission_status":"AP","submission_status_date":"20130911","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"783","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/016677s147,018016s061,016693s096ltr.pdf","date":"20130913","type":"Letter"},{"id":"11118","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/016677s147,016693s096,018016s061lbl.pdf","date":"20130917","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"39","submission_status":"AP","submission_status_date":"19870725","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"53","submission_status":"AP","submission_status_date":"20030717","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)","application_docs":[{"id":"781","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/18016scp053ltr.pdf","date":"20030728","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"51","submission_status":"AP","submission_status_date":"20010814","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"29","submission_status":"AP","submission_status_date":"19850828","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"43","submission_status":"AP","submission_status_date":"19910326","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"35","submission_status":"AP","submission_status_date":"19850415","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"27","submission_status":"AP","submission_status_date":"19840316","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"41","submission_status":"AP","submission_status_date":"19910215","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"19800618","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19790202","review_priority":"STANDARD","submission_class_code":"TYPE 5","submission_class_code_description":"Type 5 - New Formulation or New Manufacturer"},{"submission_type":"SUPPL","submission_number":"19","submission_status":"AP","submission_status_date":"19820603","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"33","submission_status":"AP","submission_status_date":"19850613","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"19800530","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"17","submission_status":"AP","submission_status_date":"19810826","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"31","submission_status":"AP","submission_status_date":"19840228","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"19790802","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"21","submission_status":"AP","submission_status_date":"19811120","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"19800628","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"13","submission_status":"AP","submission_status_date":"19810121","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"19800225","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"19810416","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"56","submission_status":"AP","submission_status_date":"20050523","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"11116","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/018016s056lbl.pdf","date":"20050525","type":"Label"},{"id":"13980","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/018016s056ltr.pdf","date":"20050525","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"48","submission_status":"AP","submission_status_date":"19970429","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"62","submission_status":"AP","submission_status_date":"20141222","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"784","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/016677Orig1s148,018016Orig1s062,019022Orig1s026ltr.pdf","date":"20141230","type":"Letter"},{"id":"11119","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019022s026lbl.pdf","date":"20150108","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"46","submission_status":"AP","submission_status_date":"19940930","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"38","submission_status":"AP","submission_status_date":"19870528","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"44","submission_status":"AP","submission_status_date":"19910429","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"36","submission_status":"AP","submission_status_date":"19860227","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"50","submission_status":"AP","submission_status_date":"19991124","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"28","submission_status":"AP","submission_status_date":"19850828","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"42","submission_status":"AP","submission_status_date":"19900524","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"34","submission_status":"AP","submission_status_date":"19850418","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"26","submission_status":"AP","submission_status_date":"19850124","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"40","submission_status":"AP","submission_status_date":"19890726","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"NDA018016","sponsor_name":"BAXTER HLTHCARE","openfda":{"application_number":["NDA018016"],"brand_name":["SODIUM CHLORIDE"],"generic_name":["SODIUM CHLORIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0043","0338-0049"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM CHLORIDE"],"rxcui":["1807551","1807552","1807627","1807630","1807631","1807632","1807633","1807634","1807639"],"spl_id":["ca0306a6-f5e3-4cbc-a39c-0ecfda6ba60c"],"spl_set_id":["f55bd888-5e01-474d-871b-24654c070178"],"package_ndc":["0338-0049-01","0338-0049-02","0338-0049-03","0338-0049-04","0338-0049-10","0338-0049-41","0338-0049-11","0338-0049-31","0338-0049-48","0338-0049-18","0338-0049-38","0338-0043-03","0338-0043-04"],"unii":["451W47IQ8X"]},"products":[{"product_number":"001","reference_drug":"Yes","brand_name":"SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER","active_ingredients":[{"name":"SODIUM CHLORIDE","strength":"450MG/100ML"}],"reference_standard":"Yes","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Prescription","te_code":"AP"}]},{"application_number":"ANDA083872","sponsor_name":"HALSEY","products":[{"product_number":"001","reference_drug":"No","brand_name":"ACETAMINOPHEN AND CODEINE PHOSPHATE","active_ingredients":[{"name":"ACETAMINOPHEN","strength":"300MG"},{"name":"CODEINE PHOSPHATE","strength":"30MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"19821119","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"19810401","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19771221","review_priority":"STANDARD","submission_class_code":"TYPE 2","submission_class_code_description":"Type 2 - New Active Ingredient"}],"application_number":"NDA018102","sponsor_name":"PHARMACIA AND UPJOHN","products":[{"product_number":"001","reference_drug":"No","brand_name":"MEDROL","active_ingredients":[{"name":"METHYLPREDNISOLONE ACETATE","strength":"40MG/BOT"}],"reference_standard":"No","dosage_form":"ENEMA","route":"RECTAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"28","submission_status":"AP","submission_status_date":"19870903","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"26","submission_status":"AP","submission_status_date":"19870702","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19760820"},{"submission_type":"SUPPL","submission_number":"24","submission_status":"AP","submission_status_date":"19860815","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"30","submission_status":"AP","submission_status_date":"19881222","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"22","submission_status":"AP","submission_status_date":"19831220","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"29","submission_status":"AP","submission_status_date":"19871110","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"27","submission_status":"AP","submission_status_date":"19880415","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"25","submission_status":"AP","submission_status_date":"19860815","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"31","submission_status":"AP","submission_status_date":"19890125","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"23","submission_status":"AP","submission_status_date":"19831220","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"ANDA084927","sponsor_name":"IMPAX LABS","products":[{"product_number":"001","reference_drug":"No","brand_name":"METHOCARBAMOL","active_ingredients":[{"name":"METHOCARBAMOL","strength":"500MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"application_number":"ANDA085373","sponsor_name":"WATSON LABS","products":[{"product_number":"001","reference_drug":"No","brand_name":"HYDROCHLOROTHIAZIDE W/ HYDRALAZINE","active_ingredients":[{"name":"HYDRALAZINE HYDROCHLORIDE","strength":"25MG"},{"name":"HYDROCHLOROTHIAZIDE","strength":"15MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"19820319","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"19","submission_status":"AP","submission_status_date":"19900511","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"17","submission_status":"AP","submission_status_date":"19890103","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"23","submission_status":"AP","submission_status_date":"19990202","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"15","submission_status":"AP","submission_status_date":"19881004","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"21","submission_status":"AP","submission_status_date":"19980528","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"13","submission_status":"AP","submission_status_date":"19880302","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"19821227","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19811105","application_docs":[{"id":"22670","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/085825_original_approval_pkg.pdf","date":"19811105","type":"Review"}]},{"submission_type":"SUPPL","submission_number":"18","submission_status":"AP","submission_status_date":"19900511","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"24","submission_status":"AP","submission_status_date":"19990219","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"14","submission_status":"AP","submission_status_date":"19891201","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"19850204","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"10","submission_status":"AP","submission_status_date":"19860717","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"19830214","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"19821227","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"ANDA085825","sponsor_name":"WATSON LABS","products":[{"product_number":"001","reference_drug":"No","brand_name":"TRIAMCINOLONE ACETONIDE","active_ingredients":[{"name":"TRIAMCINOLONE ACETONIDE","strength":"40MG/ML"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19800324"}],"application_number":"ANDA086260","sponsor_name":"MAST MM","products":[{"product_number":"001","reference_drug":"No","brand_name":"ONA-MAST","active_ingredients":[{"name":"PHENTERMINE HYDROCHLORIDE","strength":"8MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"application_number":"ANDA086942","sponsor_name":"LEDERLE","products":[{"product_number":"001","reference_drug":"No","brand_name":"PROCAINAMIDE HYDROCHLORIDE","active_ingredients":[{"name":"PROCAINAMIDE HYDROCHLORIDE","strength":"250MG"}],"reference_standard":"No","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"19951023","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"19","submission_status":"AP","submission_status_date":"19970812","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"25","submission_status":"AP","submission_status_date":"19970812","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"17","submission_status":"AP","submission_status_date":"19951023","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"31","submission_status":"AP","submission_status_date":"20081021","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"23","submission_status":"AP","submission_status_date":"19970908","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19810714"},{"submission_type":"SUPPL","submission_number":"15","submission_status":"AP","submission_status_date":"19951023","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"21","submission_status":"AP","submission_status_date":"19970218","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"13","submission_status":"AP","submission_status_date":"19951023","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"26","submission_status":"AP","submission_status_date":"19981001","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"18","submission_status":"AP","submission_status_date":"19951023","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"24","submission_status":"AP","submission_status_date":"19970812","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"16","submission_status":"AP","submission_status_date":"19951023","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"22","submission_status":"AP","submission_status_date":"19970908","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"14","submission_status":"AP","submission_status_date":"19951023","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"20","submission_status":"AP","submission_status_date":"19970812","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA087425","sponsor_name":"HIKMA INTL PHARMS","products":[{"product_number":"001","reference_drug":"No","brand_name":"ISONIAZID","active_ingredients":[{"name":"ISONIAZID","strength":"300MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20160823","submission_class_code":"N/A","submission_class_code_description":"Not Applicable"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20160823","review_priority":"UNKNOWN","submission_class_code":"N/A","submission_class_code_description":"Not Applicable"}],"application_number":"ANDA091688","sponsor_name":"INVAGEN PHARMS","openfda":{"application_number":["ANDA091688"],"brand_name":["TROSPIUM CHLORIDE"],"generic_name":["TROSPIUM CHLORIDE"],"manufacturer_name":["CIPLA USA INC.,","Exelan Pharmaceuticals Inc."],"product_ndc":["69097-912","76282-336"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["TROSPIUM CHLORIDE"],"rxcui":["857560"],"spl_id":["9058b0be-0e24-418e-9be7-597c00fe8b70","0631f266-1c3c-430c-ad8b-66e89161f861"],"spl_set_id":["6a711666-9e80-4728-b745-e7dc86f57510","a4108873-d2d2-4667-b049-02b89b8f2494"],"package_ndc":["69097-912-02","69097-912-03","69097-912-15","76282-336-60"],"unii":["1E6682427E"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"TROSPIUM CHLORIDE","active_ingredients":[{"name":"TROSPIUM CHLORIDE","strength":"20MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"20170829","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"18","submission_status":"AP","submission_status_date":"20241031","submission_class_code":"REMS","submission_class_code_description":"REMS"},{"submission_type":"SUPPL","submission_number":"16","submission_status":"AP","submission_status_date":"20210910","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20151030","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"14","submission_status":"AP","submission_status_date":"20210304","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"20191011","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"10","submission_status":"AP","submission_status_date":"20180918","submission_class_code":"REMS","submission_class_code_description":"REMS"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20120627","submission_class_code":"N/A","submission_class_code_description":"Not Applicable","application_docs":[{"id":"76322","url":"https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17","date":"20231103","type":"REMS"}]},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"20161216","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"17","submission_status":"AP","submission_status_date":"20231215","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20161216","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"20180921","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA200491","sponsor_name":"ENDO OPERATIONS","products":[{"product_number":"003","reference_drug":"No","brand_name":"TRAMADOL HYDROCHLORIDE","active_ingredients":[{"name":"TRAMADOL HYDROCHLORIDE","strength":"300MG"}],"reference_standard":"No","dosage_form":"TABLET, EXTENDED RELEASE","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"001","reference_drug":"No","brand_name":"TRAMADOL HYDROCHLORIDE","active_ingredients":[{"name":"TRAMADOL HYDROCHLORIDE","strength":"100MG"}],"reference_standard":"No","dosage_form":"TABLET, EXTENDED RELEASE","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"002","reference_drug":"No","brand_name":"TRAMADOL HYDROCHLORIDE","active_ingredients":[{"name":"TRAMADOL HYDROCHLORIDE","strength":"200MG"}],"reference_standard":"No","dosage_form":"TABLET, EXTENDED RELEASE","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20130814","submission_class_code":"N/A","submission_class_code_description":"Not Applicable","application_docs":[{"id":"69649","url":"https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/201355Orig1s000.pdf","date":"20211220","type":"Review"}]},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20160928","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20140625","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA201355","sponsor_name":"NOSTRUM LABS INC","openfda":{"application_number":["ANDA201355"],"brand_name":["NITROFURANTOIN"],"generic_name":["NITROFURANTOIN"],"manufacturer_name":["Nostrum Laboratories, Inc."],"product_ndc":["70408-239"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["NITROFURANTOIN"],"rxcui":["311989"],"spl_id":["686f8b08-4e54-4cb2-abdd-595c3fb3d16e"],"spl_set_id":["c4fc70b5-f6eb-417e-8cc9-5b6e8a6e649f"],"package_ndc":["70408-239-32"],"nui":["N0000175494","M0014892"],"pharm_class_epc":["Nitrofuran Antibacterial [EPC]"],"pharm_class_cs":["Nitrofurans [CS]"],"unii":["927AH8112L"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"NITROFURANTOIN","active_ingredients":[{"name":"NITROFURANTOIN","strength":"25MG/5ML"}],"reference_standard":"No","dosage_form":"SUSPENSION","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"application_number":"ANDA088470","sponsor_name":"ASTRAZENECA","products":[{"product_number":"001","reference_drug":"Yes","brand_name":"ISOETHARINE HYDROCHLORIDE","active_ingredients":[{"name":"ISOETHARINE HYDROCHLORIDE","strength":"0.167%"}],"reference_standard":"No","dosage_form":"SOLUTION","route":"INHALATION","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"15","submission_status":"AP","submission_status_date":"19990219","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"13","submission_status":"AP","submission_status_date":"19970729","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"19951215","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"19950126","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"19940208","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"19880803","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"19860502","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"24","submission_status":"AP","submission_status_date":"20090306","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"22","submission_status":"AP","submission_status_date":"20050411","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"14","submission_status":"AP","submission_status_date":"19990202","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19850116"},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"19961204","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"10","submission_status":"AP","submission_status_date":"19960416","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"19940208","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"19910919","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"19880803","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"19861014","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"17","submission_status":"AP","submission_status_date":"19990510","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"ANDA088771","sponsor_name":"SANDOZ","products":[{"product_number":"001","reference_drug":"No","brand_name":"DEXAMETHASONE SODIUM PHOSPHATE","active_ingredients":[{"name":"DEXAMETHASONE SODIUM PHOSPHATE","strength":"EQ 0.1% PHOSPHATE"}],"reference_standard":"No","dosage_form":"SOLUTION/DROPS","route":"OPHTHALMIC, OTIC","marketing_status":"Discontinued"}]},{"application_number":"ANDA087797","sponsor_name":"ALPHARMA US PHARMS","products":[{"product_number":"001","reference_drug":"No","brand_name":"TRIAMCINOLONE ACETONIDE","active_ingredients":[{"name":"TRIAMCINOLONE ACETONIDE","strength":"0.025%"}],"reference_standard":"No","dosage_form":"CREAM","route":"TOPICAL","marketing_status":"Discontinued"}]},{"application_number":"ANDA088139","sponsor_name":"PUREPAC PHARM","products":[{"product_number":"001","reference_drug":"No","brand_name":"CHLORTHALIDONE","active_ingredients":[{"name":"CHLORTHALIDONE","strength":"25MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"application_number":"ANDA089130","sponsor_name":"HALSEY","products":[{"product_number":"001","reference_drug":"No","brand_name":"HYDRALAZINE HYDROCHLORIDE","active_ingredients":[{"name":"HYDRALAZINE HYDROCHLORIDE","strength":"25MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"20000516","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"19981105","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"19971205","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"19940112","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"20000516","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"19980402","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"19970224","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"19910830","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19870102"}],"application_number":"ANDA089489","sponsor_name":"SUN PHARM INDUSTRIES","products":[{"product_number":"001","reference_drug":"No","brand_name":"DIPHENHYDRAMINE HYDROCHLORIDE","active_ingredients":[{"name":"DIPHENHYDRAMINE HYDROCHLORIDE","strength":"50MG"}],"reference_standard":"No","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20170131"}],"application_number":"ANDA090030","sponsor_name":"FRESENIUS KABI USA","products":[{"product_number":"002","reference_drug":"No","brand_name":"OXALIPLATIN","active_ingredients":[{"name":"OXALIPLATIN","strength":"100MG/20ML (5MG/ML)"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INTRAVENOUS","marketing_status":"Prescription","te_code":"AP"},{"product_number":"003","reference_drug":"No","brand_name":"OXALIPLATIN","active_ingredients":[{"name":"OXALIPLATIN","strength":"200MG/40ML (5MG/ML)"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INTRAVENOUS","marketing_status":"Discontinued"},{"product_number":"001","reference_drug":"No","brand_name":"OXALIPLATIN","active_ingredients":[{"name":"OXALIPLATIN","strength":"50MG/10ML (5MG/ML)"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INTRAVENOUS","marketing_status":"Prescription","te_code":"AP"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20111221"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20150902","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20150902","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA090375","sponsor_name":"HOSPIRA INC","products":[{"product_number":"002","reference_drug":"No","brand_name":"AMPICILLIN AND SULBACTAM","active_ingredients":[{"name":"AMPICILLIN SODIUM","strength":"EQ 2GM BASE/VIAL"},{"name":"SULBACTAM SODIUM","strength":"EQ 1GM BASE/VIAL"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Discontinued"},{"product_number":"001","reference_drug":"No","brand_name":"AMPICILLIN AND SULBACTAM","active_ingredients":[{"name":"AMPICILLIN SODIUM","strength":"EQ 1GM BASE/VIAL"},{"name":"SULBACTAM SODIUM","strength":"EQ 500MG BASE/VIAL"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20141206","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20141206","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20110722","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20090924"}],"application_number":"ANDA090697","sponsor_name":"ZYDUS PHARMS USA INC","openfda":{"application_number":["ANDA090697"],"brand_name":["RAMIPRIL"],"generic_name":["RAMIPRIL"],"manufacturer_name":["Zydus Pharmaceuticals USA Inc.","Zydus Lifesciences Limited"],"product_ndc":["68382-374","68382-375","68382-376","68382-377","65841-699","65841-700","65841-701","65841-702"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RAMIPRIL"],"rxcui":["251856","251857","401965","401968"],"spl_id":["0fcc9d88-ecff-40db-a5bf-870d917146ea","3c272717-5c87-4f26-ad63-6034e5c40b41"],"spl_set_id":["ee92b5bb-77d5-47cd-a8b1-d5f383b94311","3c358a20-9abb-4fc0-afb9-400e3c621fe2"],"package_ndc":["68382-374-06","68382-374-16","68382-374-01","68382-374-05","68382-374-10","68382-374-77","68382-375-06","68382-375-16","68382-375-01","68382-375-05","68382-375-10","68382-375-77","68382-376-06","68382-376-16","68382-376-01","68382-376-05","68382-376-10","68382-376-77","68382-377-06","68382-377-16","68382-377-01","68382-377-05","68382-377-10","68382-377-77","65841-699-06","65841-699-16","65841-699-01","65841-699-05","65841-699-10","65841-699-77","65841-700-06","65841-700-16","65841-700-01","65841-700-05","65841-700-10","65841-700-77","65841-701-06","65841-701-16","65841-701-01","65841-701-05","65841-701-10","65841-701-77","65841-702-06","65841-702-16","65841-702-01","65841-702-05","65841-702-10","65841-702-77"],"nui":["N0000175562","N0000000181"],"pharm_class_epc":["Angiotensin Converting Enzyme Inhibitor [EPC]"],"pharm_class_moa":["Angiotensin-converting Enzyme Inhibitors [MoA]"],"unii":["L35JN3I7SJ"]},"products":[{"product_number":"003","reference_drug":"No","brand_name":"RAMIPRIL","active_ingredients":[{"name":"RAMIPRIL","strength":"5MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"001","reference_drug":"No","brand_name":"RAMIPRIL","active_ingredients":[{"name":"RAMIPRIL","strength":"1.25MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"004","reference_drug":"No","brand_name":"RAMIPRIL","active_ingredients":[{"name":"RAMIPRIL","strength":"10MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"002","reference_drug":"No","brand_name":"RAMIPRIL","active_ingredients":[{"name":"RAMIPRIL","strength":"2.5MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20111026"}],"application_number":"ANDA091031","sponsor_name":"HIKMA","openfda":{"application_number":["ANDA091031"],"brand_name":["CEFOTETAN"],"generic_name":["CEFOTETAN"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9670","0143-9671"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CEFOTETAN"],"rxcui":["1722919","1722921"],"spl_id":["239c7e32-be35-41ea-b466-2e15d3339398"],"spl_set_id":["33b13b93-58ce-44c7-b9a2-af3b3a333f80"],"package_ndc":["0143-9670-01","0143-9670-10","0143-9671-01","0143-9671-10"],"nui":["N0000175488","M0003827"],"pharm_class_epc":["Cephalosporin Antibacterial [EPC]"],"pharm_class_cs":["Cephalosporins [CS]"],"unii":["48SPP0PA9Q"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"CEFOTETAN","active_ingredients":[{"name":"CEFOTETAN DISODIUM","strength":"EQ 1GM BASE/VIAL"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Discontinued"},{"product_number":"002","reference_drug":"No","brand_name":"CEFOTETAN","active_ingredients":[{"name":"CEFOTETAN DISODIUM","strength":"EQ 2GM BASE/VIAL"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"20220308","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"2","submission_status":"AP","submission_status_date":"20171114"},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"20241121","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20120807","application_docs":[{"id":"22726","url":"http://www.accessdata.fda.gov/drugsatfda_docs/anda/2012/091358Orig1s000Approv.pdf","date":"20130410","type":"Review"}]},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20150910","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA091358","sponsor_name":"MYLAN LABS LTD","openfda":{"application_number":["ANDA091358"],"brand_name":["OXALIPLATIN"],"generic_name":["OXALIPLATIN"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["67457-442","67457-469"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["OXALIPLATIN"],"rxcui":["1736776","1736781"],"spl_id":["a223e135-aa67-484e-84a8-4d7091e1ee0a"],"spl_set_id":["da0e8523-609a-4326-96b1-d7de78662d91"],"package_ndc":["67457-469-10","67457-442-20"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["04ZR38536J"]},"products":[{"product_number":"002","reference_drug":"No","brand_name":"OXALIPLATIN","active_ingredients":[{"name":"OXALIPLATIN","strength":"100MG/20ML (5MG/ML)"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INTRAVENOUS","marketing_status":"Prescription","te_code":"AP"},{"product_number":"003","reference_drug":"No","brand_name":"OXALIPLATIN","active_ingredients":[{"name":"OXALIPLATIN","strength":"200MG/40ML (5MG/ML)"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INTRAVENOUS","marketing_status":"Discontinued"},{"product_number":"001","reference_drug":"No","brand_name":"OXALIPLATIN","active_ingredients":[{"name":"OXALIPLATIN","strength":"50MG/10ML (5MG/ML)"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INTRAVENOUS","marketing_status":"Prescription","te_code":"AP"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20160107","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA205429","sponsor_name":"ALVOGEN","products":[{"product_number":"001","reference_drug":"No","brand_name":"DAPSONE","active_ingredients":[{"name":"DAPSONE","strength":"25MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued","te_code":"AB"},{"product_number":"002","reference_drug":"No","brand_name":"DAPSONE","active_ingredients":[{"name":"DAPSONE","strength":"100MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20130713","review_priority":"STANDARD","submission_class_code":"MEDGAS","submission_class_code_description":"Medical Gas","application_docs":[{"id":"10506","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/205828MGLtr.pdf","date":"20151002","type":"Letter"}]}],"application_number":"NDA205828","sponsor_name":"AIR LIQUIDE AMERICA LP","products":[{"product_number":"001","reference_drug":"No","brand_name":"MEDICAL AIR, USP","active_ingredients":[{"name":"MEDICAL AIR","strength":"N/A"}],"dosage_form":"GAS","route":"INHALATION","marketing_status":"Prescription"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20200626","review_priority":"STANDARD","submission_class_code":"UNKNOWN"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20230615","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA206189","sponsor_name":"MEITHEAL","openfda":{"application_number":["ANDA206189"],"brand_name":["CYTARABINE"],"generic_name":["CYTARABINE"],"manufacturer_name":["Meitheal Pharmaceuticals Inc."],"product_ndc":["71288-108"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRATHECAL","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["CYTARABINE"],"rxcui":["1731355"],"spl_id":["ba035466-3b01-4e2b-abf5-d876619a2674"],"spl_set_id":["446f6765-5375-6368-4755-4944574f5721"],"package_ndc":["71288-108-05","71288-108-06"],"nui":["N0000000233","N0000175595"],"pharm_class_moa":["Nucleic Acid Synthesis Inhibitors [MoA]"],"pharm_class_epc":["Nucleoside Metabolic Inhibitor [EPC]"],"unii":["04079A1RDZ"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"CYTARABINE","active_ingredients":[{"name":"CYTARABINE","strength":"20MG/ML"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20200414","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20200414","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20150528","submission_class_code":"UNKNOWN"},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"20210921","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20200414","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20200414","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"20230818","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA202036","sponsor_name":"YAOPHARMA CO LTD","openfda":{"application_number":["ANDA202036"],"brand_name":["VENLAFAXINE HYDROCHLORIDE"],"generic_name":["VENLAFAXINE HYDROCHLORIDE"],"manufacturer_name":["Yaopharma Co., Ltd."],"product_ndc":["50771-001","50771-002","50771-003","50771-004","50771-005"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["VENLAFAXINE HYDROCHLORIDE"],"rxcui":["313580","313582","313584","313586","314277"],"spl_id":["1b9f42fb-6131-29c6-e063-6294a90a91f3"],"spl_set_id":["38fd2c97-cd30-2f7d-e054-00144ff8d46c"],"package_ndc":["50771-001-02","50771-002-02","50771-003-02","50771-004-02","50771-005-02"],"unii":["7D7RX5A8MO"]},"products":[{"product_number":"004","reference_drug":"No","brand_name":"VENLAFAXINE HYDROCHLORIDE","active_ingredients":[{"name":"VENLAFAXINE HYDROCHLORIDE","strength":"EQ 75MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"002","reference_drug":"No","brand_name":"VENLAFAXINE HYDROCHLORIDE","active_ingredients":[{"name":"VENLAFAXINE HYDROCHLORIDE","strength":"EQ 37.5MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"005","reference_drug":"No","brand_name":"VENLAFAXINE HYDROCHLORIDE","active_ingredients":[{"name":"VENLAFAXINE HYDROCHLORIDE","strength":"EQ 100MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"003","reference_drug":"No","brand_name":"VENLAFAXINE HYDROCHLORIDE","active_ingredients":[{"name":"VENLAFAXINE HYDROCHLORIDE","strength":"EQ 50MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"001","reference_drug":"No","brand_name":"VENLAFAXINE HYDROCHLORIDE","active_ingredients":[{"name":"VENLAFAXINE HYDROCHLORIDE","strength":"EQ 25MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20111216","submission_class_code":"UNKNOWN","application_docs":[{"id":"32254","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/202385s000ltr.pdf","date":"20111227","type":"Letter"}]}],"application_number":"ANDA202385","sponsor_name":"AMNEAL PHARMS","openfda":{"application_number":["ANDA202385"],"brand_name":["FELBAMATE"],"generic_name":["FELBAMATE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["65162-686"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FELBAMATE"],"rxcui":["310285"],"spl_id":["5ae2c0c1-5f34-4c23-bb17-169302c2253f"],"spl_set_id":["2e325d79-d0a4-4af7-b09b-96ee5a5b2a37"],"package_ndc":["65162-686-88","65162-686-90"],"nui":["N0000175753","N0000008486"],"pharm_class_epc":["Anti-epileptic Agent [EPC]"],"pharm_class_pe":["Decreased Central Nervous System Disorganized Electrical Activity [PE]"],"unii":["X72RBB02N8"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"FELBAMATE","active_ingredients":[{"name":"FELBAMATE","strength":"600MG/5ML"}],"reference_standard":"No","dosage_form":"SUSPENSION","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"20130503","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"19960830","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"20141030","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"11437","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019116s009lbl.pdf","date":"20141104","type":"Label"},{"id":"1229","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/019116Orig1s009ltr.pdf","date":"20141031","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20020509","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19870225","review_priority":"STANDARD","submission_class_code":"TYPE 3","submission_class_code_description":"Type 3 - New Dosage Form"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"19941125","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"NDA019116","sponsor_name":"BAUSCH","products":[{"product_number":"001","reference_drug":"Yes","brand_name":"LOCOID","active_ingredients":[{"name":"HYDROCORTISONE BUTYRATE","strength":"0.1%"}],"reference_standard":"Yes","dosage_form":"SOLUTION","route":"TOPICAL","marketing_status":"Prescription","te_code":"AT"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19860410","review_priority":"PRIORITY","submission_class_code":"TYPE 3","submission_class_code_description":"Type 3 - New Dosage Form","submission_property_type":[{"code":"Orphan"}]},{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"19970127","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"19950512","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"19900425","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"19890112","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"20070328","review_priority":"N/A","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)","application_docs":[{"id":"11459","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/018948s024,019257s011lbl.pdf","date":"20070331","type":"Label"},{"id":"1262","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/018948s024,019257ltr.pdf","date":"20070409","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"19981215","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"19951017","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"19880511","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"19860829","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"14","submission_status":"AP","submission_status_date":"20180417","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","submission_property_type":[{"code":"Orphan"}],"application_docs":[{"id":"53735","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018948s028,019257s014lbl.pdf","date":"20180419","type":"Label"},{"id":"53760","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/018948Orig1s028,019257Orig1s014ltr.pdf","date":"20180420","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"20150529","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"11460","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018948s026,019257s012,020182s013lbl.pdf","date":"20150604","type":"Label"},{"id":"17336","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/018948Orig1s026,019257Orig1s012,020182Orig1s013ltr.pdf","date":"20150602","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"10","submission_status":"AP","submission_status_date":"20020415","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"1261","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/18948s22ltr.pdf","date":"20020415","type":"Letter"},{"id":"33711","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/18948S22lbl.pdf","date":"20020415","type":"Label"}]}],"application_number":"NDA019257","sponsor_name":"LEADIANT BIOSCI INC","openfda":{"application_number":["NDA019257"],"brand_name":["CARNITOR SF","CARNITOR"],"generic_name":["LEVOCARNITINE"],"manufacturer_name":["Leadiant Biosciences, Inc."],"product_ndc":["54482-148","54482-145"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LEVOCARNITINE"],"rxcui":["206343","315134"],"spl_id":["88041d93-8f95-4551-bba1-df964b092504","c1636127-9b6a-4443-81d9-e2607ae46e33"],"spl_set_id":["dd904490-83f3-4cd3-bb6f-68e28509b4b6","b2cbc620-59fd-47b6-9e4b-7e3e31533a1c"],"package_ndc":["54482-148-01","54482-148-02","54482-145-08","54482-145-09"],"nui":["M0003493","N0000175903"],"pharm_class_cs":["Carnitine [CS]"],"pharm_class_epc":["Carnitine Analog [EPC]"],"unii":["0G389FZZ9M"]},"products":[{"product_number":"002","reference_drug":"Yes","brand_name":"CARNITOR SF","active_ingredients":[{"name":"LEVOCARNITINE","strength":"1GM/10ML"}],"reference_standard":"No","dosage_form":"SOLUTION","route":"ORAL","marketing_status":"Prescription","te_code":"AA"},{"product_number":"001","reference_drug":"Yes","brand_name":"CARNITOR","active_ingredients":[{"name":"LEVOCARNITINE","strength":"1GM/10ML"}],"reference_standard":"Yes","dosage_form":"SOLUTION","route":"ORAL","marketing_status":"Prescription","te_code":"AA"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"20190517","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20141103","submission_class_code":"UNKNOWN"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20151117","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20151117","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA203867","sponsor_name":"SANDOZ","products":[{"product_number":"002","reference_drug":"No","brand_name":"TELMISARTAN","active_ingredients":[{"name":"TELMISARTAN","strength":"40MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"003","reference_drug":"No","brand_name":"TELMISARTAN","active_ingredients":[{"name":"TELMISARTAN","strength":"80MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"001","reference_drug":"No","brand_name":"TELMISARTAN","active_ingredients":[{"name":"TELMISARTAN","strength":"20MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20200518","submission_class_code":"UNKNOWN"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20240612","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20211112","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA203083","sponsor_name":"HETERO LABS LTD III","openfda":{"application_number":["ANDA203083"],"brand_name":["LANSOPRAZOLE"],"generic_name":["LANSOPRAZOLE"],"manufacturer_name":["Camber Pharmaceuticals, Inc.","Quallent Pharmaceuticals Health LLC"],"product_ndc":["31722-570","31722-571","82009-039"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LANSOPRAZOLE"],"rxcui":["311277","596843"],"spl_id":["03b7dceb-2128-4324-b068-7f76a2d9887e","ec1531f7-4c0d-61f4-e053-2995a90a5247"],"spl_set_id":["03b7dceb-2128-4324-b068-7f76a2d9887e","cc006372-32d3-4539-921a-6bc9ec496b28"],"package_ndc":["31722-570-30","31722-570-90","31722-570-01","31722-570-05","31722-570-10","31722-571-30","31722-571-90","31722-571-01","31722-571-05","31722-571-10","82009-039-05"],"nui":["N0000175525","N0000000147","N0000009724"],"pharm_class_epc":["Proton Pump Inhibitor [EPC]"],"pharm_class_moa":["Proton Pump Inhibitors [MoA]"],"pharm_class_pe":["Inhibition Gastric Acid Secretion [PE]"],"unii":["0K5C5T2QPG"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"LANSOPRAZOLE","active_ingredients":[{"name":"LANSOPRAZOLE","strength":"15MG"}],"reference_standard":"No","dosage_form":"CAPSULE, DELAYED REL PELLETS","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"002","reference_drug":"No","brand_name":"LANSOPRAZOLE","active_ingredients":[{"name":"LANSOPRAZOLE","strength":"30MG"}],"reference_standard":"No","dosage_form":"CAPSULE, DELAYED REL PELLETS","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20191129","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20191129","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"3","submission_status":"AP","submission_status_date":"20210504","submission_class_code":"UNKNOWN"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20150825","submission_class_code":"UNKNOWN"},{"submission_type":"ORIG","submission_number":"2","submission_status":"AP","submission_status_date":"20151221","submission_class_code":"UNKNOWN"}],"application_number":"ANDA204266","sponsor_name":"AUROLIFE PHARMA LLC","products":[{"product_number":"007","reference_drug":"No","brand_name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","active_ingredients":[{"name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","strength":"40MG"}],"reference_standard":"No","dosage_form":"CAPSULE, EXTENDED RELEASE","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"005","reference_drug":"No","brand_name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","active_ingredients":[{"name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","strength":"25MG"}],"reference_standard":"No","dosage_form":"CAPSULE, EXTENDED RELEASE","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"003","reference_drug":"No","brand_name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","active_ingredients":[{"name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","strength":"15MG"}],"reference_standard":"No","dosage_form":"CAPSULE, EXTENDED RELEASE","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"001","reference_drug":"No","brand_name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","active_ingredients":[{"name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","strength":"5MG"}],"reference_standard":"No","dosage_form":"CAPSULE, EXTENDED RELEASE","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"006","reference_drug":"No","brand_name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","active_ingredients":[{"name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","strength":"35MG"}],"reference_standard":"No","dosage_form":"CAPSULE, EXTENDED RELEASE","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"004","reference_drug":"No","brand_name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","active_ingredients":[{"name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","strength":"20MG"}],"reference_standard":"No","dosage_form":"CAPSULE, EXTENDED RELEASE","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"002","reference_drug":"No","brand_name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","active_ingredients":[{"name":"DEXMETHYLPHENIDATE HYDROCHLORIDE","strength":"10MG"}],"reference_standard":"No","dosage_form":"CAPSULE, EXTENDED RELEASE","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"20160415","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"20161202","review_priority":"STANDARD","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"46011","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204629s008lbl.pdf","date":"20161205","type":"Label"},{"id":"46031","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/204629Orig1s008ltr.pdf","date":"20161206","type":"Letter"},{"id":"64011","url":"https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/204629Orig1s008.pdf","date":"20210924","type":"Review"}]},{"submission_type":"SUPPL","submission_number":"28","submission_status":"AP","submission_status_date":"20210611","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"67782","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204629s028s029lbl.pdf","date":"20210614","type":"Label"},{"id":"67799","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/204629Orig1s028, 206073Orig1s027, 206111Orig1s025, 208658Orig1s013, 212614Orig1s008ltr.pdf","date":"20210628","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"42","submission_status":"AP","submission_status_date":"20230620","review_priority":"PRIORITY","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"74575","url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/204629Orig1s042ltr.pdf","date":"20230621","type":"Letter"},{"id":"74588","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s042lbl.pdf","date":"20230622","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"34","submission_status":"AP","submission_status_date":"20220321","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"70580","url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/204629Orig1s034;206073Orig1s031;206111Orig1s031;208658Orig1s017ltr.pdf","date":"20220322","type":"Letter"},{"id":"70617","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204629s034lbl.pdf","date":"20220328","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"26","submission_status":"AP","submission_status_date":"20210818","review_priority":"STANDARD","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"68411","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/204629Orig1s026ltr.pdf","date":"20210819","type":"Letter"},{"id":"68417","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204629s026lbl.pdf","date":"20210819","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20160205","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"19579","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204629s004lbl.pdf","date":"20160304","type":"Label"},{"id":"32575","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/204629Orig1s004ltr.pdf","date":"20160209","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"40","submission_status":"AP","submission_status_date":"20230921","review_priority":"STANDARD","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"75532","url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/204629Orig1s040ltr.pdf","date":"20230922","type":"Letter"},{"id":"75559","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s040lbl.pdf","date":"20230925","type":"Label"},{"id":"75560","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s040lbl.pdf#page=47","date":"20230925","type":"Medication Guide"}]},{"submission_type":"SUPPL","submission_number":"18","submission_status":"AP","submission_status_date":"20181026","review_priority":"901 REQUIRED","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"56157","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204629s018lbl.pdf","date":"20181029","type":"Label"},{"id":"56175","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/204629Orig1s018,206073Orig1s019,206111Orig1s018,208658Orig1s006ltr.pdf","date":"20181030","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20150626","review_priority":"STANDARD","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"40401","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204629s001s002s003lbl.pdf","date":"20150701","type":"Label"},{"id":"64667","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/204629Orig1s002.pdf","date":"20210924","type":"Review"},{"id":"10367","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/204629Orig1s001,s002,s003ltr.pdf","date":"20150630","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"16","submission_status":"AP","submission_status_date":"20171213","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"50692","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204629s016lbl.pdf","date":"20171214","type":"Label"},{"id":"50715","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/204629Orig1s016ltr.pdf","date":"20171215","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"20160708","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"10369","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/204629Orig1s012ltr.pdf","date":"20160712","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"10","submission_status":"AP","submission_status_date":"20160121","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20140801","review_priority":"STANDARD","submission_class_code":"TYPE 1","submission_class_code_description":"Type 1 - New Molecular Entity","application_docs":[{"id":"43470","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/204629Orig1s000TOC.cfm","date":"20140909","type":"Review"},{"id":"19577","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204629s000lbl.pdf","date":"20140804","type":"Label"},{"id":"24474","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/204629Orig1s000SumR.pdf","date":"20140909","type":"Summary Review"},{"id":"32572","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/204629Orig1s000ltr.pdf","date":"20140804","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"39","submission_status":"AP","submission_status_date":"20221013","review_priority":"901 REQUIRED","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"72337","url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/204629Orig1s039,206073Orig1s033,206111Orig1s036,208658Orig1s023ltr.pdf","date":"20221014","type":"Letter"},{"id":"72379","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204629s039lbl.pdf","date":"20221017","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"20160112","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"29","submission_status":"AP","submission_status_date":"20210611","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"67780","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204629s028s029lbl.pdf","date":"20210614","type":"Label"},{"id":"67800","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/204629Orig1s028, s029; 206073Orig1s027, s030; 206111Orig1s025, s026; 208658Orig1s013, s015; 212614Orig1s008, s010ltr.pdf","date":"20210615","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"20151204","review_priority":"901 REQUIRED","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"65830","url":"https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/204629Orig1s007.pdf","date":"20210106","type":"Review"},{"id":"19581","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204629s007lbl.pdf","date":"20151208","type":"Label"},{"id":"32576","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/204629Orig1s007ltr.pdf","date":"20151208","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"41","submission_status":"AP","submission_status_date":"20230912","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"75414","url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/204629Orig1s041ltr.pdf","date":"20230913","type":"Letter"},{"id":"75438","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s041lbl.pdf","date":"20230913","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20160318","review_priority":"STANDARD","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"65829","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/204629Orig1s005.pdf","date":"20210924","type":"Review"},{"id":"10368","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/204629Orig1s005ltr.pdf","date":"20160322","type":"Letter"},{"id":"19580","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204629s005lbl.pdf","date":"20160322","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"19","submission_status":"AP","submission_status_date":"20181221","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"57017","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204629s019lbl.pdf","date":"20181226","type":"Label"},{"id":"57065","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/204629Orig1s019Ltr.pdf","date":"20181230","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"33","submission_status":"AP","submission_status_date":"20220224","review_priority":"PRIORITY","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"70270","url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/204629Orig1s033ltr.pdf","date":"20220228","type":"Letter"},{"id":"70276","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204629s033lbl.pdf","date":"20220228","type":"Label"},{"id":"73523","url":"https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/204629Orig1s033.pdf","date":"20230216","type":"Review"}]},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20150626","review_priority":"STANDARD","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"40402","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204629s001s002s003lbl.pdf","date":"20150701","type":"Label"},{"id":"64668","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/204629Orig1s003.pdf","date":"20210924","type":"Review"},{"id":"32574","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/204629Orig1s001,s002,s003ltr.pdf","date":"20150630","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20150626","review_priority":"STANDARD","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"64666","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/204629Orig1s001.pdf","date":"20210924","type":"Review"},{"id":"19578","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204629s001s002s003lbl.pdf","date":"20150701","type":"Label"},{"id":"32573","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/204629Orig1s001,s002,s003ltr.pdf","date":"20150630","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"23","submission_status":"AP","submission_status_date":"20200124","review_priority":"901 REQUIRED","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"61663","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204629s023lbl.pdf","date":"20200127","type":"Label"},{"id":"61672","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/204629Orig1s023,206073Orig1s023,206111Orig1s022,208658Orig1s009ltr.pdf","date":"20200127","type":"Letter"}]}],"application_number":"NDA204629","sponsor_name":"BOEHRINGER INGELHEIM","openfda":{"application_number":["NDA204629"],"brand_name":["JARDIANCE"],"generic_name":["EMPAGLIFLOZIN"],"manufacturer_name":["Boehringer Ingelheim Pharmaceuticals, Inc."],"product_ndc":["0597-0152","0597-0153"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["EMPAGLIFLOZIN"],"rxcui":["1545658","1545664","1545666","1545668"],"spl_id":["691d5f55-2b16-4cf3-9cef-efa755e11127"],"spl_set_id":["faf3dd6a-9cd0-39c2-0d2e-232cb3f67565"],"package_ndc":["0597-0152-90","0597-0152-07","0597-0152-70","0597-0152-37","0597-0152-30","0597-0153-37","0597-0153-30","0597-0153-90","0597-0153-07","0597-0153-70"],"nui":["N0000187059","N0000187058"],"pharm_class_epc":["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"],"pharm_class_moa":["Sodium-Glucose Transporter 2 Inhibitors [MoA]"],"unii":["HDC1R2M35U"]},"products":[{"product_number":"002","reference_drug":"Yes","brand_name":"JARDIANCE","active_ingredients":[{"name":"EMPAGLIFLOZIN","strength":"25MG"}],"reference_standard":"Yes","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"001","reference_drug":"Yes","brand_name":"JARDIANCE","active_ingredients":[{"name":"EMPAGLIFLOZIN","strength":"10MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"20210504","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20210504","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"14","submission_status":"AP","submission_status_date":"20230609","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20191016","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20190306","review_priority":"STANDARD","submission_class_code":"UNKNOWN"},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"20210504","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA204991","sponsor_name":"LUPIN LTD","openfda":{"application_number":["ANDA204991"],"brand_name":["ATORVASTATIN CALCIUM"],"generic_name":["ATORVASTATIN CALCIUM"],"manufacturer_name":["Lupin Pharmaceuticals, Inc."],"product_ndc":["68180-635","68180-636","68180-637","68180-638"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["ATORVASTATIN CALCIUM TRIHYDRATE"],"rxcui":["259255","617310","617311","617312"],"spl_id":["ab716c10-785b-4d43-a5f0-59f95b0b78c8"],"spl_set_id":["a5767370-15a2-45e5-b980-7af9523aea7b"],"package_ndc":["68180-635-02","68180-635-09","68180-635-06","68180-636-02","68180-636-09","68180-636-06","68180-637-02","68180-637-09","68180-637-06","68180-638-02","68180-638-09","68180-638-06"],"unii":["48A5M73Z4Q"]},"products":[{"product_number":"003","reference_drug":"No","brand_name":"ATORVASTATIN CALCIUM","active_ingredients":[{"name":"ATORVASTATIN CALCIUM","strength":"EQ 40MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued","te_code":"BX"},{"product_number":"001","reference_drug":"No","brand_name":"ATORVASTATIN CALCIUM","active_ingredients":[{"name":"ATORVASTATIN CALCIUM","strength":"EQ 10MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued","te_code":"BX"},{"product_number":"004","reference_drug":"No","brand_name":"ATORVASTATIN CALCIUM","active_ingredients":[{"name":"ATORVASTATIN CALCIUM","strength":"EQ 80MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued","te_code":"BX"},{"product_number":"002","reference_drug":"No","brand_name":"ATORVASTATIN CALCIUM","active_ingredients":[{"name":"ATORVASTATIN CALCIUM","strength":"EQ 20MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued","te_code":"BX"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"TA","submission_status_date":"20240605","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA210311","sponsor_name":"INDOCO REMEDIES"},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"TA","submission_status_date":"20241022","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA210685","sponsor_name":"MSN LABORATORIES PRIVATE LTD"},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20190826","review_priority":"STANDARD","submission_class_code":"UNKNOWN","application_docs":[{"id":"60138","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/211041Orig1s000ltr.pdf","date":"20190927","type":"Letter"}]}],"application_number":"ANDA211041","sponsor_name":"NOVITIUM PHARMA","openfda":{"application_number":["ANDA211041"],"brand_name":["NITISINONE"],"generic_name":["NITISINONE"],"manufacturer_name":["Endo USA, Inc."],"product_ndc":["0254-3020","0254-3021","0254-3022"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["NITISINONE"],"rxcui":["351173","351174","351175"],"spl_id":["8367a743-d475-4205-8be9-aadd30786555"],"spl_set_id":["437868f5-1c9e-4b0f-8a03-77df8ac0900d"],"package_ndc":["0254-3020-02","0254-3021-02","0254-3022-02"],"nui":["N0000175809","N0000175808","N0000185504","N0000193955","N0000190110","N0000190111"],"pharm_class_epc":["4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC]"],"pharm_class_moa":["Hydroxyphenylpyruvate Dioxygenase Inhibitors [MoA]","Cytochrome P450 2C9 Inhibitors [MoA]","Cytochrome P450 2E1 Inducers [MoA]","Organic Anion Transporter 1 Inhibitors [MoA]","Organic Anion Transporter 3 Inhibitors [MoA]"],"unii":["K5BN214699"]},"products":[{"product_number":"002","reference_drug":"No","brand_name":"NITISINONE","active_ingredients":[{"name":"NITISINONE","strength":"5MG"}],"reference_standard":"No","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"003","reference_drug":"No","brand_name":"NITISINONE","active_ingredients":[{"name":"NITISINONE","strength":"10MG"}],"reference_standard":"No","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"001","reference_drug":"No","brand_name":"NITISINONE","active_ingredients":[{"name":"NITISINONE","strength":"2MG"}],"reference_standard":"No","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"20160422","review_priority":"PRIORITY","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"40560","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206619s009lbl.pdf","date":"20160427","type":"Label"},{"id":"10585","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/206619Orig1s009ltr.pdf","date":"20160426","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"20150922","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"18","submission_status":"AP","submission_status_date":"20180723","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"54975","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/206619Orig1s018ltr.pdf","date":"20180725","type":"Letter"},{"id":"55357","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206619s018lbl.pdf","date":"20180829","type":"Label"},{"id":"55360","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206619s018lbl.pdf#page=50","date":"20180829","type":"Medication Guide"}]},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20150720","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"10583","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/206619Orig1s005ltr.pdf","date":"20150722","type":"Letter"},{"id":"19727","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206619s005lbl.pdf","date":"20150722","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20150325","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"40558","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206619s003lbl.pdf","date":"20150326","type":"Label"},{"id":"32818","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/206619Orig1s003ltr.pdf","date":"20150326","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20150619","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"14","submission_status":"AP","submission_status_date":"20170214","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"47212","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206619s014lbl.pdf","date":"20170215","type":"Label"},{"id":"47219","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/206619Orig1s014ltr.pdf","date":"20170215","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"20","submission_status":"AP","submission_status_date":"20191206","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"61196","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206619s020lbl.pdf","date":"20191209","type":"Label"},{"id":"61197","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206619s020lbl.pdf#page=49","date":"20191209","type":"Medication Guide"},{"id":"61207","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/206619Orig1s020ltr.pdf","date":"20191210","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"20160817","review_priority":"UNKNOWN","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"10","submission_status":"AP","submission_status_date":"20160128","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","submission_property_type":[{"code":"Orphan"}],"application_docs":[{"id":"40561","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206619s010lbl.pdf","date":"20160201","type":"Label"},{"id":"10586","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/206619Orig1s010ltr.pdf","date":"20160129","type":"Letter"}]},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20141219","review_priority":"PRIORITY","submission_class_code":"TYPE 1/4","submission_class_code_description":"Type 1 - New Molecular Entity and Type 4 - New Combination","application_docs":[{"id":"40557","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206619lbl.pdf","date":"20141223","type":"Label"},{"id":"44947","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206619Orig1s000SumR.pdf","date":"20150123","type":"Summary Review"},{"id":"23024","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206619Orig1s000TOC.cfm","date":"20150123","type":"Review"},{"id":"32817","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/206619Orig1s000ltr.pdf","date":"20141223","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"20151022","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","submission_property_type":[{"code":"Orphan"}],"application_docs":[{"id":"40559","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206619s008lbl.pdf","date":"20151023","type":"Label"},{"id":"10584","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/206619Orig1s008ltr.pdf","date":"20151026","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"20151013","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"19728","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206619s006lbl.pdf","date":"20151015","type":"Label"},{"id":"32819","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/206619Orig1s006ltr.pdf","date":"20151014","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"17","submission_status":"AP","submission_status_date":"20171109","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"50378","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/206619Orig1s017ltr.pdf","date":"20171113","type":"Letter"},{"id":"50396","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206619s017lbl.pdf","date":"20171113","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20150730","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"15","submission_status":"AP","submission_status_date":"20170322","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"47649","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206619s013s015lbl.pdf","date":"20170323","type":"Label"},{"id":"47674","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/206619Orig1s013,206619Orig1s015ltr.pdf","date":"20170324","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20150709","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"13","submission_status":"AP","submission_status_date":"20170322","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"47648","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206619s013s015lbl.pdf","date":"20170323","type":"Label"},{"id":"47675","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/206619Orig1s013,206619Orig1s015ltr.pdf","date":"20170324","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"20160621","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","submission_property_type":[{"code":"Orphan"}],"application_docs":[{"id":"40562","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206619Orig1s011lbl.pdf","date":"20160623","type":"Label"},{"id":"10587","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/206619Orig1s011ltr.pdf","date":"20160623","type":"Letter"}]}],"application_number":"NDA206619","sponsor_name":"ABBVIE","products":[{"product_number":"001","reference_drug":"Yes","brand_name":"VIEKIRA PAK (COPACKAGED)","active_ingredients":[{"name":"DASABUVIR SODIUM","strength":"EQ 250MG BASE"},{"name":"OMBITASVIR, PARITAPREVIR, RITONAVIR","strength":"12.5MG, 75MG, 50MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20190329","review_priority":"STANDARD","submission_class_code":"UNKNOWN"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20201016","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA207004","sponsor_name":"MICRO LABS","openfda":{"application_number":["ANDA207004"],"brand_name":["RASAGILINE"],"generic_name":["RASAGILINE"],"manufacturer_name":["Micro Labs Limited"],"product_ndc":["42571-220","42571-221"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RASAGILINE MESYLATE"],"rxcui":["608328","636664"],"spl_id":["d277f481-a137-7df3-e053-2a95a90a664a"],"spl_set_id":["42f8d62f-2c57-47bc-92e7-b28111aa8cd1"],"package_ndc":["42571-220-30","42571-220-05","42571-220-10","42571-221-30","42571-221-05","42571-221-10"],"unii":["LH8C2JI290"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"RASAGILINE MESYLATE","active_ingredients":[{"name":"RASAGILINE MESYLATE","strength":"EQ 0.5MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"002","reference_drug":"No","brand_name":"RASAGILINE MESYLATE","active_ingredients":[{"name":"RASAGILINE MESYLATE","strength":"EQ 1MG BASE"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20161115","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA207386","sponsor_name":"MIKART","products":[{"product_number":"001","reference_drug":"No","brand_name":"BUTALBITAL AND ACETAMINOPHEN","active_ingredients":[{"name":"ACETAMINOPHEN","strength":"300MG"},{"name":"BUTALBITAL","strength":"50MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AA"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20180524","review_priority":"STANDARD","submission_class_code":"UNKNOWN"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20240301","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA207769","sponsor_name":"ZYDUS PHARMS","openfda":{"application_number":["ANDA207769"],"brand_name":["DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE"],"generic_name":["DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE"],"manufacturer_name":["Zydus Pharmaceuticals USA Inc.","Zydus Lifesciences Limited"],"product_ndc":["68382-640","70771-1356"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DUTASTERIDE","TAMSULOSIN HYDROCHLORIDE"],"rxcui":["996097"],"spl_id":["9e44a416-1d3d-418c-a113-f6c65175b564","63766352-5eec-410d-a059-3c07a9f17a3d"],"spl_set_id":["d6557691-7910-4006-9268-410583e437d1","4b89b07e-9d19-47a2-bd53-bc5eef9deed1"],"package_ndc":["68382-640-06","68382-640-16","70771-1356-3","70771-1356-9"],"nui":["N0000175836","N0000000126"],"pharm_class_epc":["5-alpha Reductase Inhibitor [EPC]"],"pharm_class_moa":["5-alpha Reductase Inhibitors [MoA]"],"unii":["O0J6XJN02I","11SV1951MR"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE","active_ingredients":[{"name":"DUTASTERIDE","strength":"0.5MG"},{"name":"TAMSULOSIN HYDROCHLORIDE","strength":"0.4MG"}],"reference_standard":"No","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"TA","submission_status_date":"20160304","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA208167","sponsor_name":"ZYDUS PHARMS USA INC","products":[{"product_number":"001","reference_drug":"No","brand_name":"CLOFARABINE","active_ingredients":[{"name":"CLOFARABINE","strength":"20MG/20ML"}],"dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"None (Tentative Approval)"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20190603","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20190410","review_priority":"STANDARD","submission_class_code":"UNKNOWN","application_docs":[{"id":"54163","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208560Orig1s000TAltr.pdf","date":"20180511","type":"Letter"}]}],"application_number":"ANDA208560","sponsor_name":"LUPIN","openfda":{"application_number":["ANDA208560"],"brand_name":["TESTOSTERONE"],"generic_name":["TESTOSTERONE"],"manufacturer_name":["Lupin Pharmaceuticals, Inc."],"product_ndc":["68180-941"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TRANSDERMAL"],"substance_name":["TESTOSTERONE"],"rxcui":["1597076"],"spl_id":["a11c56a6-b81c-46bf-a1e0-67231dc21add"],"spl_set_id":["61387416-510d-40c5-9e2d-24bfb7f56d08"],"package_ndc":["68180-941-11"],"nui":["N0000175824","N0000000146","M0001109"],"pharm_class_epc":["Androgen [EPC]"],"pharm_class_moa":["Androgen Receptor Agonists [MoA]"],"pharm_class_cs":["Androstanes [CS]"],"unii":["3XMK78S47O"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"TESTOSTERONE","active_ingredients":[{"name":"TESTOSTERONE","strength":"1.62% (20.25MG/1.25GM ACTUATION)"}],"reference_standard":"No","dosage_form":"GEL, METERED","route":"TRANSDERMAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20181211","review_priority":"STANDARD","submission_class_code":"TYPE 5","submission_class_code_description":"Type 5 - New Formulation or New Manufacturer","application_docs":[{"id":"56716","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208901s000lbl.pdf","date":"20181212","type":"Label"},{"id":"56838","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/208901Orig1s000ltr.pdf","date":"20181220","type":"Letter"},{"id":"58804","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/208901Orig1s000TOC.cfm","date":"20190521","type":"Review"}]},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20241025","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"80023","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/208901s004lbl.pdf","date":"20241028","type":"Label"},{"id":"80032","url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/208901Orig1s004ltr.pdf","date":"20241029","type":"Letter"}]}],"application_number":"NDA208901","sponsor_name":"MAYNE PHARMA","openfda":{"application_number":["NDA208901"],"brand_name":["TOLSURA"],"generic_name":["ITRACONAZOLE"],"manufacturer_name":["Mayne Pharma Commercial LLC"],"product_ndc":["51862-462"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["ITRACONAZOLE"],"rxcui":["2106642","2106648"],"spl_id":["c702a36f-070c-4146-bb06-33534783db7a"],"spl_set_id":["306352d1-9d5a-49ad-b72d-893b99546861"],"package_ndc":["51862-462-60","51862-462-88","51862-462-08"],"nui":["N0000175487","M0002083","N0000182141","N0000185503","N0000190113"],"pharm_class_epc":["Azole Antifungal [EPC]"],"pharm_class_cs":["Azoles [CS]"],"pharm_class_moa":["Cytochrome P450 3A4 Inhibitors [MoA]","P-Glycoprotein Inhibitors [MoA]","Breast Cancer Resistance Protein Inhibitors [MoA]"],"unii":["304NUG5GF4"]},"products":[{"product_number":"001","reference_drug":"Yes","brand_name":"TOLSURA","active_ingredients":[{"name":"ITRACONAZOLE","strength":"65MG"}],"reference_standard":"Yes","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Prescription"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20200127","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"13","submission_status":"AP","submission_status_date":"20230511","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"20201030","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"20200127","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"10","submission_status":"AP","submission_status_date":"20201030","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"20201030","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20171129","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA209635","sponsor_name":"SCIEGEN PHARMS INC","openfda":{"application_number":["ANDA209635"],"brand_name":["QUETIAPINE EXTENDED RELEASE"],"generic_name":["QUETIAPINE"],"manufacturer_name":["ACI Healthcare USA, Inc.","ScieGen Pharmaceuticals, Inc"],"product_ndc":["71093-135","71093-136","71093-137","71093-138","71093-139","50228-380","50228-381","50228-382","50228-383","50228-384"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUETIAPINE FUMARATE"],"rxcui":["721791","721794","721796","853201","895670"],"spl_id":["8a3515c7-6fc7-4150-a898-23443e4802fd","1e7ec657-9aea-67d7-e063-6294a90a57ca"],"spl_set_id":["07e4f3f4-42cb-4b22-bf8d-8c3279d26e97","5e4a84b1-fb8c-44d0-8213-51e43d71db69"],"package_ndc":["71093-135-02","71093-136-02","71093-137-02","71093-138-02","71093-139-02","50228-380-30","50228-380-60","50228-380-10","50228-381-30","50228-381-60","50228-381-10","50228-382-30","50228-382-60","50228-382-10","50228-383-30","50228-383-60","50228-383-05","50228-384-30","50228-384-60","50228-384-05"],"unii":["2S3PL1B6UJ"]},"products":[{"product_number":"002","reference_drug":"No","brand_name":"QUETIAPINE FUMARATE","active_ingredients":[{"name":"QUETIAPINE FUMARATE","strength":"EQ 200MG BASE"}],"reference_standard":"No","dosage_form":"TABLET, EXTENDED RELEASE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"005","reference_drug":"No","brand_name":"QUETIAPINE FUMARATE","active_ingredients":[{"name":"QUETIAPINE FUMARATE","strength":"EQ 50MG BASE"}],"reference_standard":"No","dosage_form":"TABLET, EXTENDED RELEASE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"003","reference_drug":"No","brand_name":"QUETIAPINE FUMARATE","active_ingredients":[{"name":"QUETIAPINE FUMARATE","strength":"EQ 300MG BASE"}],"reference_standard":"No","dosage_form":"TABLET, EXTENDED RELEASE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"001","reference_drug":"No","brand_name":"QUETIAPINE FUMARATE","active_ingredients":[{"name":"QUETIAPINE FUMARATE","strength":"EQ 150MG BASE"}],"reference_standard":"No","dosage_form":"TABLET, EXTENDED RELEASE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"004","reference_drug":"No","brand_name":"QUETIAPINE FUMARATE","active_ingredients":[{"name":"QUETIAPINE FUMARATE","strength":"EQ 400MG BASE"}],"reference_standard":"No","dosage_form":"TABLET, EXTENDED RELEASE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"TA","submission_status_date":"20231006","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA209981","sponsor_name":"SANDOZ INC"},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20180108","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA209284","sponsor_name":"DR REDDYS","openfda":{"application_number":["ANDA209284"],"brand_name":["TETRABENAZINE"],"generic_name":["TETRABENAZINE"],"manufacturer_name":["Dr. Reddys Laboratories Inc"],"product_ndc":["43598-394","43598-395"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["TETRABENAZINE"],"rxcui":["199592","805464"],"spl_id":["b3ddb23f-3cc7-7c18-982b-970f7acc8766"],"spl_set_id":["ef5f9dd4-945f-ec27-518d-90996a7bd4b6"],"package_ndc":["43598-394-67","43598-394-05","43598-395-67","43598-395-05"],"nui":["N0000190856","N0000190855"],"pharm_class_epc":["Vesicular Monoamine Transporter 2 Inhibitor [EPC]"],"pharm_class_moa":["Vesicular Monoamine Transporter 2 Inhibitors [MoA]"],"unii":["Z9O08YRN8O"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"TETRABENAZINE","active_ingredients":[{"name":"TETRABENAZINE","strength":"12.5MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"002","reference_drug":"No","brand_name":"TETRABENAZINE","active_ingredients":[{"name":"TETRABENAZINE","strength":"25MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20230927","review_priority":"STANDARD","submission_class_code":"UNKNOWN"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20240328","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA215997","sponsor_name":"SUN PHARM INDS INC","openfda":{"application_number":["ANDA215997"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-950","57664-951","57664-952","57664-953"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["AMPHETAMINE ASPARTATE MONOHYDRATE","AMPHETAMINE SULFATE","DEXTROAMPHETAMINE SACCHARATE","DEXTROAMPHETAMINE SULFATE"],"rxcui":["1927610","1927617","1927630","1927637"],"spl_id":["10af8563-97ec-8a5e-e063-6394a90a52f8"],"spl_set_id":["30e515c3-a18f-499a-87c4-be8d64cfdbc6"],"package_ndc":["57664-950-88","57664-951-88","57664-952-88","57664-953-88"],"unii":["G83415V073","6DPV8NK46S","JJ768O327N","O1ZPV620O4"]},"products":[{"product_number":"003","reference_drug":"No","brand_name":"DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE","active_ingredients":[{"name":"AMPHETAMINE ASPARTATE","strength":"9.375MG"},{"name":"AMPHETAMINE SULFATE","strength":"9.375MG"},{"name":"DEXTROAMPHETAMINE SACCHARATE","strength":"9.375MG"},{"name":"DEXTROAMPHETAMINE SULFATE","strength":"9.375MG"}],"reference_standard":"No","dosage_form":"CAPSULE, EXTENDED RELEASE","route":"ORAL","marketing_status":"Prescription","te_code":"AB2"},{"product_number":"001","reference_drug":"No","brand_name":"DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE","active_ingredients":[{"name":"AMPHETAMINE ASPARTATE","strength":"3.125MG"},{"name":"AMPHETAMINE SULFATE","strength":"3.125MG"},{"name":"DEXTROAMPHETAMINE SACCHARATE","strength":"3.125MG"},{"name":"DEXTROAMPHETAMINE SULFATE","strength":"3.125MG"}],"reference_standard":"No","dosage_form":"CAPSULE, EXTENDED RELEASE","route":"ORAL","marketing_status":"Prescription","te_code":"AB2"},{"product_number":"004","reference_drug":"No","brand_name":"DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE","active_ingredients":[{"name":"AMPHETAMINE ASPARTATE","strength":"12.5MG"},{"name":"AMPHETAMINE SULFATE","strength":"12.5MG"},{"name":"DEXTROAMPHETAMINE SACCHARATE","strength":"12.5MG"},{"name":"DEXTROAMPHETAMINE SULFATE","strength":"12.5MG"}],"reference_standard":"No","dosage_form":"CAPSULE, EXTENDED RELEASE","route":"ORAL","marketing_status":"Prescription","te_code":"AB2"},{"product_number":"002","reference_drug":"No","brand_name":"DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE","active_ingredients":[{"name":"AMPHETAMINE ASPARTATE","strength":"6.25MG"},{"name":"AMPHETAMINE SULFATE","strength":"6.25MG"},{"name":"DEXTROAMPHETAMINE SACCHARATE","strength":"6.25MG"},{"name":"DEXTROAMPHETAMINE SULFATE","strength":"6.25MG"}],"reference_standard":"No","dosage_form":"CAPSULE, EXTENDED RELEASE","route":"ORAL","marketing_status":"Prescription","te_code":"AB2"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20230118","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA216492","sponsor_name":"RUBICON","openfda":{"application_number":["ANDA216492"],"brand_name":["GABAPENTIN"],"generic_name":["GABAPENTIN"],"manufacturer_name":["Advagen Pharma Ltd"],"product_ndc":["72888-104"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["GABAPENTIN"],"rxcui":["283523"],"spl_id":["0d47d8f7-0106-6111-e063-6294a90a55d0"],"spl_set_id":["bfee67dc-d2b1-4a00-92d9-a42be3189c74"],"package_ndc":["72888-104-25"],"nui":["N0000008486"],"pharm_class_pe":["Decreased Central Nervous System Disorganized Electrical Activity [PE]"],"unii":["6CW7F3G59X"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"GABAPENTIN","active_ingredients":[{"name":"GABAPENTIN","strength":"250MG/5ML"}],"reference_standard":"No","dosage_form":"SOLUTION","route":"ORAL","marketing_status":"Prescription","te_code":"AA"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20231226","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA215550","sponsor_name":"LUPIN LTD","products":[{"product_number":"001","reference_drug":"No","brand_name":"LOTEPREDNOL ETABONATE","active_ingredients":[{"name":"LOTEPREDNOL ETABONATE","strength":"0.2%"}],"reference_standard":"No","dosage_form":"SUSPENSION/DROPS","route":"OPHTHALMIC","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20200228","review_priority":"STANDARD","submission_class_code":"UNKNOWN","application_docs":[{"id":"62168","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/211393Orig1s000ltr.pdf","date":"20200317","type":"Letter"}]}],"application_number":"ANDA211393","sponsor_name":"HIKMA","openfda":{"application_number":["ANDA211393"],"brand_name":["DIHYDROERGOTAMINE MESYLATE"],"generic_name":["DIHYDROERGOTAMINE MESYLATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["24201-463"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["NASAL"],"substance_name":["DIHYDROERGOTAMINE MESYLATE"],"rxcui":["861668"],"spl_id":["01aa3f3f-2547-4fb2-aa4e-f7b2e49326f0"],"spl_set_id":["9ffe6d5a-7348-0498-e053-2a95a90a97a8"],"package_ndc":["24201-463-08","24201-463-01"],"unii":["81AXN7R2QT"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"DIHYDROERGOTAMINE MESYLATE","active_ingredients":[{"name":"DIHYDROERGOTAMINE MESYLATE","strength":"0.5MG/SPRAY"}],"reference_standard":"No","dosage_form":"SPRAY, METERED","route":"NASAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20230703","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA211747","sponsor_name":"ZYDUS","products":[{"product_number":"003","reference_drug":"No","brand_name":"OXCARBAZEPINE","active_ingredients":[{"name":"OXCARBAZEPINE","strength":"600MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued","te_code":"AB"},{"product_number":"001","reference_drug":"No","brand_name":"OXCARBAZEPINE","active_ingredients":[{"name":"OXCARBAZEPINE","strength":"150MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued","te_code":"AB"},{"product_number":"002","reference_drug":"No","brand_name":"OXCARBAZEPINE","active_ingredients":[{"name":"OXCARBAZEPINE","strength":"300MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19540128","review_priority":"STANDARD","submission_class_code":"TYPE 5","submission_class_code_description":"Type 5 - New Formulation or New Manufacturer"}],"application_number":"NDA009276","sponsor_name":"BOWMAN PHARMS","products":[{"product_number":"003","reference_drug":"No","brand_name":"HIWOLFIA","active_ingredients":[{"name":"RAUWOLFIA SERPENTINA ROOT","strength":"50MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"004","reference_drug":"No","brand_name":"HIWOLFIA","active_ingredients":[{"name":"RAUWOLFIA SERPENTINA ROOT","strength":"100MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"005","reference_drug":"No","brand_name":"HIWOLFIA","active_ingredients":[{"name":"RAUWOLFIA SERPENTINA ROOT","strength":"50MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"19971126","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"31","submission_status":"AP","submission_status_date":"20120820","review_priority":"UNKNOWN","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"34485","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020291s031lbl.pdf","date":"20120820","type":"Label"},{"id":"24747","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020291Orig1s031ltr.pdf","date":"20120822","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"19970408","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"23","submission_status":"AP","submission_status_date":"20081110","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"24743","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020291s023ltr.pdf","date":"20081113","type":"Letter"},{"id":"34482","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020291s023lbl.pdf","date":"20081112","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"19990916","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"19980619","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"26","submission_status":"AP","submission_status_date":"20090507","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"12421","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020291s026lbl.pdf","date":"20090511","type":"Label"},{"id":"2303","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020291s026ltr.pdf","date":"20090513","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"19971014","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"30","submission_status":"AP","submission_status_date":"20120917","review_priority":"UNKNOWN","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"24746","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020291Orig1s030ltr.pdf","date":"20120920","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"20","submission_status":"AP","submission_status_date":"20060601","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"24742","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020291s020LTR.pdf","date":"20060602","type":"Letter"},{"id":"34481","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020291s020lbl.pdf","date":"20060602","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"20010723","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19961024","review_priority":"STANDARD","submission_class_code":"TYPE 4","submission_class_code_description":"Type 4 - New Combination"},{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"19990818","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"29","submission_status":"AP","submission_status_date":"20110401","review_priority":"UNKNOWN","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"24745","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020291s029ltr.pdf","date":"20110406","type":"Letter"},{"id":"34484","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020291s029lbl.pdf","date":"20110401","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"19990222","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"27","submission_status":"AP","submission_status_date":"20090602","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"24744","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020291s027ltr.pdf","date":"20090608","type":"Letter"},{"id":"34483","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020291s027lbl.pdf","date":"20090604","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"19990323","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"NDA020291","sponsor_name":"BOEHRINGER INGELHEIM","products":[{"product_number":"001","reference_drug":"No","brand_name":"COMBIVENT","active_ingredients":[{"name":"ALBUTEROL SULFATE","strength":"EQ 0.09MG BASE/INH"},{"name":"IPRATROPIUM BROMIDE","strength":"0.018MG/INH"}],"reference_standard":"No","dosage_form":"AEROSOL, METERED","route":"INHALATION","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"20240103","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20211008","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20191127","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA212883","sponsor_name":"AJANTA PHARMA LTD","openfda":{"application_number":["ANDA212883"],"brand_name":["SILDENAFIL"],"generic_name":["SILDENAFIL"],"manufacturer_name":["Ajanta Pharma USA Inc."],"product_ndc":["27241-175"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["SILDENAFIL CITRATE"],"rxcui":["1307427"],"spl_id":["48242562-2dd5-4614-bfe7-45bff63561ef"],"spl_set_id":["283790ed-2acb-4714-a0af-b348bb642785"],"package_ndc":["27241-175-29"],"unii":["BW9B0ZE037"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"SILDENAFIL CITRATE","active_ingredients":[{"name":"SILDENAFIL CITRATE","strength":"EQ 10MG BASE/ML"}],"reference_standard":"No","dosage_form":"FOR SUSPENSION","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20230602","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20230602","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20210114","review_priority":"STANDARD","submission_class_code":"UNKNOWN"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20211117","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"20230824","review_priority":"UNKNOWN","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"ANDA213279","sponsor_name":"EUGIA PHARMA","openfda":{"application_number":["ANDA213279"],"brand_name":["NALOXONE HYDROCHLORIDE"],"generic_name":["NALOXONE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-345"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["NALOXONE HYDROCHLORIDE"],"rxcui":["1191250"],"spl_id":["e354dc61-1dc9-4d85-bfad-6d0383871402"],"spl_set_id":["8bcf426a-b4fc-4f24-9ad0-fb26168a0b56"],"package_ndc":["55150-345-01","55150-345-10"],"unii":["F850569PQR"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"NALOXONE HYDROCHLORIDE","active_ingredients":[{"name":"NALOXONE HYDROCHLORIDE","strength":"1MG/ML"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Prescription","te_code":"AP"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"20220909","review_priority":"STANDARD","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"72065","url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/203415Orig1s019; 213674Orig1s006ltr.pdf","date":"20220912","type":"Letter"},{"id":"72073","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203415s019,213674s006lbl.pdf","date":"20220913","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20210524","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"67587","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213674s002lbl.pdf","date":"20210525","type":"Label"},{"id":"67588","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/213674Orig1s002ltr.pdf","date":"20210525","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"10","submission_status":"AP","submission_status_date":"20231116","review_priority":"PRIORITY","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"76592","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213674s010,203415s022lbl.pdf","date":"20231117","type":"Label"},{"id":"76627","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/213674Orig1s010; 203415Orig1s022ltr.pdf","date":"20231117","type":"Letter"}]},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20200804","review_priority":"STANDARD","submission_class_code":"TYPE 3","submission_class_code_description":"Type 3 - New Dosage Form","application_docs":[{"id":"64201","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213674s000lbl.pdf","date":"20200805","type":"Label"},{"id":"65975","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/213674Orig1s000TOC.cfm","date":"20210125","type":"Review"}]},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20220113","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"69891","url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/203415Orig1s018; 213674Orig1s005ltr.pdf","date":"20220118","type":"Letter"},{"id":"69924","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203415s018,213674s005lbl.pdf","date":"20220119","type":"Label"}]}],"application_number":"NDA213674","sponsor_name":"ASTELLAS","openfda":{"application_number":["NDA213674"],"brand_name":["XTANDI"],"generic_name":["ENZALUTAMIDE"],"manufacturer_name":["Astellas Pharma US, Inc."],"product_ndc":["0469-0625","0469-0125","0469-0725","0469-1125","0469-1725"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["ENZALUTAMIDE"],"rxcui":["1307303","1307309","2390644","2390646","2390648","2390650"],"spl_id":["bddcc9f9-afad-4b83-a6d7-551f3cfd9cdb"],"spl_set_id":["b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf"],"package_ndc":["0469-0125-99","0469-0625-99","0469-0725-60","0469-1125-56","0469-1725-56"],"nui":["N0000175560","N0000000243","N0000185506","N0000185507","N0000185607"],"pharm_class_epc":["Androgen Receptor Inhibitor [EPC]"],"pharm_class_moa":["Androgen Receptor Antagonists [MoA]","Cytochrome P450 3A4 Inducers [MoA]","Cytochrome P450 2C9 Inducers [MoA]","Cytochrome P450 2C19 Inducers [MoA]"],"unii":["93T0T9GKNU"]},"products":[{"product_number":"002","reference_drug":"Yes","brand_name":"XTANDI","active_ingredients":[{"name":"ENZALUTAMIDE","strength":"80MG"}],"reference_standard":"Yes","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription"},{"product_number":"001","reference_drug":"Yes","brand_name":"XTANDI","active_ingredients":[{"name":"ENZALUTAMIDE","strength":"40MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20210126","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA214140","sponsor_name":"CARNEGIE","openfda":{"application_number":["ANDA214140"],"brand_name":["AMINOCAPROIC ACID"],"generic_name":["AMINOCAPROIC ACID"],"manufacturer_name":["Biocon Pharma Inc.","Carnegie Pharmaceuticals, LLC"],"product_ndc":["70377-104","80005-130"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["AMINOCAPROIC ACID"],"rxcui":["582299"],"spl_id":["4c94e9c7-476c-8256-83cf-723ff8e5107b","acb7cc2c-2aea-4c13-96b5-e2d1840ea1d2"],"spl_set_id":["c3cadb3a-4f63-06ee-0dd2-6828dbc1fffa","0d6560a3-c67e-428e-b9b8-fab538856b41"],"package_ndc":["70377-104-11","80005-130-22"],"nui":["N0000175634","N0000175632"],"pharm_class_epc":["Antifibrinolytic Agent [EPC]"],"pharm_class_pe":["Decreased Fibrinolysis [PE]"],"unii":["U6F3787206"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"AMINOCAPROIC ACID","active_ingredients":[{"name":"AMINOCAPROIC ACID","strength":"0.25GM/ML"}],"reference_standard":"No","dosage_form":"SOLUTION","route":"ORAL","marketing_status":"Prescription","te_code":"AA"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20221220","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA214580","sponsor_name":"HUMANWELL PURACAP","openfda":{"application_number":["ANDA214580"],"brand_name":["AMANTADINE HYDROCHLORIDE"],"generic_name":["AMANTADINE HYDROCHLORIDE"],"manufacturer_name":["EPIC PHARMA LLC"],"product_ndc":["42806-716"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["AMANTADINE HYDROCHLORIDE"],"rxcui":["849389"],"spl_id":["acbbbee6-9f36-468f-8c0c-4f39b2071dbd"],"spl_set_id":["0f70c79a-92a4-4a38-bbdd-900adc4c2e93"],"package_ndc":["42806-716-11","42806-716-05"],"unii":["M6Q1EO9TD0"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"AMANTADINE HYDROCHLORIDE","active_ingredients":[{"name":"AMANTADINE HYDROCHLORIDE","strength":"100MG"}],"reference_standard":"No","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20211117","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA215037","sponsor_name":"ZYDUS PHARMS","openfda":{"application_number":["ANDA215037"],"brand_name":["NELARABINE"],"generic_name":["NELARABINE"],"manufacturer_name":["Zydus Lifesciences Limited","Zydus Pharmaceuticals USA Inc."],"product_ndc":["70771-1685","70710-1839","70710-1726"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["NELARABINE"],"rxcui":["603566"],"spl_id":["d96809f2-f942-4f6d-92b9-0a23ec84226d","28dca455-17e3-49d3-a2a1-7f50f70cca2d","814101e5-1b88-4f7f-a56a-0d41e0cb8dff"],"spl_set_id":["877b69a0-0899-455d-926e-f5a7478c31f8","8cb23281-93ca-40b8-b8e0-c57dd4298322","e425731e-626b-4141-a997-fb85e077c2a4"],"package_ndc":["70771-1685-1","70771-1685-8","70710-1839-1","70710-1839-8","70710-1726-1","70710-1726-8"],"nui":["N0000000233","N0000175595"],"pharm_class_moa":["Nucleic Acid Synthesis Inhibitors [MoA]"],"pharm_class_epc":["Nucleoside Metabolic Inhibitor [EPC]"],"unii":["60158CV180"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"NELARABINE","active_ingredients":[{"name":"NELARABINE","strength":"250MG/50ML (5MG/ML)"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INTRAVENOUS","marketing_status":"Prescription","te_code":"AP"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20061016","review_priority":"STANDARD","submission_class_code":"TYPE 3","submission_class_code_description":"Type 3 - New Dosage Form","application_docs":[{"id":"37959","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021963lbl.pdf","date":"20061018","type":"Label"},{"id":"42361","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021963TOC.cfm","date":"20080314","type":"Review"},{"id":"28929","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021963s000ltr.pdf","date":"20061023","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"20190530","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"58906","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021963s007lbl.pdf","date":"20190531","type":"Label"},{"id":"58961","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021963Orig1s007ltr.pdf","date":"20190604","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20080625","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"37960","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020872s018,021963s002lbl.pdf","date":"20080630","type":"Label"},{"id":"6547","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021963s002, 020872s018ltr.pdf","date":"20080630","type":"Letter"}]}],"application_number":"NDA021963","sponsor_name":"CHATTEM SANOFI","products":[{"product_number":"001","reference_drug":"Yes","brand_name":"ALLEGRA","active_ingredients":[{"name":"FEXOFENADINE HYDROCHLORIDE","strength":"30MG/5ML"}],"reference_standard":"No","dosage_form":"SUSPENSION","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"16","submission_status":"AP","submission_status_date":"20160720","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"14","submission_status":"AP","submission_status_date":"20141120","review_priority":"STANDARD","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"17250","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022331s014lbl.pdf","date":"20141216","type":"Label"},{"id":"29605","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/022331Orig1s014ltr.pdf","date":"20141121","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"20130212","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"7246","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022331Orig1s012ltr.pdf","date":"20130214","type":"Letter"},{"id":"17249","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022331s012lbl.pdf","date":"20130214","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20100928","review_priority":"STANDARD","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"17247","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022331s001s002lbl.pdf","date":"20101007","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"15","submission_status":"AP","submission_status_date":"20150605","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"38587","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022331s015lbl.pdf","date":"20150610","type":"Label"},{"id":"29606","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022331Orig1s015ltr.pdf","date":"20150610","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"21","submission_status":"AP","submission_status_date":"20200206","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"61838","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/022331Orig1s021ltr.pdf","date":"20200207","type":"Letter"},{"id":"61848","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022331s021lbl.pdf","date":"20200207","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"13","submission_status":"AP","submission_status_date":"20160816","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"45130","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/022331Orig1s013ltr.pdf","date":"20160816","type":"Letter"},{"id":"45195","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022331s013lbl.pdf","date":"20160816","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20100928","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"17248","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022331s005lbl.pdf","date":"20101007","type":"Label"},{"id":"29604","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022331s005ltr.pdf","date":"20101004","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20100928","review_priority":"STANDARD","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"48433","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022331Orig1s001.pdf","date":"20170517","type":"Review"},{"id":"29603","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022331s001,s002ltr.pdf","date":"20101004","type":"Letter"},{"id":"38586","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022331s001s002lbl.pdf","date":"20101007","type":"Label"}]},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20090929","review_priority":"STANDARD","submission_class_code":"TYPE 3","submission_class_code_description":"Type 3 - New Dosage Form","application_docs":[{"id":"38585","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022331lbl.pdf","date":"20091007","type":"Label"},{"id":"66952","url":"https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/22331-Clonidine-ClinPharm-PREA-1.pdf","date":"19000101","type":"Pediatric Medical Review"},{"id":"66953","url":"https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/22331-Clonidine-ClinPharm-PREA.pdf","date":"19000101","type":"Pediatric Clinical Pharmacology Review"},{"id":"66954","url":"https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/22331-Clonidine-Statistical-PREA.pdf","date":"19000101","type":"Pediatric Statistical Review"},{"id":"7245","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022331s000ltr.pdf","date":"20091007","type":"Letter"},{"id":"21995","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022331_jenloga_toc.cfm","date":"20091110","type":"Review"}]},{"submission_type":"SUPPL","submission_number":"18","submission_status":"AP","submission_status_date":"20160503","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"NDA022331","sponsor_name":"CONCORDIA PHARMS INC","products":[{"product_number":"003","reference_drug":"Yes","brand_name":"KAPVAY","active_ingredients":[{"name":"CLONIDINE HYDROCHLORIDE","strength":"0.1MG"}],"reference_standard":"No","dosage_form":"TABLET, EXTENDED RELEASE","route":"ORAL","marketing_status":"Discontinued","te_code":"AB1"},{"product_number":"001","reference_drug":"Yes","brand_name":"JENLOGA","active_ingredients":[{"name":"CLONIDINE HYDROCHLORIDE","strength":"0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"}],"reference_standard":"No","dosage_form":"TABLET, EXTENDED RELEASE","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"004","reference_drug":"Yes","brand_name":"KAPVAY","active_ingredients":[{"name":"CLONIDINE HYDROCHLORIDE","strength":"0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"}],"reference_standard":"No","dosage_form":"TABLET, EXTENDED RELEASE","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"002","reference_drug":"Yes","brand_name":"JENLOGA","active_ingredients":[{"name":"CLONIDINE HYDROCHLORIDE","strength":"0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"}],"reference_standard":"No","dosage_form":"TABLET, EXTENDED RELEASE","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20240620","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA217013","sponsor_name":"ASPIRO","products":[{"product_number":"001","reference_drug":"No","brand_name":"PROPOFOL","active_ingredients":[{"name":"PROPOFOL","strength":"10MG/ML"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20240430","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA217626","sponsor_name":"RK PHARMA","openfda":{"application_number":["ANDA217626"],"brand_name":["CUPRIC CHLORIDE"],"generic_name":["CUPRIC CHLORIDE"],"manufacturer_name":["Archis Pharma LLC","Northstar Rx LLC"],"product_ndc":["72819-234","72603-351"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CUPRIC CHLORIDE"],"rxcui":["204536"],"spl_id":["249680fd-f7e7-6e1a-e063-6394a90a87e7","23070470-7866-f913-e063-6394a90add5f","2472ecab-62ab-84e2-e063-6394a90a86c5"],"spl_set_id":["45586a5f-4864-4b01-9211-002c77585249","db988413-2998-4fc0-bcdf-11076256bf6e","77e9dd68-baed-4d62-9284-daecd995de2c"],"package_ndc":["72819-234-96","72819-234-99","72603-351-01","72603-351-25","72819-234-06","72819-234-16"],"unii":["S2QG84156O"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"CUPRIC CHLORIDE","active_ingredients":[{"name":"CUPRIC CHLORIDE","strength":"EQ 0.4MG COPPER/ML"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Prescription","te_code":"AP"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20240202","review_priority":"STANDARD","submission_class_code":"UNKNOWN"}],"application_number":"ANDA218306","sponsor_name":"MSN","openfda":{"application_number":["ANDA218306"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Novadoz Pharmaceuticals LLC"],"product_ndc":["72205-132","72205-133","72205-134","72205-135","72205-136","72205-137"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"],"spl_set_id":["a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"],"package_ndc":["72205-132-91","72205-133-91","72205-134-91","72205-135-91","72205-136-91","72205-137-91"],"unii":["SJT761GEGS"]},"products":[{"product_number":"006","reference_drug":"No","brand_name":"LISDEXAMFETAMINE DIMESYLATE","active_ingredients":[{"name":"LISDEXAMFETAMINE DIMESYLATE","strength":"60MG"}],"reference_standard":"No","dosage_form":"TABLET, CHEWABLE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"004","reference_drug":"No","brand_name":"LISDEXAMFETAMINE DIMESYLATE","active_ingredients":[{"name":"LISDEXAMFETAMINE DIMESYLATE","strength":"40MG"}],"reference_standard":"No","dosage_form":"TABLET, CHEWABLE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"002","reference_drug":"No","brand_name":"LISDEXAMFETAMINE DIMESYLATE","active_ingredients":[{"name":"LISDEXAMFETAMINE DIMESYLATE","strength":"20MG"}],"reference_standard":"No","dosage_form":"TABLET, CHEWABLE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"005","reference_drug":"No","brand_name":"LISDEXAMFETAMINE DIMESYLATE","active_ingredients":[{"name":"LISDEXAMFETAMINE DIMESYLATE","strength":"50MG"}],"reference_standard":"No","dosage_form":"TABLET, CHEWABLE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"003","reference_drug":"No","brand_name":"LISDEXAMFETAMINE DIMESYLATE","active_ingredients":[{"name":"LISDEXAMFETAMINE DIMESYLATE","strength":"30MG"}],"reference_standard":"No","dosage_form":"TABLET, CHEWABLE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"},{"product_number":"001","reference_drug":"No","brand_name":"LISDEXAMFETAMINE DIMESYLATE","active_ingredients":[{"name":"LISDEXAMFETAMINE DIMESYLATE","strength":"10MG"}],"reference_standard":"No","dosage_form":"TABLET, CHEWABLE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20191115","review_priority":"PRIORITY","submission_class_code":"TYPE 1","submission_class_code_description":"Type 1 - New Molecular Entity","submission_property_type":[{"code":"Orphan"}],"application_docs":[{"id":"60858","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761128s000lbl.pdf","date":"20191115","type":"Label"},{"id":"60957","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/761128Orig1s000ltr.pdf","date":"20191119","type":"Letter"},{"id":"61294","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/761128Orig1s000TOC.cfm","date":"20191217","type":"Review"}]},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20220908","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","submission_property_type":[{"code":"Orphan"}],"application_docs":[{"id":"72054","url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/761128Orig1s005ltr.pdf","date":"20220909","type":"Letter"},{"id":"72058","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761128s005lbl.pdf","date":"20220910","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20210712","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","submission_property_type":[{"code":"Orphan"}],"application_docs":[{"id":"68079","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/761128Orig1s001ltr.pdf","date":"20210714","type":"Letter"},{"id":"68086","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761128s001lbl.pdf","date":"20210714","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"20240626","review_priority":"STANDARD","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","submission_property_type":[{"code":"Orphan"}],"application_docs":[{"id":"78909","url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761128Orig1s006ltr.pdf","date":"20240628","type":"Letter"},{"id":"78972","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761128s006lbl.pdf","date":"20240702","type":"Label"}]}],"application_number":"BLA761128","sponsor_name":"NOVARTIS PHARMS CORP","openfda":{"application_number":["BLA761128"],"brand_name":["ADAKVEO"],"generic_name":["CRIZANLIZUMAB"],"manufacturer_name":["Novartis Pharmaceuticals Corporation"],"product_ndc":["0078-0883"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CRIZANLIZUMAB"],"rxcui":["2262425","2262430"],"spl_id":["3cc2e9ff-1775-41ab-aeee-03b5c0a682b5"],"spl_set_id":["b2b7f8b4-fe9a-4a86-8129-9e43f99a20c6"],"package_ndc":["0078-0883-61"],"nui":["N0000194032","N0000194031"],"pharm_class_epc":["Selectin Blocker [EPC]"],"pharm_class_moa":["P-Selectin Blockers [MoA]"],"unii":["L7451S9126"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"ADAKVEO","active_ingredients":[{"name":"CRIZANLIZUMAB-TMCA","strength":"100MG/10ML"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Prescription"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"30","submission_status":"AP","submission_status_date":"20101215","review_priority":"UNKNOWN","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"35640","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020918s030lbl.pdf","date":"20101222","type":"Label"},{"id":"3743","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020918s030ltr.pdf","date":"20101221","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"20041223","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)","application_docs":[{"id":"13733","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20918s012lbl.pdf","date":"20041229","type":"Label"},{"id":"3742","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20918s012ltr.pdf","date":"20041229","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"20040301","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"35638","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20918slr008_glucagen_lbl.pdf","date":"20040405","type":"Label"},{"id":"41811","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/020918_S008_GLUCAGEN.pdf","date":"20070720","type":"Review"},{"id":"26188","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20918slr008ltr.pdf","date":"20040302","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"49","submission_status":"AP","submission_status_date":"20180418","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"53737","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020918s049lbl.pdf","date":"20180419","type":"Label"},{"id":"53763","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/020918Orig1s049ltr.pdf","date":"20180420","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"47","submission_status":"AP","submission_status_date":"20160211","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"39","submission_status":"AP","submission_status_date":"20130426","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20020401","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"53","submission_status":"AP","submission_status_date":"20200903","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"64589","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/020918Orig1s053ltr.pdf","date":"20200917","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20000818","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"43","submission_status":"AP","submission_status_date":"20151210","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"3746","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020918Orig1s043ltr.pdf","date":"20151215","type":"Letter"},{"id":"13735","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020918s043lbl.pdf","date":"20151215","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"17","submission_status":"AP","submission_status_date":"20051114","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"26189","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020918s017ltr.pdf","date":"20051118","type":"Letter"},{"id":"35639","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020918s017lbl.pdf","date":"20051118","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"23","submission_status":"AP","submission_status_date":"20070628","review_priority":"N/A","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"56","submission_status":"AP","submission_status_date":"20210720","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"68144","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/020918Orig1s056ltr.pdf","date":"20210722","type":"Letter"},{"id":"68169","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020918s056lbl.pdf","date":"20210723","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20020805","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"54","submission_status":"AP","submission_status_date":"20210311","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"66761","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/020918Orig1s054ltr.pdf","date":"20210312","type":"Letter"},{"id":"66764","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020918Orig1s054lbl.pdf","date":"20210312","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20020711","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"41810","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020918_S003_GLUCAGEN.pdf","date":"20070720","type":"Review"},{"id":"3741","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20918slr003ltr.pdf","date":"20020711","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"38","submission_status":"AP","submission_status_date":"20130116","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"52","submission_status":"AP","submission_status_date":"20180706","review_priority":"901 REQUIRED","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"54866","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020918s052lbl.pdf","date":"20180709","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"44","submission_status":"AP","submission_status_date":"20151008","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20000530","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19980622","review_priority":"PRIORITY","submission_class_code":"TYPE 3","submission_class_code_description":"Type 3 - New Dosage Form","application_docs":[{"id":"41809","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020918s000_GlucagenTOC.cfm","date":"20050623","type":"Review"},{"id":"13732","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20918lbl.pdf","date":"19980622","type":"Label"},{"id":"26187","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20918_ltr.pdf","date":"19980622","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"42","submission_status":"AP","submission_status_date":"20140314","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"3745","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/020918Orig1s042ltr.pdf","date":"20140319","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"34","submission_status":"AP","submission_status_date":"20111229","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"13734","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020918s034lbl.pdf","date":"20120106","type":"Label"},{"id":"26190","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020918s034ltr.pdf","date":"20120117","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"40","submission_status":"AP","submission_status_date":"20130426","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"3744","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020918Orig1s040ltr.pdf","date":"20130430","type":"Letter"}]}],"application_number":"NDA020918","sponsor_name":"NOVO NORDISK","openfda":{"application_number":["NDA020918"],"brand_name":["GLUCAGEN HYPOKIT"],"generic_name":["GLUCAGON HYDROCHLORIDE"],"manufacturer_name":["Novo Nordisk"],"product_ndc":["0169-7065"],"product_type":["HUMAN PRESCRIPTION DRUG"],"rxcui":["153095","310497"],"spl_id":["d98fb620-f619-4ca0-a960-a61168993078"],"spl_set_id":["f09feb8e-6651-4708-a811-bb5264712059"],"package_ndc":["0169-7065-15","0169-7065-21"]},"products":[{"product_number":"001","reference_drug":"Yes","brand_name":"GLUCAGEN","active_ingredients":[{"name":"GLUCAGON HYDROCHLORIDE","strength":"EQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"}],"reference_standard":"No","dosage_form":"POWDER","route":"INTRAMUSCULAR, INTRAVENOUS","marketing_status":"Discontinued"},{"product_number":"002","reference_drug":"Yes","brand_name":"GLUCAGEN","active_ingredients":[{"name":"GLUCAGON HYDROCHLORIDE","strength":"EQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"}],"reference_standard":"No","dosage_form":"POWDER","route":"INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20060216","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"4780","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020592s027s032,021086s009s013,021253s004s012ltr.pdf","date":"20060222","type":"Letter"},{"id":"14753","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020592s027s032,021086s009s013,021253s004s012lbl.pdf","date":"20060222","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"33","submission_status":"AP","submission_status_date":"20080814","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"4786","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020592s049,021086s028,021253s033ltr.pdf","date":"20080819","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"15","submission_status":"AP","submission_status_date":"20050913","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"4783","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020592s034,021086s015,021253s015ltr.pdf","date":"20050915","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"21","submission_status":"AP","submission_status_date":"20061129","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"4785","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020592s038, 021086s020, 021253s021ltr.pdf","date":"20061228","type":"Letter"},{"id":"14757","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020592s038,021086s020,021253s021lbl.pdf","date":"20061204","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"58","submission_status":"AP","submission_status_date":"20170223","review_priority":"901 REQUIRED","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"47343","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020592s068s069,021086s044s045,021253s057s058lbl.pdf","date":"20170227","type":"Label"},{"id":"47380","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/020592Orig1s068,s069,021086Orig1s044,s045,021253Orig1s057,s058,022173Orig1s026,s028ltr.pdf","date":"20170302","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"56","submission_status":"AP","submission_status_date":"20161006","review_priority":"901 REQUIRED","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"45534","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020592Orig1s067,021086Orig1s043,021253Orig1s056,022173Orig1s025,021520Orig1s046ltr.pdf","date":"20161014","type":"Letter"},{"id":"45982","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020592s067,021086s043,021253s056lbl.pdf","date":"20161201","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"48","submission_status":"AP","submission_status_date":"20141219","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"4791","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/020592Orig1s062,021086Orig1s040,021253Orig1s048,022173s015,021520Origs034ltr.pdf","date":"20141223","type":"Letter"},{"id":"36473","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020592s062021086s040021253s048lbl.pdf","date":"20150109","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"62","submission_status":"AP","submission_status_date":"20200421","review_priority":"901 REQUIRED","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"62631","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/020592Orig1s075,021086Orig1s049,021253Orig1s062,022173Orig1s036,021520Orig1s053ltr.pdf","date":"20200422","type":"Letter"},{"id":"62638","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf","date":"20200422","type":"Label"},{"id":"62639","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37","date":"20200422","type":"Medication Guide"}]},{"submission_type":"SUPPL","submission_number":"60","submission_status":"AP","submission_status_date":"20191022","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"60637","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/020592Orig1s072, 021086Orig1s047, 021253Orig1s060, 022173Orig1s030ltr.pdf","date":"20191023","type":"Letter"},{"id":"60682","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020592s072,021086s047,021253s060lbl.pdf","date":"20191025","type":"Label"},{"id":"60683","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020592s072,021086s047,021253s060lbl.pdf#page=37","date":"20191025","type":"Medication Guide"}]},{"submission_type":"SUPPL","submission_number":"52","submission_status":"AP","submission_status_date":"20140811","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"44","submission_status":"AP","submission_status_date":"20140930","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"36","submission_status":"AP","submission_status_date":"20090831","review_priority":"UNKNOWN","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"4787","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020592s051,021086s030,021253s036ltr.pdf","date":"20091119","type":"Letter"},{"id":"14758","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020592s051,021086s030,021253s036lbl.pdf","date":"20090917","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"26","submission_status":"AP","submission_status_date":"20070706","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"36470","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020592s042s043,021086s022s023,021253s026lbl.pdf","date":"20070710","type":"Label"},{"id":"27225","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020592s042s043_021086s022s023_021253s026_ltr.pdf","date":"20070710","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"16","submission_status":"AP","submission_status_date":"20060223","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"4784","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021253s016,021086s016,020592s035ltr.pdf","date":"20060301","type":"Letter"},{"id":"14756","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021253s016,021086s016,020592s035lbl.pdf","date":"20060228","type":"Label"}]},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20040329","review_priority":"STANDARD","submission_class_code":"TYPE 3","submission_class_code_description":"Type 3 - New Dosage Form","application_docs":[{"id":"42056","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21253_Zyprexa.TOC.cfm","date":"20050713","type":"Review"},{"id":"23638","url":"http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm094303.htm","date":"20111222","type":"Other Important Information from FDA"},{"id":"27224","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21253ltr.pdf","date":"20040407","type":"Letter"},{"id":"36469","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21253_zyprexa_lbl.pdf","date":"20040405","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"59","submission_status":"AP","submission_status_date":"20180327","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"53474","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020592s071,021086s046,021253s059lbl.pdf","date":"20180328","type":"Label"},{"id":"53522","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/020592Orig1s071,021086Orig1s046,021253Orig1s059,022173Orig1s029ltr.pdf","date":"20180329","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"20060216","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"4782","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020592s027s032,021086s009s013,021253s004s012ltr.pdf","date":"20060222","type":"Letter"},{"id":"14755","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020592s027s032,021086s009s013,021253s004s012lbl.pdf","date":"20060222","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"57","submission_status":"AP","submission_status_date":"20170223","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"47342","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020592s068s069,021086s044s045,021253s057s058lbl.pdf","date":"20170227","type":"Label"},{"id":"47381","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/020592Orig1s068,s069,021086Orig1s044,s045,021253Orig1s057,s058,022173Orig1s026,s028ltr.pdf","date":"20170302","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"49","submission_status":"AP","submission_status_date":"20150723","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"36474","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020592s064,021086s042,021253s049lbl.pdf","date":"20150724","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"55","submission_status":"AP","submission_status_date":"20161027","review_priority":"N/A","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"61","submission_status":"AP","submission_status_date":"20200423","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"62666","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s074,021086s048,021253s061lbl.pdf","date":"20200424","type":"Label"},{"id":"62667","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s074,021086s048,021253s061lbl.pdf#page=37","date":"20200424","type":"Medication Guide"},{"id":"62678","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/020592Orig1s074, 021086Orig1s048, 021253Orig1s061, 022173Orig1s034ltr.pdf","date":"20200424","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"39","submission_status":"AP","submission_status_date":"20100527","review_priority":"UNKNOWN","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"27226","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020592s055,s053,021086s034,s032,021253s043,s039ltr.pdf","date":"20100603","type":"Letter"},{"id":"36471","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020592s053s055,021086s032s034,021253s039s043lbl.pdf","date":"20100603","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"45","submission_status":"AP","submission_status_date":"20101201","review_priority":"901 REQUIRED","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"4790","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020592s057,021086s036,021253s045ltr.pdf","date":"20101206","type":"Letter"},{"id":"36472","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020592s057,021086s036,021253s045lbl.pdf","date":"20101204","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"37","submission_status":"AP","submission_status_date":"20100127","review_priority":"UNKNOWN","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"4788","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020592s052,021086s031,021253s037ltr.pdf","date":"20100201","type":"Letter"},{"id":"14759","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020592s052,021086s031,021253s037lbl.pdf","date":"20100129","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"20060825","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"4781","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020592s029, 021086s011, 021253s006ltr.pdf","date":"20060918","type":"Letter"},{"id":"14754","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020592s029_021086s011_021253s006lbl.pdf","date":"20060829","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"43","submission_status":"AP","submission_status_date":"20100527","review_priority":"UNKNOWN","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"4789","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020592s055,s053,021086s034,s032,021253s043,s039ltr.pdf","date":"20100603","type":"Letter"},{"id":"14760","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020592s053s055,021086s032s034,021253s039s043lbl.pdf","date":"20100603","type":"Label"}]}],"application_number":"NDA021253","sponsor_name":"CHEPLAPHARM","openfda":{"application_number":["NDA021253"],"brand_name":["ZYPREXA INTRAMUSCULAR"],"generic_name":["OLANZAPINE"],"manufacturer_name":["Eli Lilly and Company","H2-Pharma LLC"],"product_ndc":["0002-7597","0002-4112","0002-4115","0002-4116","0002-4117","0002-4415","0002-4420","0002-4453","0002-4454","0002-4455","0002-4456","61269-640","61269-630","61269-631","61269-632","61269-633","61269-634","61269-635","61269-650","61269-651","61269-652","61269-653"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["OLANZAPINE"],"rxcui":["153046","153047","153048","200034","212405","261337","283639","284514","312076","312077","312078","312079","314154","314155","351107","351108","485968","545353","754503","754504","754505","754506"],"spl_id":["c5ba5946-0f0a-445b-b370-6b98a6dbf6a3","0862bfd3-af21-4d39-b301-15300f571a14"],"spl_set_id":["d5051fbc-846b-4946-82df-341fb1216341","b418946a-1ab4-4d89-a012-d94fc361a3c4"],"package_ndc":["0002-4112-30","0002-4115-30","0002-4116-30","0002-4117-30","0002-4415-30","0002-4420-30","0002-4453-01","0002-4453-85","0002-4454-01","0002-4454-85","0002-4455-01","0002-4455-85","0002-4456-01","0002-4456-85","0002-7597-01","61269-630-30","61269-631-30","61269-632-30","61269-633-30","61269-634-30","61269-635-30","61269-650-01","61269-650-35","61269-651-01","61269-651-35","61269-652-01","61269-652-35","61269-653-01","61269-653-35","61269-640-20"],"nui":["N0000175430"],"pharm_class_epc":["Atypical Antipsychotic [EPC]"],"unii":["N7U69T4SZR"]},"products":[{"product_number":"001","reference_drug":"Yes","brand_name":"ZYPREXA","active_ingredients":[{"name":"OLANZAPINE","strength":"10MG/VIAL"}],"reference_standard":"Yes","dosage_form":"INJECTABLE","route":"INTRAMUSCULAR","marketing_status":"Prescription","te_code":"AP"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"13","submission_status":"AP","submission_status_date":"20160229","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"20090715","review_priority":"N/A","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)","application_docs":[{"id":"15821","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021583s011lbl.pdf","date":"20090716","type":"Label"},{"id":"28175","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021583s011ltr.pdf","date":"20090717","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"20071005","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"5780","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021583s006ltr.pdf","date":"20071010","type":"Letter"},{"id":"15820","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021583s006lbl.pdf","date":"20071010","type":"Label"}]},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20041217","review_priority":"STANDARD","submission_class_code":"TYPE 3","submission_class_code_description":"Type 3 - New Dosage Form","application_docs":[{"id":"42218","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021583s000TOC.cfm","date":"20070509","type":"Review"},{"id":"15818","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021583lbl.pdf","date":"20041230","type":"Label"},{"id":"28173","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/021583ltr.pdf","date":"20041230","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"34","submission_status":"AP","submission_status_date":"20201204","review_priority":"STANDARD","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"65519","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021583Orig1s033, s034ltr.pdf","date":"20201208","type":"Letter"},{"id":"65577","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021583s033s034lbl.pdf","date":"20201211","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"26","submission_status":"AP","submission_status_date":"20150123","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"5782","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020246Orig1s054,021583Orig1s026ltr.pdf","date":"20150126","type":"Letter"},{"id":"15823","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020246s054,021583s026lbl.pdf","date":"20150129","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"40","submission_status":"AP","submission_status_date":"20240711","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"79063","url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/021583Orig1s040ltr.pdf","date":"20240715","type":"Letter"},{"id":"79082","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021583s040lbl.pdf","date":"20240715","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"32","submission_status":"AP","submission_status_date":"20161014","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"45557","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021583Orig1s032ltr.pdf","date":"20161019","type":"Letter"},{"id":"45621","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021583s032lbl.pdf","date":"20161017","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"24","submission_status":"AP","submission_status_date":"20191223","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"61453","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021583Orig1s016, s024, s029ltr.pdf","date":"20191226","type":"Letter"},{"id":"61488","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021583s016, s024, s029lbl.pdf","date":"20191231","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"16","submission_status":"AP","submission_status_date":"20191223","review_priority":"UNKNOWN","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"61452","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021583Orig1s016, s024, s029ltr.pdf","date":"20191226","type":"Letter"},{"id":"61489","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021583s016, s024, s029lbl.pdf","date":"20191231","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20051108","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"5779","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021583s003ltr.pdf","date":"20051118","type":"Letter"},{"id":"15819","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021583s003lbl.pdf","date":"20051116","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20050502","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"28174","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021583s001ltr.pdf","date":"20050504","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"29","submission_status":"AP","submission_status_date":"20191223","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"61454","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021583Orig1s016, s024, s029ltr.pdf","date":"20191226","type":"Letter"},{"id":"61487","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021583s016, s024, s029lbl.pdf","date":"20191231","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"27","submission_status":"AP","submission_status_date":"20160804","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"33","submission_status":"AP","submission_status_date":"20201204","review_priority":"STANDARD","submission_class_code":"EFFICACY","submission_class_code_description":"Efficacy","application_docs":[{"id":"65518","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021583Orig1s033, s034ltr.pdf","date":"20201208","type":"Letter"},{"id":"65578","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021583s033s034lbl.pdf","date":"20201211","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"25","submission_status":"AP","submission_status_date":"20150130","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"5781","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021583Orig1s025ltr.pdf","date":"20150202","type":"Letter"},{"id":"15822","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021583s025lbl.pdf","date":"20150203","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"17","submission_status":"AP","submission_status_date":"20180301","review_priority":"UNKNOWN","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"52790","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021583s17ltr.pdf","date":"20180302","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"31","submission_status":"AP","submission_status_date":"20161216","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"46288","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021583s031lbl.pdf","date":"20161220","type":"Label"},{"id":"46471","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021583Orig1s031ltr.pdf","date":"20161222","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"23","submission_status":"AP","submission_status_date":"20170131","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"47082","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021583Orig1s023ltr.pdf","date":"20170201","type":"Letter"},{"id":"47088","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021583s023lbl.pdf","date":"20170201","type":"Label"}]}],"application_number":"NDA021583","sponsor_name":"PFIZER","openfda":{"application_number":["NDA021583"],"brand_name":["DEPO-SUBQ PROVERA"],"generic_name":["MEDROXYPROGESTERONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-4709"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["MEDROXYPROGESTERONE ACETATE"],"rxcui":["1000156","1000158"],"spl_id":["d928273f-521e-4d04-8968-fa3016f3d23c"],"spl_set_id":["390087a6-f3c3-4f0b-a930-79acf412f153"],"package_ndc":["0009-4709-13"],"unii":["C2QI4IOI2G"]},"products":[{"product_number":"001","reference_drug":"Yes","brand_name":"DEPO-SUBQ PROVERA 104","active_ingredients":[{"name":"MEDROXYPROGESTERONE ACETATE","strength":"104MG/0.65ML"}],"reference_standard":"Yes","dosage_form":"INJECTABLE","route":"SUBCUTANEOUS","marketing_status":"Prescription"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20150813","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20120904","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20090723"}],"application_number":"ANDA065149","sponsor_name":"HQ SPECLT PHARMA","openfda":{"application_number":["ANDA065149"],"brand_name":["PENICILLIN G POTASSIUM"],"generic_name":["PENICILLIN G POTASSIUM"],"manufacturer_name":["WG Critical Care, LLC"],"product_ndc":["44567-310","44567-311","44567-312"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["PENICILLIN G POTASSIUM"],"rxcui":["863538"],"spl_id":["0e0fed39-36b5-410c-9e3c-f1bed1b2ddb0"],"spl_set_id":["e0ced9d8-b9ea-466e-bf2c-10e9cc636f3f"],"package_ndc":["44567-310-10","44567-311-10","44567-312-01","44567-312-10"],"unii":["VL775ZTH4C"]},"products":[{"product_number":"003","reference_drug":"No","brand_name":"PENICILLIN G POTASSIUM","active_ingredients":[{"name":"PENICILLIN G POTASSIUM","strength":"20,000,000 UNITS/VIAL"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Prescription","te_code":"AP"},{"product_number":"001","reference_drug":"No","brand_name":"PENICILLIN G POTASSIUM","active_ingredients":[{"name":"PENICILLIN G POTASSIUM","strength":"1,000,000 UNITS/VIAL"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Prescription"},{"product_number":"002","reference_drug":"No","brand_name":"PENICILLIN G POTASSIUM","active_ingredients":[{"name":"PENICILLIN G POTASSIUM","strength":"5,000,000 UNITS/VIAL"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Prescription","te_code":"AP"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"39","submission_status":"AP","submission_status_date":"19920805","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"37","submission_status":"AP","submission_status_date":"19891011","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"29","submission_status":"AP","submission_status_date":"19830422","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"35","submission_status":"AP","submission_status_date":"19861104","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"27","submission_status":"AP","submission_status_date":"19800404","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"41","submission_status":"AP","submission_status_date":"19960621","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"33","submission_status":"AP","submission_status_date":"19861104","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"25","submission_status":"AP","submission_status_date":"19790801","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"31","submission_status":"AP","submission_status_date":"19840516","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"23","submission_status":"AP","submission_status_date":"19781030","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19620330","review_priority":"STANDARD","submission_class_code":"TYPE 3","submission_class_code_description":"Type 3 - New Dosage Form"},{"submission_type":"SUPPL","submission_number":"38","submission_status":"AP","submission_status_date":"19921016","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"36","submission_status":"AP","submission_status_date":"19861104","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"28","submission_status":"AP","submission_status_date":"19810504","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"34","submission_status":"AP","submission_status_date":"19860507","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"26","submission_status":"AP","submission_status_date":"19800404","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"32","submission_status":"AP","submission_status_date":"19851001","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"24","submission_status":"AP","submission_status_date":"19790529","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"30","submission_status":"AP","submission_status_date":"19840430","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"NDA013220","sponsor_name":"MERCK","products":[{"product_number":"002","reference_drug":"Yes","brand_name":"PERIACTIN","active_ingredients":[{"name":"CYPROHEPTADINE HYDROCHLORIDE","strength":"2MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"}],"reference_standard":"No","dosage_form":"SYRUP","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"19920422","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"19870909","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19851118"},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"19911011","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"19880610","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"19870909","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"ANDA070187","sponsor_name":"IVAX SUB TEVA PHARMS","products":[{"product_number":"001","reference_drug":"No","brand_name":"DISOPYRAMIDE PHOSPHATE","active_ingredients":[{"name":"DISOPYRAMIDE PHOSPHATE","strength":"EQ 150MG BASE"}],"reference_standard":"No","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"10","submission_status":"AP","submission_status_date":"19900309","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"19890908","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"19901009","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"19900108","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19860707"},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"19910516","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA070518","sponsor_name":"ROXANE","products":[{"product_number":"001","reference_drug":"No","brand_name":"PROPRANOLOL HYDROCHLORIDE","active_ingredients":[{"name":"PROPRANOLOL HYDROCHLORIDE","strength":"40MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20020327","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19960304"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"19980821","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"19970708","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20000321","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"ANDA040122","sponsor_name":"WATSON LABS","products":[{"product_number":"001","reference_drug":"No","brand_name":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","active_ingredients":[{"name":"ACETAMINOPHEN","strength":"500MG"},{"name":"HYDROCODONE BITARTRATE","strength":"5MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"002","reference_drug":"No","brand_name":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","active_ingredients":[{"name":"ACETAMINOPHEN","strength":"750MG"},{"name":"HYDROCODONE BITARTRATE","strength":"7.5MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20030121"}],"application_number":"ANDA040425","sponsor_name":"BARR","openfda":{"application_number":["ANDA040425"],"brand_name":["FLUDROCORTISONE ACETATE"],"generic_name":["FLUDROCORTISONE ACETATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0555-0997"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FLUDROCORTISONE ACETATE"],"rxcui":["313979"],"spl_id":["ff82c388-18e1-44f6-af03-f52337219dc7"],"spl_set_id":["f5cffa20-9a22-43c5-9e89-3225852c2dfa"],"package_ndc":["0555-0997-02"],"unii":["V47IF0PVH4"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"FLUDROCORTISONE ACETATE","active_ingredients":[{"name":"FLUDROCORTISONE ACETATE","strength":"0.1MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20090129","application_docs":[{"id":"22152","url":"http://www.accessdata.fda.gov/drugsatfda_docs/anda/2009/040719Orig1s000.pdf","date":"20130510","type":"Review"}]},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20140421","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA040719","sponsor_name":"SANDOZ","products":[{"product_number":"001","reference_drug":"No","brand_name":"METHYLPREDNISOLONE ACETATE","active_ingredients":[{"name":"METHYLPREDNISOLONE ACETATE","strength":"40MG/ML"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Prescription","te_code":"AB"},{"product_number":"002","reference_drug":"No","brand_name":"METHYLPREDNISOLONE ACETATE","active_ingredients":[{"name":"METHYLPREDNISOLONE ACETATE","strength":"80MG/ML"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Prescription","te_code":"AB"}]},{"application_number":"ANDA061588","sponsor_name":"PUREPAC PHARM","products":[{"product_number":"003","reference_drug":"No","brand_name":"PENICILLIN G POTASSIUM","active_ingredients":[{"name":"PENICILLIN G POTASSIUM","strength":"400,000 UNITS"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"001","reference_drug":"No","brand_name":"PENICILLIN G POTASSIUM","active_ingredients":[{"name":"PENICILLIN G POTASSIUM","strength":"200,000 UNITS"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"002","reference_drug":"No","brand_name":"PENICILLIN G POTASSIUM","active_ingredients":[{"name":"PENICILLIN G POTASSIUM","strength":"250,000 UNITS"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"19950724","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19710602"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"19960911","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"19970117","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"19960307","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"NDA050341","sponsor_name":"BRISTOL MYERS SQUIBB","products":[{"product_number":"003","reference_drug":"No","brand_name":"FUNGIZONE","active_ingredients":[{"name":"AMPHOTERICIN B","strength":"100MG/ML"}],"reference_standard":"No","dosage_form":"SUSPENSION","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"20080328","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"18207","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050760s11,050761s11,050754s12,050542s25lbl.pdf","date":"20080401","type":"Label"},{"id":"30500","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/050760s011, 050761s011,050754s012, 050542s025ltr.pdf","date":"20080402","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"20021204","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"20020425","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19990415","review_priority":"STANDARD","submission_class_code":"TYPE 3","submission_class_code_description":"Type 3 - New Dosage Form","application_docs":[{"id":"42726","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/050761_s000_AmoxilTOC.cfm","date":"20050802","type":"Review"},{"id":"8234","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/50761ltr.pdf","date":"20040527","type":"Letter"},{"id":"39299","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/50761lbl.pdf","date":"20040527","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20010417","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"18","submission_status":"AP","submission_status_date":"20221102","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"72564","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050542Orig1s031,050754Orig1s021,050760Orig1s021,050761Orig1s018lbl.pdf","date":"20221104","type":"Label"},{"id":"72566","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050542s031,050754s021,050760s021,050761s018lbl.pdf","date":"20221104","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"16","submission_status":"AP","submission_status_date":"20150924","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"8242","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/050542Origs029,050754Orig1s019,050760Orig1s019,050761Orig1s016ltr.pdf","date":"20150928","type":"Letter"},{"id":"18211","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/50542s02950754s01950760s01950761s016lbl.pdf","date":"20150929","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"20060126","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"8238","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/050761s009_050760s009ltr.pdf","date":"20060130","type":"Letter"},{"id":"18206","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050761s009_050760s009lbl.pdf","date":"20060127","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"20111116","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"8239","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/050542s026,s027,s028,050754s013,s014,s017,050760s012,s013,s015,050761s012,s013,s015ltr.pdf","date":"20111121","type":"Letter"},{"id":"18208","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/050542s026s027s028,050754s013s014s017,050760s012s013s015,050761s012s013s015lbl.pdf","date":"20111121","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"20031218","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"8236","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/50542slr021,50760slr007,50754slr008,50761slr007ltr.pdf","date":"20031222","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"10","submission_status":"AP","submission_status_date":"20080609","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"39300","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050542s24,050754s11,050760s10,050761s10lbl.pdf","date":"20080612","type":"Label"},{"id":"30499","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/050542s024, 050754s011, 050760s010, 050761s010ltr.pdf","date":"20080613","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20020501","review_priority":"STANDARD","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20030512","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"8235","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/50542slr019,50754slr004,50760slr003,50761slr003ltr.pdf","date":"20030608","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"20000516","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"42727","url":"http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/50-542s017_50-754s002_50-760s001_50-761s001_Amoxil.cfm","date":"20040909","type":"Review"}]},{"submission_type":"SUPPL","submission_number":"19","submission_status":"AP","submission_status_date":"20240501","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"78350","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/050542s032,050754s022,050760s023,050761s019lbl.pdf","date":"20240502","type":"Label"},{"id":"78362","url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/050542Orig1s032, 050754Orig1s022, 050760Orig1s023, 050761Orig1s019ltr.pdf","date":"20240502","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"17","submission_status":"AP","submission_status_date":"20151203","submission_public_notes":"Please see \u003Ca href=\"https://www.fda.gov/STIC/\">www.fda.gov/STIC\u003C/a> for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"18212","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050542s030,050754s020,050760s020,050761s017lbl.pdf","date":"20151208","type":"Label"},{"id":"30501","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/050542Orig1s030,050754Orig1s020,050760Orig1s020,050761Orig1s017ltr.pdf","date":"20151208","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"15","submission_status":"AP","submission_status_date":"20111116","review_priority":"UNKNOWN","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"8241","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/050542s026,s027,s028,050754s013,s014,s017,050760s012,s013,s015,050761s012,s013,s015ltr.pdf","date":"20111121","type":"Letter"},{"id":"18210","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/050542s026s027s028,050754s013s014s017,050760s012s013s015,050761s012s013s015lbl.pdf","date":"20111121","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"13","submission_status":"AP","submission_status_date":"20111116","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"8240","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/050542s026,s027,s028,050754s013,s014,s017,050760s012,s013,s015,050761s012,s013,s015ltr.pdf","date":"20111121","type":"Letter"},{"id":"18209","url":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/050542s026s027s028,050754s013s014s017,050760s012s013s015,050761s012s013s015lbl.pdf","date":"20111121","type":"Label"}]},{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"20040713","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"8237","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50542s022,50754s009,50760s008,50761s008rltr.pdf","date":"20040721","type":"Letter"}]}],"application_number":"NDA050761","sponsor_name":"US ANTIBIOTICS","products":[{"product_number":"002","reference_drug":"No","brand_name":"AMOXIL","active_ingredients":[{"name":"AMOXICILLIN","strength":"400MG"}],"reference_standard":"No","dosage_form":"TABLET, CHEWABLE","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"001","reference_drug":"No","brand_name":"AMOXIL","active_ingredients":[{"name":"AMOXICILLIN","strength":"200MG"}],"reference_standard":"No","dosage_form":"TABLET, CHEWABLE","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"19","submission_status":"AP","submission_status_date":"20141110","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"20020715","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"19930408","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"19920910","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"18","submission_status":"AP","submission_status_date":"20160801","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19820825"},{"submission_type":"SUPPL","submission_number":"20","submission_status":"AP","submission_status_date":"20160801","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"20021205","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"19921215","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"19881123","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"ANDA062365","sponsor_name":"FRESENIUS KABI USA","openfda":{"application_number":["ANDA062365"],"brand_name":["CHLORAMPHENICOL SODIUM SUCCINATE"],"generic_name":["CHLORAMPHENICOL SODIUM SUCCINATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-011"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CHLORAMPHENICOL SODIUM SUCCINATE"],"rxcui":["239200"],"spl_id":["f0af962d-5024-47cf-b7a0-da9b5ff3c994"],"spl_set_id":["aed29594-211d-49ef-813f-131975a8d0e3"],"package_ndc":["63323-011-15"],"unii":["872109HX6B"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"CHLORAMPHENICOL SODIUM SUCCINATE","active_ingredients":[{"name":"CHLORAMPHENICOL SODIUM SUCCINATE","strength":"EQ 1GM BASE/VIAL"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"20090706","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19861222"},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"20040317","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"19980420","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"14","submission_status":"AP","submission_status_date":"20220310","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"12","submission_status":"AP","submission_status_date":"20220310","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"10","submission_status":"AP","submission_status_date":"20090928","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA062746","sponsor_name":"AZURITY","openfda":{"application_number":["ANDA062746"],"brand_name":["ERYTHROMYCIN"],"generic_name":["ERYTHROMYCIN"],"manufacturer_name":["Arbor Pharmaceuticals, Inc."],"product_ndc":["24338-120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["ERYTHROMYCIN"],"rxcui":["310154"],"spl_id":["6f949818-8773-4dfd-96bd-a0d67ffc92c0"],"spl_set_id":["ddd9ad9a-fc60-409a-a2b3-be51482ef751"],"package_ndc":["24338-120-13"],"nui":["N0000009982","N0000175877","N0000175935","M0028311"],"pharm_class_pe":["Decreased Sebaceous Gland Activity [PE]"],"pharm_class_epc":["Macrolide [EPC]","Macrolide Antimicrobial [EPC]"],"pharm_class_cs":["Macrolides [CS]"],"unii":["63937KV33D"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"ERYTHROMYCIN","active_ingredients":[{"name":"ERYTHROMYCIN","strength":"250MG"}],"reference_standard":"No","dosage_form":"CAPSULE, DELAYED REL PELLETS","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"80","submission_status":"AP","submission_status_date":"19890728","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"58","submission_status":"AP","submission_status_date":"19810302","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"72","submission_status":"AP","submission_status_date":"19850920","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"64","submission_status":"AP","submission_status_date":"19830503","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"56","submission_status":"AP","submission_status_date":"19810302","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"70","submission_status":"AP","submission_status_date":"19840815","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"62","submission_status":"AP","submission_status_date":"19810625","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"54","submission_status":"AP","submission_status_date":"19800304","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"46","submission_status":"AP","submission_status_date":"19780125","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"60","submission_status":"AP","submission_status_date":"19800903","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"38","submission_status":"AP","submission_status_date":"19750918","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"52","submission_status":"AP","submission_status_date":"19791106","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"44","submission_status":"AP","submission_status_date":"19770301","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"36","submission_status":"AP","submission_status_date":"19750917","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"50","submission_status":"AP","submission_status_date":"19810302","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"89","submission_status":"AP","submission_status_date":"19981224","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"42","submission_status":"AP","submission_status_date":"19760917","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"87","submission_status":"AP","submission_status_date":"19961230","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"79","submission_status":"AP","submission_status_date":"19910624","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"93","submission_status":"AP","submission_status_date":"20030729","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"12031","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/12703slr093,12704slr046ltr.pdf","date":"20030806","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"32","submission_status":"AP","submission_status_date":"19810309","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"85","submission_status":"AP","submission_status_date":"19950713","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"77","submission_status":"AP","submission_status_date":"19881212","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"91","submission_status":"AP","submission_status_date":"20010122","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"69","submission_status":"AP","submission_status_date":"19840307","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"83","submission_status":"AP","submission_status_date":"19940601","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"75","submission_status":"AP","submission_status_date":"19880226","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"67","submission_status":"AP","submission_status_date":"19830526","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"81","submission_status":"AP","submission_status_date":"19910624","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19610407","review_priority":"PRIORITY","submission_class_code":"TYPE 1","submission_class_code_description":"Type 1 - New Molecular Entity","application_docs":[{"id":"44001","url":"http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/UCM096273","date":"20070509","type":"Other Important Information from FDA"}]},{"submission_type":"SUPPL","submission_number":"59","submission_status":"AP","submission_status_date":"19800623","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"73","submission_status":"AP","submission_status_date":"19860710","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"65","submission_status":"AP","submission_status_date":"19840521","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"57","submission_status":"AP","submission_status_date":"19810904","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"71","submission_status":"AP","submission_status_date":"19840913","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"49","submission_status":"AP","submission_status_date":"19800129","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"61","submission_status":"AP","submission_status_date":"19810323","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"39","submission_status":"AP","submission_status_date":"19761028","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"53","submission_status":"AP","submission_status_date":"19800129","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"37","submission_status":"AP","submission_status_date":"19750918","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"43","submission_status":"AP","submission_status_date":"19760802","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"35","submission_status":"AP","submission_status_date":"19750917","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"88","submission_status":"AP","submission_status_date":"20000405","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"41","submission_status":"AP","submission_status_date":"19760802","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"86","submission_status":"AP","submission_status_date":"20000405","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"78","submission_status":"AP","submission_status_date":"19880408","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"92","submission_status":"AP","submission_status_date":"20010327","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling","application_docs":[{"id":"339","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/12704S45LTR.PDF","date":"20010327","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"84","submission_status":"AP","submission_status_date":"20000405","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"76","submission_status":"AP","submission_status_date":"19910624","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"90","submission_status":"AP","submission_status_date":"20000405","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"68","submission_status":"AP","submission_status_date":"19830315","review_priority":"PRIORITY","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"82","submission_status":"AP","submission_status_date":"19940601","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"74","submission_status":"AP","submission_status_date":"19860402","review_priority":"PRIORITY","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"NDA012703","sponsor_name":"ASTRAZENECA","products":[{"product_number":"005","reference_drug":"Yes","brand_name":"ELAVIL","active_ingredients":[{"name":"AMITRIPTYLINE HYDROCHLORIDE","strength":"75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"003","reference_drug":"Yes","brand_name":"ELAVIL","active_ingredients":[{"name":"AMITRIPTYLINE HYDROCHLORIDE","strength":"25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"001","reference_drug":"Yes","brand_name":"ELAVIL","active_ingredients":[{"name":"AMITRIPTYLINE HYDROCHLORIDE","strength":"10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"006","reference_drug":"Yes","brand_name":"ELAVIL","active_ingredients":[{"name":"AMITRIPTYLINE HYDROCHLORIDE","strength":"100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"004","reference_drug":"Yes","brand_name":"ELAVIL","active_ingredients":[{"name":"AMITRIPTYLINE HYDROCHLORIDE","strength":"50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"007","reference_drug":"Yes","brand_name":"ELAVIL","active_ingredients":[{"name":"AMITRIPTYLINE HYDROCHLORIDE","strength":"150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19981130","application_docs":[{"id":"8629","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/75352ltr.pdf","date":"19981130","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"20060411","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA075352","sponsor_name":"NOVITIUM PHARMA","openfda":{"application_number":["ANDA075352"],"brand_name":["SELEGILINE HYDROCHLORIDE"],"generic_name":["SELEGILINE HYDROCHLORIDE"],"manufacturer_name":["Novitium Pharma LLC"],"product_ndc":["70954-504"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["SELEGILINE HYDROCHLORIDE"],"rxcui":["859186"],"spl_id":["e42d99b0-c62e-49d4-b792-1301bb539b92"],"spl_set_id":["e42d99b0-c62e-49d4-b792-1301bb539b92"],"package_ndc":["70954-504-10","70954-504-20"],"unii":["6W731X367Q"]},"products":[{"product_number":"001","reference_drug":"No","brand_name":"SELEGILINE HYDROCHLORIDE","active_ingredients":[{"name":"SELEGILINE HYDROCHLORIDE","strength":"5MG"}],"reference_standard":"No","dosage_form":"CAPSULE","route":"ORAL","marketing_status":"Prescription","te_code":"AB"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"20210304","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"20030505","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20011212"},{"submission_type":"SUPPL","submission_number":"10","submission_status":"AP","submission_status_date":"20210304","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"20210304","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA075639","sponsor_name":"SUN PHARM INDUSTRIES","products":[{"product_number":"001","reference_drug":"No","brand_name":"FAMOTIDINE","active_ingredients":[{"name":"FAMOTIDINE","strength":"40MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"},{"product_number":"002","reference_drug":"No","brand_name":"FAMOTIDINE","active_ingredients":[{"name":"FAMOTIDINE","strength":"20MG"}],"reference_standard":"No","dosage_form":"TABLET","route":"ORAL","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"20040609","application_docs":[{"id":"8834","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/75928ltr.pdf","date":"20040610","type":"Letter"},{"id":"31047","url":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/75928.ta.pdf","date":"20030410","type":"Letter"}]},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"20050422","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"15","submission_status":"AP","submission_status_date":"20110525","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"ANDA075928","sponsor_name":"RUBICON","products":[{"product_number":"001","reference_drug":"No","brand_name":"CIPROFLOXACIN HYDROCHLORIDE","active_ingredients":[{"name":"CIPROFLOXACIN HYDROCHLORIDE","strength":"EQ 0.3% BASE"}],"reference_standard":"No","dosage_form":"SOLUTION/DROPS","route":"OPHTHALMIC","marketing_status":"Prescription","te_code":"AT"}]},{"submissions":[{"submission_type":"SUPPL","submission_number":"9","submission_status":"AP","submission_status_date":"19980109","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"7","submission_status":"AP","submission_status_date":"19960228","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"5","submission_status":"AP","submission_status_date":"19921027","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"3","submission_status":"AP","submission_status_date":"19890630","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"19890630","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"10","submission_status":"AP","submission_status_date":"19971107","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"17","submission_status":"AP","submission_status_date":"20210621","review_priority":"STANDARD","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"8","submission_status":"AP","submission_status_date":"19960924","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19870211"},{"submission_type":"SUPPL","submission_number":"6","submission_status":"AP","submission_status_date":"19930630","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"},{"submission_type":"SUPPL","submission_number":"4","submission_status":"AP","submission_status_date":"19920826","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"11","submission_status":"AP","submission_status_date":"20011107","submission_class_code":"LABELING","submission_class_code_description":"Labeling"},{"submission_type":"SUPPL","submission_number":"2","submission_status":"AP","submission_status_date":"19920205","submission_class_code":"MANUF (CMC)","submission_class_code_description":"Manufacturing (CMC)"}],"application_number":"ANDA070820","sponsor_name":"AM REGENT","products":[{"product_number":"001","reference_drug":"No","brand_name":"DOPAMINE HYDROCHLORIDE","active_ingredients":[{"name":"DOPAMINE HYDROCHLORIDE","strength":"80MG/ML"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Discontinued"}]},{"submissions":[{"submission_type":"ORIG","submission_number":"1","submission_status":"AP","submission_status_date":"19900228"},{"submission_type":"SUPPL","submission_number":"1","submission_status":"AP","submission_status_date":"19921118","submission_class_code":"LABELING","submission_class_code_description":"Labeling"}],"application_number":"ANDA071159","sponsor_name":"SANOFI AVENTIS US","products":[{"product_number":"001","reference_drug":"No","brand_name":"NITRO-BID","active_ingredients":[{"name":"NITROGLYCERIN","strength":"10MG/ML"}],"reference_standard":"No","dosage_form":"INJECTABLE","route":"INJECTION","marketing_status":"Discontinued"}]}]},"h":{},"s":200,"st":"OK","u":"https://api.fda.gov/drug/drugsfda.json?limit=100","rt":"json"},"__nghData__":[{"t":{"5":"t4"},"c":{"5":[{"i":"t4","r":1,"x":8}]}},{"t":{"7":"t0","8":"t1","9":"t2","10":"t3","11":"t5","12":"t6","13":"t7"},"c":{"7":[{"i":"t0","r":1}],"8":[],"9":[],"10":[{"i":"t3","r":1}],"11":[],"12":[],"13":[]}},{}]}</script></body></html>
